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Flavonoids form a vast group of natural products that occur ubiquitously 
throughout the plant kingdom.  These compounds play a significant role in the 
field of phytochemistry and are of nutritional interest due to numerous reports of 
their benefits to human health.  Structural characterization of individual flavonoid 
derivatives is challenging because of widespread isomerism and a lack of 
sensitive and specific analytical techniques.  The goal of this work is to present 
practical tandem mass spectrometry methods for systematic isomer differentiation 
of flavonoid glycosides and flavonoid glucuronides. 
Metal complexation is used extensively as a strategy to achieve this aim.  
In this approach, flavonoid derivatives and metal ions are mixed in solution, 
vi 
resulting in the rapid self-assembly of complexes which are subsequently infused 
into a quadrupole ion trap mass spectrometer.  Collision-induced dissociation of 
these flavonoid/metal complexes results in fragment ions that are highly 
characteristic of specific structural features of the flavonoid derivatives.  These 
methods are adaptable to LC-MS analysis via post-column addition of the 
complexation reagents. 
Methods to differentiate the five most common glycosylation sites of 
monoglucosyl flavonoids are described.  Based on the fragment ions yielded from 
magnesium or manganese complexes, specific indicators of 3-O-glucosylation, 7-
O-glucosylation, 4′-O-glucosylation, 6-C-glucosylation and 8-C-glucosylation are 
observed.  The manganese complexation method also differentiates isomeric 
glucose and galactose sugars at the 3 position, as well as arabinose and xylose 
sugars.  Differentiation of isomeric flavonoid glucuronide metabolites is achieved 
by cobalt complexation with auxiliary ligands. 
The effectiveness of these methods is proven in numerous practical 
applications.  Flavonoid glycosides are identified in extracts from apples, onions, 
and Silphium albiflorum.  Flavonoid glucuronide metabolites are identified in 
urine samples and a cell culture extract.  The identifications are achieved without 
the use of standards or additional analytical techniques.  Finally, an enzymatic 
synthesis of flavonoid glucuronides is used to establish the regioselectivity of 
UGT1A1, an enzyme involved in flavonoid metabolism.  The cobalt 
vii 
complexation method successfully identifies many hitherto uncharacterized 
metabolites.  The significance of this work lies in its potential application to 
problems in botanical, agricultural, nutritional and disease-prevention studies in 
which precise flavonoid identification is required. 
viii 
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Chapter 1: Introduction 
 
1.1 FLAVONOIDS: OCCURRENCE AND SIGNIFICANCE 
Flavonoids form a vast group of natural products comprising thousands of 
individual members.  The Handbook of Natural Flavonoids1 lists 6467 known  
naturally-occurring members of the flavonoid family, a number that has surely 
grown since the handbook’s compilation in 1999.  Flavonoids are found 
universally throughout higher plants, as well as in many lower plants such as 
mosses and liverworts.1  Plants use them for various purposes, including 
protection from solar radiation in the ultraviolet wavelengths, internal regulators, 
chemical messengers, and defense against insect herbavores.2  Some flavonoids 
(the anthocyanidins) are very brightly colored, and are responsible for most red, 
blue and violet colors of fruit and flowers.2  Although flavonoids are ubiquitous 
throughout the plant kingdom, each plant species tends to produce a characteristic 
array of flavonoids, with closely-related species producing similar compounds.  
For example, 8-hydroxy derivatives of the flavonoids apigenin and luteolin are 
found mainly in the Lamiaceae (mint) family.2  The correlation between genetic 
relationships and flavonoid occurrence has made flavonoid analysis an important 
tool in the study of plant chemotaxonomy (the classification of species based on 
chemical composition). 
2 
As flavonoids are present in nearly all plant tissue, they make up an 
integral part of the human diet.  However, there is disagreement over the amount 
of dietary exposure to these compounds.  A 1976 report by Kuhnau estimated the 
mean flavonoid intake of Americans at approximately 1 g/day,3 but this value has 
since been judged far too high.  More recent studies done in 19954 and 20025 
estimated American flavonoid intake at 12.9 mg/day and 20-22 mg/day, 
respectively.  But a 2007 study revised these values up to 189.7 mg/day.6  The 
inconsistency of these estimates can be attributed to different subsets of 
flavonoids quantified, different quantification methods, and a lack of thorough 
knowledge regarding the flavonoid content of different food items.  These 
problems underscore the importance of developing comprehensive and reliable 
methods for analyzing the flavonoid content of foodstuffs.  
Flavonoids have generated much interest from nutritionists and 
biochemists in the past decade or so due to their purported role in disease 
prevention, particularly of cardiovascular disease and cancer.7-19  However, the 
evidence for such health benefits is inconsistent and controversial.  In 2005, Arts 
and Hollman conducted a meta-analysis of published epidemiological studies 
tracking flavonoid intake and incidence of disease.20  Seven12,21-26 out of 
twelve12,21-31 cohort studies for coronary artery disease reported a correlation 
between flavonoid intake and reduced incidence of disease; however one of these 
studies showed significant risk reduction only for men, not for women.22  Another 
3 
study reported significant effects only in men with previous incidence of coronary 
artery disease.29 Conversely, one study reported a positive correlation between 
flavonoid intake and coronary heart disease.30  Only two31,32 out of five23,24,31-33 
epidemiological studies found a decreased risk of stroke due to flavonoid intake.  
Studies dealing with flavonoids and cancer show some evidence of reduced risk 
of lung34,35 and colorectal cancer35 attributed to dietary flavonoids, but no reduced 
risk of stomach, urinary tract, prostate, breast, testicular or ovarian cancers.20 
In addition to these epidemiological studies, a large number of in vitro 
experiments have provided evidence of the beneficial effects of flavonoids on 
human health.  Yet these findings are also disputed, as in vitro studies frequently 
employ conditions that are not realistically achieved in vivo.  For example, an 
informal survey of twelve in vitro studies36-47 on the effects of flavonoids on 
cancer cells published in peer-reviewed journals during the first five months of 
2007 reveals some disturbing trends.  Of these twelve studies, ten report anti-
cancer effects such as apoptosis or decreased cell proliferation at flavonoids 
concentrations exceeding 10 µM.  However, peak plasma concentrations 
occurring in humans after consuming flavonoid-rich meals are typically around 1 
µM at best.48-52  Only one36 of the twelve studies reports any activity at such low 
concentrations, and many of the studies do not even test the effects of exposure at 
these concentrations.  Even worse, all twelve of the studies treat the cancer cells 
with the aglycon forms of various flavonoids, but most flavonoids (except 
4 
catechins) that are absorbed by the human body undergo rapid metabolism such 
that the chemical structures living cells are exposed to are different from the ones 
consumed in food.50  These metabolites usually demonstrate lower bioactivity 
than the original molecules.53  Not one of the twelve studies employs flavonoids 
in the relevant biochemical form.  For these reasons, the value of in vitro studies 
of flavonoids has recently been called into question.54,55  It has been argued that in 
order to gain true insight into the health benefits of flavonoids, it is the metabolic 
forms that must be studied, not the precursors that occur in food items.  However, 
knowledge about these metabolites remains limited and very few have been 
positively identified.48  There is an urgent need for new analytical tools and 
procedures for probing these compounds.  
 
1.2 CHEMICAL STRUCTURE AND NAMING CONVENTIONS OF FLAVONOIDS 
 The basic chemical structure of all flavonoids consists of two aromatic 
six-carbon rings linked by a three-carbon bridge, in a C6-C3-C6 motif.  The 
characteristics of the three-carbon bridge determine the class of flavonoid, while 
substituents on the two C6 rings distinguish individual members of each flavonoid 
class.  Some of the possible variants of the bridge include cyclization, 
hydroxylation, oxygenation, charging, and double-bonding.  As a result of all 
these variants, there are over a dozen classes of flavonoids.  Prototypical 
structures of several of these classes are shown in Figure 1.1.  Flavonols, flavones 
5 
and anthocyanidins are distributed throughout the plant kingdom, while the 
remaining classes are far less widely-occurring.  For example, isoflavones are 
limited to the Faboideae, one of three subfamilies of Fabaceae (legumes) that 
includes soybeans and related plants.  Flavanones are highly characteristic of 























Figure 1.1: Prototype structures of several classes of flavonoids.  
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6 
cocoa and tea.1  In this dissertation, the focus will be on three of these classes: 
flavones, flavonols and flavanones. 
The simplest flavonoid structures are aglycons, those compounds lacking 
attached saccharide moieties.  The aglycons that comprise each flavonoid class 
differ in the number and locations of hydroxyl and methoxyl groups distributed 
around the flavonoid skeleton.  The structures of all flavonoid aglycons 
mentioned in the following chapters are given in Figure 1.2.  Flavonoid aglycons 
may be referred to by either trivial or systematic names, but the trivial names are 
often preferred for their simplicity (e.g. luteolin vs. 5,7,3′,4′-tetrahydroxyflavone)  
Throughout this dissertation, aglycons and the aglycon portion of flavonoid 
derivatives will be referred to only by their trivial names.   
Flavonoids in plants are typically encountered as glycosides, meaning that 
one or more saccharide moieties have been attached to the flavonoid aglycon.  
These saccharides are most often attached via hydroxyl group oxygen atoms, 
forming compounds that are collectively known as flavonoid O-glycosides.  
While any hydroxyl group may be the site of O-glycosylation, some naturally 
occur far more often than others.  In flavonols the 3-hyrdoxyl group is the most 
common glycosylation site, while the 7-hydroxyl group is most common for 
flavones and flavanones.56  A saccharide group attached directly to a flavonoid 
carbon atom (forming a C-glycosyl flavonoid) may also occur, but this situation is 
limited to members of the flavone class, and even then C-glycosylation is only 
7 
known to occur at carbons 6 and 8 on the flavone skeleton.56-58  Several different 
and often isomeric monosaccharides have been found in naturally-occurring 







































































































































Figure 1.2: Chemical structures of flavonoid aglycons analyzed or 
mentioned in this work.  CAS numbers are given in brackets.  Class, chemical 
formula and mass are also provided.
8 
arabinose and xylose are often observed as well.  Mannose, fructose, allose, 
apiose, glucuronic acid and galacturonic acid are also encountered in plant 
flavonoids, but more rarely.56 
The presence of saccharides greatly complicates the structural analysis of 
flavonoids.  To properly identify a flavonoid glycoside, it is necessary to identify 
not only the aglycon and all of the attached saccharides, but also the position of 
attachment of each saccharide moiety.  To further complicate matters, most 
glycosyl groups can occur in either a five-membered ring (furanose) or a six-
membered ring (pyranose) form.  In practice, however, only arabinose exhibits 
this variability as far as flavonoid glycosides are concerned; the other commonly-
occurring saccharide groups nearly always adopt the pyranose form when 
conjugated to flavonoids.  The stereochemistries of the sugar (D/L and α/β 
designations) are also potentially variable.  However, when conjugated to 
flavonoids most saccharides adopt a preferred stereochemistry, with glucose, 
galactose and rhamnose typically occurring as the β-D isomer, and rhamnose and 
arabinose occurring as the α-L isomer.  These preferred stereochemistries are 
nearly universal, as evidenced by the compounds listed in The Handbook of 
Natural Flavonoids.1  Of the 1097 flavonol glycosides included in the handbook, 
there are only six compounds that contradict these generalizations: two examples 
of an α-D-glucoside, one example of an α-D-galactoside, two examples of a β-L-
9 
arabinoside, and one example of a D-arabinoside (the α/β stereochemistry of the 
anomeric carbon is unspecified). 
Another layer of complication is introduced when disaccharides or 
trisaccharides are involved.  In addition to the above structural issues, the linkage 
positions between the saccharide monomers must be determined.  Linkage 
isomerism is not uncommon, as in the case of hesperidin and neohesperidin 
(Figure 1.3), both found in orange juice.  These flavanone glycosides are both 
Figure 1.3: Chemical structures of two isomeric flavanone 
glycosides, hesperidin and neohesperidin.  These compounds are 






















































based on the aglycon hesperetin, and are glycosylated at the 7 position.  In both 
compounds β-D-glucopyranose is conjugated to the hesperetin aglycon via carbon 
1′′ of the sugar.  α-L-rhamnopyranose is linked to the glucose moiety.  The sole 
difference between the two compounds lies in the intersaccharide linkage.  
Hesperidin links carbon 1′′′ of rhamnose to oxygen 6′′ of glucose, while 
neohesperidin links carbon 1′′′ of rhamnose to oxygen 2′′ of glucose. 
The naming convention for flavonoid glycosides first gives the name of 
the aglycon on which the structure is based, followed by the glycosylation 
position, an indication of whether the saccharide is linked through a oxygen or 
carbon atom, and finally the name of the saccharide (e.g. kaempferol 3-O-
glucoside).  The saccharide stereochemistry may optionally be included, but since 
this is strongly dependent on the identity of the saccharide, it will be omitted in 
this work.  The furanose/pyranose distinction will also be omitted except in the 
case of flavonoid arabinosides.  Many flavonoid glycosides also have trivial 
names, such as “astragalin” for kaempferol 3-O-glucoside.  Whenever trivial 
names for flavonoid glycosides are used, the systematic name will also be given at 
the first occurrence in each chapter. 
 
1.3 ESTABLISHED METHODS FOR IDENTIFYING FLAVONOID DERIVATIVES 
While there are some established methods for flavonoid identification, 
there are drawbacks to each of them.  The gold standard for structural 
11 
identification of any organic compound is nuclear magnetic resonance (NMR) 
spectroscopy.  This powerful technique allows the structures of unknown 
molecules to be deduced with little prior information required.  However, NMR 
has the liability of requiring relatively large amounts (milligram quantities) of 
very pure samples.  This is particularly true for flavonoid compounds, which often 
require 13C NMR for confident structural assignment.59,60  Isolation of individual 
compounds is a difficult and time-consuming process, and some compounds may 
not be present in sufficient quantities for NMR analysis.  In particular, this 
technique is rarely used to identify flavonoid metabolites because these 
compounds are produced in such small quantities.  Recently significant efforts 
have been put forth to couple liquid chromatography to NMR spectroscopy in 
order to combat some of these drawbacks.60-62  Coupling these two technologies is 
a significant technical challenge and while some progress has been made, the 
approach is still uncommon, not least because of the long data acquisition time 
and high monetary costs (for deuterated solvents) associated with this strategy.63 
An alternative method based on UV-Vis (ultraviolet-visible) spectroscopy 
was introduced by Tom Mabry and co-workers.64  By taking spectra of hundreds 
of flavonoids and flavonoid glycosides, many strong correlations were found 
between chemical structure and UV absorption characteristics.  Several UV shift 
reagents, such as sodium acetate and aluminum chloride are systematically used 
to alter the UV spectra in structurally-dependent ways.  Information on the 
12 
identity of the flavonoid aglycon and the positions of saccharide groups are 
possible with this methodology, although the identities of the saccharide groups 
cannot be deduced in this way.  Coupling UV-Vis detection to HPLC analysis is 
simple and prevents the need for isolating individual compounds.  But the 
complex set of rules and experiments and shift reagents needed to deduce 
structures makes it somewhat inconvenient, so it would be advantageous to 
develop a simpler means to obtain the same information. 
Mass spectrometry (MS) is a good alternative to both NMR and UV-Vis 
techniques.  MS is more sensitive than traditional NMR by several orders of 
magnitude, and recent progress in commercialization has made mass spectrometry 
a routine technique in many laboratories.  It is more easily coupled to HPLC than 
NMR, does not require the use of expensive deuterated solvents, and entails 
shorter acquisition times.  However, full structural analysis of flavonoids has not 
yet been achieved via MS.  Progress has been made toward this end in recent 
years, but the information obtained is still not as complete as can be achieved by 
NMR spectroscopy. 
Mass spectrometry is a quickly-evolving analytical technique.  While a 
considerable body of mass spectrometric work on flavonoids was done using 
electron ionization (EI), fast-atom bombardment (FAB) and liquid secondary ion 
mass spectrometry (LSIMS) techniques,65 these approaches are now somewhat 
dated.  For example, EI only works on volatile analytes, so much effort went into 
13 
finding suitable derivatization methods to volatilize flavonoids to allow them to 
be analyzed by this technique.  More modern approaches to mass spectrometry do 
not require volatile analytes and have thus replaced EI mass spectrometry except 
in gas chromatography applications.  Currently, the ionization method of choice 
for flavonoids is electrospray ionization (ESI).  Since its adaptation to mass 
spectrometry in the late 1980’s,66 ESI has become one of the most popular 
ionization methods and is now a mainstay of most commercial mass 
spectrometers.  Older ionization techniques such as FAB and LSIMS have been 
largely supplanted by newer methods, and are only encountered on older 
instruments or in highly specialized applications.  The discussion of the current 
state of MS analysis of flavonoids will thus focus mainly on ESI methodology. 
ESI analysis may be performed on either positively-charged or negatively-
charged flavonoids.  There are advantages and disadvantages to both approaches.  
Users of negative ion mode ESI report higher sensitivity and avoid the unwanted 
sodium adducts that often plague positive mode analysis of flavonoids.67-70  
Proponents of positive ion mode report more varied ion fragmentation, which is 
useful for structural characterization of flavonoids.  The incidental sodium 
adducts sometimes are also studied to provide additional structural information.57  
Under the conditions used in the following studies, it was often impossible to 
observe non-adducted flavonoids and flavonoid derivatives in positive ESI mode 
14 
due to the overwhelming presence of sodium adducts, so negative ion mode was 
used exclusively for the analysis of unmodified compounds. 
Identifying flavonoid aglycons using negative ion mode ESI is usually a 
fairly simple process when collision-induced dissociation (CID) is employed.  
Although isomerism prevents identification based on mass alone, a single stage of 
CID fragmentation is often enough to reveal the structure.  The fragmentation of 
flavonoid aglycons usually yields a highly characteristic set of product ions that 
can be used to identify the compound.71-74 For example, Figure 1.4 shows 
negative ion mode CID spectra of the isomers quercetin and morin (exact mass = 
Figure 1.4: Negative ion mode CID MS/MS data for four isobaric 
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302.04 Da) as well as isobaric compounds hesperetin and homoeriodictyol (exact 
mass = 302.08 Da).  The array of ions yielded by each compound is sufficient to 
differentiate each one despite the similarity of their structures and their 
indistinguishable masses. 
Identifying the aglycon on which a flavonoid glycoside is based works 
very much the same way in the case of the ubiquitous O-glycosides.  CID of 
negatively-charged flavonoid O-glycosides results in the neutral loss of the 
saccharide moieties.  If more than one saccharide is present, it may take multiple 
CID steps to remove all them.  Once the bare deprotonated aglycon is left, it will 
almost always fragment nearly identically to a native aglycon.  Thus it is usually 
possible to identify the aglycon portion of unknown flavonoid glycosides by 
comparison with a library of aglycon fragmentation patterns.  Exceptions to this 
generalization will be discussed in Chapter 8. 
In contrast, limited information is obtained about the saccharide portions 
of flavonoid O-glycosides.  Since the saccharide portions of O-glycosyl 
flavonoids are typically removed intact via neutral-loss mechanisms, it is possible 
to determine how many saccharide moieties are present and to learn the mass of 
each one.  But this does not reveal the glycosylation position(s), nor does it 
provide the exact identities of the individual saccharides.  For example, the loss of 
162 Da indicates a hexose sugar but does not specify whether that sugar is glucose 
or galactose.  The loss of 132 Da may indicate either arabinose of xylose.  
16 
Rhamnose, on the other hand, is the only deoxyhexose known to form natural 
flavonoid conjugates, so a loss of 146 Da is sufficient to identify this sugar.75 
C-glycosyl flavonoids follow dissociation pathways involving cross-ring 
cleavages of the saccharide moiety, resulting in characteristic losses of 90 Da or 
120 Da (from glucose).58  Cross-ring cleavages will be described in more detail in 
Section 2.4.  Dehydration pathways involving the loss of one or more water 
molecules has also been reported in mass spectral analysis of deprotonated C-
glycosyl flavonoids.  The systematic differentiation of the 6-C and 8-C 
glycosylation sites based on MS data has been reported.58,70,76-78 
Several good review articles on using mass spectrometry to identify 
flavonoids and flavonoid glycosides have been written.  A 2004 review by 
Cuyckens and Claeys57 provides more information on all of the aspects described 
in this section.  Summaries of techniques using older MS methods can be found in 
other review articles.65,79-81  
 
1.4 GOALS AND OVERVIEW 
This dissertation presents a body of work aimed at developing facile new 
MS methods for structural characterization of monoglycosyl flavonoids.  While 
much work has already been done using mass spectrometry for this type of 
application, there are still structural determinations that cannot be made using 
mass spectrometry alone.  This work is geared towards allowing mass 
17 
spectrometry to be the sole characterization technique required for full structural 
analysis of flavonoids and flavonoid glycosides, using methods that are more 
sensitive and less laborious than either NMR or UV-Vis strategies. 
Chapter 2 gives a general description of the methods employed in the 
subsequent chapters as well as additional technical background.  Metal ion 
complexation is introduced as a novel method to obtain structural information 
about flavonoids using MS techniques.  The use of HPLC data to glean additional 
evidence of structure is discussed.  Finally, the conventions for naming MS 
fragmentation pathways of flavonoids are provided. 
Chapters 3 and 4 describe ways of overcoming two of the primary 
shortcomings of mass spectrometric identification of flavonoid glycosides.  
Chapter 3 is concerned with the determination of the glycosylation site of 
monoglucosyl flavonoids, while Chapter 4 deals with the specific identification of 
the saccharide moiety.  Metal complexation is the key step in providing both 
pieces of information.  These chapters will cover different types of complexes and 
the ability of each type to provide the desired information. 
Chapter 5 discusses the practical implementation of the techniques 
described in the previous two chapters.  The flavonoid glycosides in apple peel, 
red onions and Silphium albiflorum are identified based on these methods.  The 
first two applications were checked for accuracy against previously published 
studies, providing enough confidence in the method to perform an analysis of 
18 
Silphium albiflorum, a plant whose flavonoids have not been previously identified 
and could not be verified by NMR spectroscopy. 
Chapter 6 changes the focus from flavonoid glycosides to flavonoid 
metabolites.  Metal complexes that can identify glucuronidated flavonoid 
metabolites are discussed.  Implementation of these methods is also covered.  
Human flavonoid metabolites found in urine following the consumption of 
grapefruit juice and orange juice were identified using these methods.  Several of 
the metabolites have not been previously reported in humans.  Metabolites in a 
cell culture treated with flavonoids were also identified. 
Chapter 7 uses the methodology introduced in Chapter 6 to explore the 
regioselectivity of UDP-glucuronosyltransferase 1A1, an enzyme that is 
responsible for glucuronidation of flavonoids.  An enzymatic synthesis was 
performed using several flavonoids as substrates for the reaction.  The products 
were identified using only LC-MS methods, particularly the metal complexes 
found to elucidate the glucuronidation positions of flavonoids.  The product 
distributions of the various substrates allow general trends to be deduced.  The 
success of the metal complexation method also provides confirmation of its 
efficacy. 
Chapter 8 explores a particular problem in the fragmentation behavior of 
flavonoid glycosides by tandem mass spectrometry.  As mentioned earlier, 
sequential dissociation of flavonoid glycosides usually will yield a fragmentation 
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spectrum similar to that of the native aglycon after all of the saccharides have 
been cleaved.  This provides a simple method for identifying the aglycon portion 
of flavonoid glycosides.  Chapter 8 explores a few cases in which this does not 
occur.  Implications for the identification of flavonoid glycosides by mass 
spectrometry are discussed. 
Finally, Chapter 9 gives a summary and critical analysis of the research 
presented in this dissertation.  The general capabilities and limitations of the 
described methods are assessed, and implementation concerns are addressed.  The 
impact of this work on flavonoids research is also evaluated. 
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Chapter 2: Experimental Methods and Theory 
 
2.1 INSTRUMENTATION AND TECHNIQUES 
All mass spectrometric experiments described in the following chapters 
were performed on a quadrupole ion trap (QIT) mass spectrometer, equipped with 
an electrospray ionization (ESI) source.  There are several advantages to using 
ESI-QIT mass spectrometry in the study of flavonoids and other molecules.  ESI 
is a very gentle ionization technique, allowing analytes to be charged and 
transferred to the gas phase with very little fragmentation.  Thus it is usual to 
observe the intact analyte ion when using this ionization technique.1,2  ESI is also 
gentle enough to transfer non-covalent complexes into the gas phase.3-7  This is 
important because many of the methods described in the following chapters rely 
on the analysis of non-covalent complexes between flavonoids and metal ions.  A 
harsher ionization method would break apart such complexes, rendering them 
useless for subsequent analysis. 
A particular strength of the QIT mass analyzer that will be heavily 
exploited in the following chapters is the facile implementation of multiple-stage 
tandem mass spectrometry, or MSn.  It has been established experimentally that 
operating a QIT with a low level of bath gas (~10-3 Torr) in the trap increases the 
efficiency of ion trapping and transmission.8-10  The presence of this gas also 
provides the basis for collision-induced dissociation (CID), a process involving 
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the excitation of selected ions in the trap, low-energy collisions with the bath gas 
molecules, and subsequent fragmentation of the ions.9-11  In a QIT, this process 
can be repeated several times, so as to trace a specific precursor ion through many 
successive fragmentation stages.  A great deal of information about the structure 
of unknown analytes may be obtained in this manner.  CID is achieved by 
applying a supplementary radio frequency (RF) waveform to the endcaps of the 
ion trap to cause increased ion motion and therefore more energetic collisions 
between the ions and the bath gas.9,10  The energy imparted to ions is not 
controlled directly, but is instead governed by the applied RF voltage.  This 
voltage is often reported as a percentage of a maximum 5 Vp-p, normalized for the 
mass of the ion being dissociated (as more massive ions require more energy to 
fragment to the same extent as less massive ions).12  In most places in the 
following chapters, the collision energy used in experiments will be reported 
simply as this percentage. 
High-performance liquid chromatography (HPLC) is another method that 
is employed heavily in this research.  HPLC is a popular tool for automated 
separation of mixtures.  Reversed-phased chromatography, the type of 
chromatography used in these experiments, employs a hydrophobic column that is 
eluted using a mobile phase gradient that begins with a highly aqueous solvent 
mixture that becomes more organic over time.  Analyte molecules are 
differentially retained on the column according to their hydrophobicity, such that 
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non-polar components are retained on the column longer than polar components.13  
A well-chosen method comprising proper selection of column, mobile phase 
solvents, and gradient will allow even very similar molecules to be separated.  In 
these experiments, the HPLC apparatus is coupled directly to the mass 
spectrometer so that the analytes can be mass-analyzed in real time, as they elute 
from the column. 
Solid phase extraction (SPE) is a sample preparation technique that is 
closely related to HPLC, and is used in many of the experiments described in the 
following chapters.  It allows the partial purification of analytes from complex 
mixtures, including biological matrices.  In reversed-phased SPE, a disposable 
column packed with a hydrophobic stationary phase is used.    The sample 
mixture is loaded onto the column in a high-aqueous solvent so that the analyte of 
interest will be retained on the stationary phase.  The column is first washed with 
a weak (mostly aqueous) solvent to remove weakly-retained matrix molecules, 
then a stronger (mostly organic) solvent is used to elute the analyte of interest, 
leaving irreversibly-bound components on the disposable column.14  SPE is useful 
because it reduces the presence of very hydrophilic (e.g. salts) and hydrophobic 
compounds from the mixture, resulting in a simpler sample mixture for analysis.  




2.2 METAL COMPLEXATION OF FLAVONOIDS FOR STRUCTURAL 
CHARACTERIZATION  
One of the primary goals of this research is to fill in some of the 
aforementioned gaps (discussed in Section 1.3) in the capability of mass 
spectrometry to provide complete structural characterization of flavonoid 
glycosides.  The most important obstacles are the determination of the 
glycosylation site(s) and the identity of the saccharide(s).  Metal complexation 
was seen as a promising approach to overcome these obstacles.  Many research 
groups have used metal complexation as a means of altering the fragmentation 
pathways of compounds analyzed by mass spectrometry.15-24  These complexes 
often provide more varied fragmentation than underivatized analytes.  Metal 
complexation techniques are particularly suited to flavonoids, which have natural 
chelation properties and are known to spontaneously form complexes with various 
metal ions including iron, copper and aluminum.25-33   
In recent years, much effort has been devoted to the development of metal 
complexation mass spectrometry methods for the structural elucidation of 
flavonoid glycosides.34-45  One of the early observations was that the degree of 
glycosylation plays a major role in the type of metal complexes required to solve 
a particular structural problem.  In particular, methods that proved effective for 
diglycosyl flavonoids did not work for monoglycosyl flavonoids, and vice versa.  
Thus, efforts were divided by flavonoid structure.  There is precedent for this type 
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of division in the work of Leary and co-workers, who have used metal 
complexation to differentiate isomeric saccharides.  They have reported that 
different complexes are required for differentiation of hexoses, hexosamines and 
N-acetylated hexosamines.15-17  The focus of this work is accordingly limited to 
the monoglycosyl flavonoids.  Similar similar methods for diglycosyl flavonoids 
have been reported.35-39 
The formation of the complexes simply entails mixing a purified flavonoid 
glycoside and a metal salt in a 1:1 ratio in methanol (a good solvent for ESI 
methods).  The complexes rapidly self-assemble, and the reaction mixture can be 
infused directly into the mass spectrometer without clean-up or purification steps.  
The standard concentration used in the following studies is 10 µM flavonoid 
glycoside and 10 µM metal salt.  Although ESI is a soft ionization source, the 
spray parameters can be altered to make the process more or less gentle.  Very 
gentle conditions are preferred for this work due to the fragile nature of the non-
covalent complexes.  It was experimentally determined that the ESI gas flow rates 
(sheath gas and auxiliary gas) are most important for obtaining optimal signal 
from metal/flavonoid glycoside complexes.  These gas flows were kept as low as 
possible, taking care not to deteriorate the performance of the ESI source.  
Because the needle position is routinely altered as part of signal optimization, the 
sheath and auxiliary gas flows must also be optimized on a day-to-day or run-to-
run basis. 
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Purified flavonoid glycosides are not available for most practical 
applications, so it was necessary to devise a means of coupling metal 
complexation with LC-MS separations of mixtures.  Attempts were made to inject 
the reaction mixture containing flavonoid glycosides and metal salts onto the 
HPLC column, but the complexes do not survive chromatography.  Instead, an 
effective post-column complexation method was devised, illustrated in Figure 2.1.  
In this approach, the analyte is injected as usual onto the HPLC column.  Between 
the UV detector and the mass spectrometer (or between the column and the mass 
spectrometer, in applications not employing a UV detector), a methanolic solution 
of the metal salt (and auxiliary ligand, when necessary) is added to the column 
Figure 2.1. Schematic of the instrumental set-up for LC-MS 
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effluent via a tee connection.  The flow of the post-column reagent(s) is controlled 
by a syringe pump.  The flavonoid analytes and post-column reagents mix at the 
tee, allowing the complexes to form as analytes elute from the column.  These 
complexes can be analyzed in real-time in the same manner as the directly-infused 
complexes. 
The exact structures of the metal complexes are unknown as is the precise 
mechanism by which they promote different fragmentation pathways for very 
similar flavonoid glycosides.  However, work by Clowers and Hill has provided 
insight on both of these problems.46  Their research used a hybrid ion mobility-
quadrupole ion trap mass spectrometer to study the metal complexes of flavonoid 
diglycosides discovered by Zhang and Brodbelt38 which have been shown to 
provide similar structural determinations as the complexes described in this 
dissertation.  Ion mobility spectrometry separates ions based on size/charge ratio 
rather than the mass/charge ratio involved with mass spectrometry.  Metal 
complexes of isomeric flavonoid diglycosides were determined to have 
distinguishable mobilities, indicating that sizes and shapes or these complexes 
were different despite having the same mass.  Moreover, some complexes such as 
a sodium complex of the flavanone diglycoside hesperidin exhibited bimodal 
mobility distributions, indicating two different conformations.46  It is plausible 
that the metal complexes of isomeric flavonoid glycosides adopt conformations 
that promote distinct fragmentation patterns, allowing isomer differentiation that 
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is impossible with unmodified flavonoid glycosides.  Some complexes may have 
more than one distinct geometry, so the different fragmentation patterns may also 
be the result of different proportions of conformations among isomeric metal 
complexes.  Some molecular modeling of the metal complexes of flavonoid 
diglycosides has also been performed, providing further evidence that isomeric 
complexes have different stable conformations.36,37 
 
2.3 HPLC RETENTION TIME ANALYSIS FOR CHARACTERIZATION OF 
FLAVONOIDS 
In LC-MS applications, the retention time of various analytes may be used 
in addition to the MS data for compound identification.  In the simplest form, this 
entails comparing the retention time of an authenticated standard to those of the 
various analytes in an unknown sample.  If a sample component matches the 
standard in terms of retention time and mass, then it is strongly indicated that the 
two are the same compound.  However, retention time analysis can also be used in 
the absence of standards, as flavonoid structure is known to track systematically 
with retention time.  In reversed-phase HPLC, it has been reported that flavonoid 
diglycosides elute before monoglycosides, which elute before aglycons.  For 
isomer pairs with the same aglycon and glycosylation position, flavonoid 
rutinosides elute before flavonoid neohesperidosides, and galactosides before 
glucosides.47  Trends of this nature will be used confirm, and in some cases, 
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identify flavonoid components from botanical and biological samples.  A more 
complete treatment of this approach is given in Section 7.3.2. 
 
2.4 NOMENCLATURE FOR FRAGMENT IONS OF FLAVONOID AGLYCONS, 
FLAVONOID GLYCOSIDES AND METAL COMPLEXES 
As these studies deal extensively with the fragmentation of flavonoids and 
flavonoid glycosides, a brief overview of the naming conventions used for 
flavonoid fragment ions is warranted.  Flavonol, flavone and flavanone aglycons 
undergo two major types of CID fragmentation: small molecule losses and retro 
Diels-Alder cleavages.48  Small molecule losses involve the removal of a few 
atoms from the flavonoid skeleton, often H2O, CO or CO2.48,49  The retro Diels-
Alder fragments involve the cleavage of two bonds of the C ring, resulting in 
complementary fragments containing an intact A ring or B ring.50-52  Claeys and 
co-workers have proposed a notation for such fragment ions, in the form i,jA+/- and 
i,jB+/-, where i and j denote the numbers of the two broken bonds of the C ring, A 
or B denotes that the fragment ion contains an intact A or B ring, and either a + or 
– sign indicates the charge of the ion.50  For saccharide cleavages of flavonoid 
glycosides, Domon and Costello notation for glycoconjugates is used.53  In this 
dissertation, the important saccharide cleavage product ions are Y0, indicating the 
loss of an intact saccharide moiety cleaved at the glycosidic bond, and i,jX,  which 
indicates the cross-ring cleavage of a sugar ring, with i and j indicating the 
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specific bonds of the saccharide ring that were cleaved.  The Claeys and the 
Domon and Costello systems are illustrated in Figure 2.2. 
New notation has been devised for metal complexes and their 
fragmentation products.  A generic complex may be abbreviated as [M(II) (FG-H)  
(Aux)]+.  In this example, FG stands for any flavonoid glycoside.  M refers to a 
generic metal ion, in this instance in the +2 oxidation state.  The chemical symbol 




























Figure 2.2. Shorthand nomenclature for some common flavonoid 
fragmentation pathways, using quercetin 4′-O-glucoside as an 
example.  Arrow direction indicates the portion of the molecule that 
retains the charge after fragmentation.  A and B ions illustrate retro 
Diels-Alder fragmentation, using notation introduced by Claeys and 
co-workers.50 X ions illustrate cross-ring saccharide cleavages.  X 
and Y ions follow Domon and Costello naming conventions for 
glycoconjugate fragment ions.53 The bond numbering schemes for 
both systems are indicated.
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complexes employ neutral auxiliary ligands, generically abbreviated as Aux, 
though the actually ligand may be named in specific applications.  -H indicates 
the loss of a hydrogen nucleus, i.e. deprotonation.  Certain types of CID fragment 
ions of such metal complexes occur often enough to warrant abbreviation.  –FG 
indicates the loss of an intact flavonoid glycoside, -Agl indicates the loss of the 
aglycon portion of a flavonoid glycoside, and -Aux represents the loss of an 
auxiliary ligand.    –Hex and –Pent refer to losses of unspecified hexose or 
pentose moieties (corresponding to the Y0 ion of uncomplexed flavonoid 
glycosides).  Standard abbreviations will be used for specific saccharide losses; 
hence -Glc, -Gal, -Rha, -Ara, -Xyl and -GlcA, represent losses of glucose, 
galactose, rhamnose, arabinose, xylose and glucuronic acid moieties, respectively.  
Cross-ring saccharide cleavages (corresponding to the X ions of uncomplexed 
flavonoid glycosides) will be indicated by the specific mass losses, such as -90 
Da, -120 Da, etc.  Other abbreviated fragment ions will be explained as they 
appear unless obvious (e.g. –H2O).  Precursor ions in CID spectra are indicated by 
an asterisk (*). 
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Chapter 3: Determination of the Glycosylation Site of 
Monoglucosyl Flavonoids Using Metal Complexation  
and Tandem Mass Spectrometry 
 
3.1 INTRODUCTION 
Much research has been devoted to the structural elucidation of flavonoids 
and their derivatives by mass spectrometry.1-5  But mass spectrometric analysis 
has not yet reached the point where de novo identification of flavonoids is 
possible.  Analysis of flavonoids in plant extracts,6-12 foodstuffs,13-18 and human 
biological fluids19-21 have been reported, but the identity of flavonoids in these 
complex matrices generally must be confirmed by comparison to commercial 
standards.  Otherwise only tentative identifications can be made, particularly in 
terms of saccharide location and identity, unless supplementary analytical 
methods are employed, such as UV-Vis or NMR spectroscopy. 
Some significant progress has been made towards systematic structural 
characterization of flavonoids by mass spectrometry.  As noted in Chapter 1, the 
fragmentation pathways of flavonoid aglycons obtained by tandem mass 
spectrometry are well-documented.22-26  In addition, commonly encountered 
diglycosyl flavonoids can often be distinguished by their fragmentation 
pathways.27-31  For less common flavonoid glycosides, methods have recently 
been proposed for determining the saccharide identity,32 as well as the linkage 
order.27  Furthermore, distinctive patterns have been reported for methoxylated 
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flavonoids33,34 and for chlorinated and nitrated isoflavonoids.35  
Hydrogen/deuterium exchange has also been explored as a method for flavonoid 
isomer differentiation.36 
The problem of determining the glycosylation site of monoglycosyl 
flavonoids has also been addressed.  The general fragmentation differences 
between flavonoid glycosides bonded through carbon versus oxygen atoms have 
been established,3 along with differentiation of 6-C-glycosyl and 8-C-glycosyl 
flavonoids.3,10,37-39  However, no one had proposed a robust universal mass 
spectrometric method for determining five of the most common glucosylation 
positions encountered for the monoglucosyl flavonoids: attachment through 
oxygen at position 3, 4′, or 7; or through carbon at position 6 or 8.  The following 
methods for achieving this latter goal based on metal complexation and tandem 
mass spectrometry have been published.40  Subsequent to this, another mass 
spectrometry method for the systematic differentiation of flavonoid O-glycosides 
was reported by Cuyckens and Claeys.41  Their method involves high-energy 
collision-induced dissociation (CID) on a hybrid magnetic sector / time-of-flight 
mass spectrometer, so it is non-competitive with the low-energy CID methods 
described herein.    
A number of groups have studied metal complexes by mass spectrometry 
and found that the fragmentation pathways of analytes can be significantly 
altered, allowing new opportunities for structural determination.42-58  The 
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Brodbelt group has shown that metal complexation combined with the use of a 
neutral auxiliary ligand dramatically increases sensitivity for detection of 
flavonoids while also providing a richer array of fragments to aid in isomer 
differentiation.26,30,31,59  In this study, new metal complexation strategies were 
developed for resolving many isomeric monoglucosyl flavonoids.  The resulting 
fragmentation pathways were remarkably consistent based on the position of the 
glucose moiety, providing a simple means for determining the glycosylation site 
of flavonoid glucosides.  Fourteen flavonoid glucosides are included in this study 
(Table 3.1), involving glycosylation at five different positions on the flavonoid 
skeleton.  The flavone, flavonol, and flavanone classes are represented by the 
sample compounds.  Structures of the parent aglycons were shown in Figure 1.2. 
Table 3.1.  Flavonoid glucosides employed in this study 
compound trivial name 
molecular 
weight 
kaempferol 3-O-glucoside astragalin 448 
quercetin 3-O-glucoside isoquercitrin 464 
isorhamnetin 3-O-glucoside — 478 
syringetin 3-O-glucuoside — 508 
luteolin 4′-O-glucuoside juncein 448 
quercetin 4′-O-glucuoside spiraeoside 464 
apigenin 7-O-glucuoside cosmetin 432 
naringenin 7-O-glucuoside prunin 434 
luteolin 7-O-glucuoside cynaroside 448 
quercetin 7-O-glucuoside quercimeritrin 464 
apigenin 6-C-glucuoside isovitexin 432 
luteolin 6-C-glucuoside homoorientin 448 
apigenin 8-C-glucuoside vitexin 432 
luteolin 8-C-glucuoside orientin 448 
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3.2 EXPERIMENTAL 
All experiments were performed with an LCQ Duo quadrupole ion trap 
mass spectrometer (Thermo Electron, Waltham, MA) with an electrospray 
ionization (ESI) source.  The ESI flow rate was 5 µL/min, and the ion injection 
time was typically 10 msec for full scans and 50 msec for MS/MS and MS3 
experiments.  100 microscans were averaged for each spectrum.  The mass 
spectrometer was tuned for maximum intensity of the ion of interest.  Protonated 
flavonoid glucosides, metal complexes, and sodium adducts were analyzed in the 
positive ion mode; and deprotonated flavonoid glucosides were analyzed in the 
negative ion mode.  The needle voltage was set to +5 kV and a heated capillary 
temperature of 200 °C was used.  The sheath gas and auxiliary gas flow rates were 
optimized manually on a daily basis, while the ion optics were optimized using 
the Autotune feature of the LCQ software. 
Quercetin 3-O-glucoside, quercetin 3-O-galactoside, syringetin 3-O-
glucoside, syringetin 3-O-galactoside, quercetin 4′-O-glucoside, naringenin 7-O-
glucoside, kaempferol 7-O-neohesperidoside and luteolin 6-C-glucoside were 
purchased from Extrasynthèse (Genay, France).  Kaempferol 3-O-glucoside, 
isorhamnetin 3-O-glucoside, luteolin-4′-O-glucoside, apigenin-7-O-glucoside, 
luteolin-7-O-glucoside, apigenin 8-C-glucoside, apigenin 6-C-glucoside, luteolin 
8-C-glucoside and quercetin 3-O-rhamnoside were purchased from Indofine 
(Somerville, NJ).  Quercetin-7-O-glucoside, quercetin 3-O-arabinofuranoside and 
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quercetin 3-O-xyloside were purchased from Apin Chemicals (Abingdon, UK).  
Quercetin 3-O-rutinoside was purchased from Sigma-Aldrich (St. Louis, MO).  
Certified ACS Spectranalyzed® methanol was purchased from Fisher Scientific 
(Pittsburgh, PA).  CoBr2, NiBr2, CuBr2, MnCl2, MgCl2 and 4,7-diphenyl-1,10-
phenanthroline (4,7-dpphen) were purchased from Aldrich (Milwaukee, WI).  
CaBr2 was purchased from Matheson, Coleman & Bell (Cincinnati, OH).  All 
materials were used without further purification. 
Analyte solutions were made in methanol, with the flavonoid glucoside 
and metal salt each added at 1.0 x 10-5 M except where otherwise noted.  The 
intensities from the collision–induced dissociation (CID) experiments are reported 
relative to the most intense peak in the spectrum, which is designated as 100%.  In 
collecting MS/MS and MS3 data, the collision energy was increased until the 
parent ion was reduced to 5-10% relative abundance.  The normalized collision 
energy range was 18-25%; this corresponds to approximately 0.8-1.1 V applied to 
the ion trap.60  The isolation window was typically 2 m/z units, though for some 
complexes it was necessary to increase the window to as much as 4 m/z units to 
obtain a stable signal due to the fragile nature of the complexes.61  All tables list 
fragment ions down to 2% relative abundance.   Post-CID solvent adducts (e.g. 
[fragment ion + CH3OH]+) were apparent in several instances, but as their 
appearance is dependent on the background pressure and the contents of the trap, 
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they are not regarded as reliable diagnostic products, and are generally excluded 
from the analysis. 
 
3.3 RESULTS AND DISCUSSION 
3.3.1 General Results 
Until the recent development and application of metal complexation 
strategies, flavonoids have generally been analyzed as protonated or deprotonated 
species by mass spectrometry.  Greater sensitivity has been reported in the 
negative ion mode than in the positive ion mode,10,62-64 a factor attributed to the 
substantial acidities of flavonoids and the ease of deprotonation due to their 
multiple hydroxyl groups.  However, the CID spectra of deprotonated flavonoid 
glucosides generally show few fragments, and are therefore not particularly useful 
for isomer differentiation.  The most successful and confident isomer 
differentiation results in unique fragment ions for different isomers, although 
sometimes differences in ratios or distributions of fragment ions may be 
considered.  The goal was to develop a simple but robust method based on metal 
complexation and CID for differentiation of flavonoid glucosides.  Several metals, 
including Ca(II), Mg(II), Mn(II), Co(II), Ni(II), and Cu(II), were evaluated for 
their ability to form useful complexes that give diagnostic fragmentation patterns 
upon CID.  These results are discussed in detail in this chapter. 
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Studies have suggested that certain structural features are required for 
metal chelation by flavonoids.  Proposed chelation sites include the 4-keto and 5-
OH groups, the 4-keto and 3-OH groups, and the 3′-OH and 4′-OH groups.59,65-68  
It is possible that more than one of these sites is active for flavonoids containing 
multiple binding groups.  Every flavonoid glucoside in this study contains at least 
the 4-keto and 5-OH groups, allowing them to form metal complexes.  Flavonoids 
lacking suitable chelation sites are unlikely to be amenable to metal complexation. 
The complexes were produced from methanolic solutions containing 1:1 
flavonoid glucoside/metal salt.  No pH adjustment was performed on the analyte 
solutions.  Under these conditions, the flavonoid glucosides formed 1:1 and 2:1 
analyte/metal complexes of the type [M(II) (FG-H)]+ and [M(II) (FG-H) (FG)]+.  
Additionally, larger complexes were occasionally observed, including 3:1, 3:2, 
4:1, and 4:2 analyte/metal stoichiometries.  Some of these stoichiometries have 
been previously reported for copper and iron complexes of flavonoids.69  Figure 
3.1 shows the full scan mass spectrum of isovitexin and Ca(II), which form 
complexes of several different stoichiometries.  The intensities of the 1:1 
analyte/metal complexes are often very low, and CID results in complicated mass 
spectra that often do not assist in compound identification.  In contrast, the 2:1 
complexes are more intense, and they give simple CID spectra with easily-
assigned fragments and a variety of dissociation pathways for structural 
determination.  A possible structure for the 2:1 complexes is shown in Schemes 
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3.1 and 3.2.  The complexes involve a doubly-charged metal ion, one 
deprotonated flavonoid glucoside and one neutral flavonoid glucoside.  The 
chelation site is speculative and likely to be compound-dependent; and it is even 
possible that more than one structure forms for some analyte/metal complexes.  
Likewise, the coordination geometry of the complexes is unknown, though 
particular metals are known to favor certain geometries over others.   
One of the common features of all of the metal complexes, regardless of 
the type of metal ion, is that the C-glucosides and O-glucosides form complexes 
that fragment very differently from each other.  Typical dissociation routes for O-
glucosyl flavonoid complexes include loss of one or two glucose moieties, loss of 
an entire flavonoid glucoside molecule, and loss of the aglycon portion of one 
flavonoid glucoside (Scheme 3.1).  These types of fragments are not obtained 



























Figure 3.1. Full scan spectrum of isovitexin and Ca(II).  FG = 
isovitexin.  0,2 cross-ring cleavages of m/z 433 and 903 are represented 
by ▼.  Other minor ions include 471: [Ca(II) (FG-H)]+; 1335: [Ca(II) 











pathways involving dehydration and cross-ring cleavages of the glucose moiety, 
resulting in losses of 90 Da or 120 Da (Scheme 3.2).  Figure 2.2 more clearly 

















































































Scheme 3.1. Speculative structures of fragment ions commonly observed 



























































































Scheme 3.2. Speculative structures of fragment ions commonly observed 
for metal complexes of C-glucosyl flavonoids (isovitexin shown as 
example).
These types of losses are well-known for C-glycosyl flavonoids, and were 
discussed in detail by Waridel et al.38  The loss of one or more water molecules 
observed with some C-glycosyl flavonoid complexes has also been reported in 
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mass spectral analysis of deprotonated C-glycosyl flavonoids10,37,38 and alternate 
structures for these ions have been proposed.37 
A direct comparison of the CID mass spectra of deprotonated flavonoid 
glucosides and flavonoid glucoside/metal complexes illustrates the advantage of 
the metal complexation strategy.  Figure 3.2 shows CID mass spectra obtained for 
three isomeric deprotonated flavonoid glucosides and the corresponding Mg(II) 
complexes.  The three compounds are all quercetin derivatives, with the glucose 





















































Figure 3.2. CID spectra of quercetin monoglucosides, 
MW=464.  (a) Fragments obtained from deprotonated 
analytes.  (b) Fragments obtained from [Mg(II) (FG-H) (FG)]+.
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dominant fragmentation pathway of the deprotonated flavonoid glucosides is the 
loss of the glucose moiety, -162 Da (Figure 3.2 a).  Both quercetin-3-O-glucoside 
and quercetin-7-O-glucoside undergo a radical loss of the glucose moiety (-163 
Da) and a cross-ring saccharide cleavage resulting in loss of 120 Da, but the latter 
pathway results in fragment ions with less than 5% relative intensity.  The few 
fragmentation pathways of deprotonated flavonoid glucosides are insufficient for 
differentiating these isomers, which differ only by the position of glucosylation.  
Similarly, protonated flavonoid glucosides and sodium adducts of the form [Na 
(FG)]+ and [Na (FG)2]+ produce few fragments upon dissociation, and in many 
cases isomer differentiation is not possible (data not shown).  In contrast, alkaline 
earth metal complexes show greater variety in their dissociation pathways.  The 
CID mass spectra of the magnesium complexes exhibit distinctive features for 
each of the three isomers (Figure 3.2 b).  The major fragmentation pathway is loss 
of the glucose moiety for all three complexes.  This is the only significant 
fragment observed for the quercetin 3-O-glucoside complex.  The [Mg(II) (FG – 
H) (FG)]+ complex of quercetin 4′-O-glucoside additionally undergoes loss of an 
aglycon unit and elimination of one flavonoid glucoside molecule, providing 
sufficient differentiation from quercetin 3-O-glucoside.  The quercetin 7-O-
glucoside complex displays a unique ion of m/z 831, corresponding to a 0,2 cross-
ring cleavage of one glucose moiety (-120 Da, 20% intensity).  All three 
complexes display unique CID mass spectra that allow differentiation of the 
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flavonoid glucosides.  Furthermore, the pattern of fragments observed for many of 
the metal complexes is strongly dependent on the site of glucosylation.   Figure 
3.3 shows the CID mass spectra of the four 7-O-glucosyl flavonoids complexed to 
Mg(II).  The types of fragments and their relative intensities are very similar, 






















































Figure 3.3. CID spectra of [Mg(II) (FG-H) (FG)]+ complexes of 7-O-
glucosyl flavonoids.  The ion labeled 674 corresponds to ([2 Mg(II) 
(FG-H)2 (FG)2]2+ - FG).
674
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dissociation patterns of the magnesium complexes are correlated with the 
glucosylation site, and may be used to determine this information for unknown 
flavonoid glucosides. 
In the following sections, the CID mass spectra of the calcium, 
magnesium, manganese, cobalt, nickel, and copper complexes are discussed, with 
an emphasis on the diagnostic utility of the fragmentation patterns for 
glycosylation site determination. 
 
3.3.2 Calcium Complexes 
The list of fragments observed upon CID of the [Ca(II) (FG-H) (FG)]+ 
complexes is shown in Table 3.2.  The complexes involving O-glucosyl 
flavonoids are readily differentiated from those involving C-glucosyl flavonoids.  
For all of the O-glucosyl flavonoids, the most intense fragment results from the 
elimination of one glucose residue.  In contrast, the complexes of the C-glucosyl 
flavonoids do not display this loss.  Their dominant dissociation pathway is a 0,2 
cross-ring cleavage of one glucose moiety, resulting in the loss of 120 Da.  
Precise identification of the glycosylation site is possible using the strategy 
outlined in Scheme 3.3. The complexes involving 7-O-glucosyl flavonoids are the 
only ones to display both the loss of an intact glucose moiety and a 0,2 cross-ring 
cleavage of one glucose moiety.  The 4′-O-glucosyl flavonoids are differentiated 
from the 3-O-glucosyl flavonoids by minor losses of one flavonoid glucoside 
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glucoside -Glc -FG -Agl -2Glc DC-FG (FG+H)+ -120 
-(2 
x 120) -90 
kaempferol 3-O-Glc 100 — — — — — — — — 
quercetin 3-O-Glc 100 — — — — — — — — 
isorhamnetin 3-O-Glc 100 — — — 6 — — — — 
luteolin 4′-O-Glc 100 8 5 — 25 — — — — 
quercetin 4′-O-Glc 100 4 4 — 19 — — — — 
apigenin 7-O-Glc 100 3 — 5 — 6 15 — — 
naringenin 7-O-Glc 100 5 — — 9 — 8 — — 
luteolin 7-O-Glc 100 2 — 6 — 5 15 — — 
quercetin 7-O-Glc 100 4 — — — 3 12 — — 
apigenin 6-C-Glc — — — — — — 100 3 8 
luteolin 6-C-Glc — — — — — — 100 2 8 
apigenin 8-C-Glc — — — — — — 100 5 6 
luteolin 8-C-Glc — — — — — — 100 — 6 
 
 
b) MS3 of –Glc ion 
 
flavonoid 
glucoside -Glc -Agl -H2O -FG + adducts 
kaempferol 3-O-Glc 20 100 — — 
quercetin 3-O-Glc 12 100 — — 
isorhamnetin 3-O-Glc 17 100 — — 
luteolin 4′-O-Glc 100 80 3 variable 
quercetin 4′-O-Glc 12 100 6 variable 
 
c) MS3 of -120 ion 
 
flavonoid 
glucoside -120 -(FG-120) -60 -[(FG-120) & 60)] -H2O 
apigenin 6-C-Glc 100 3 — — 3 
luteolin 6-C-Glc 100 3 — — 4 
apigenin 8-C-Glc 100 37 6 8 — 
luteolin 8-C-Glc 100 21 6 7 — 
 
 
Relative intensity of each fragment ion is an average of 2 to 4 experiments carried out on different 
days.  Abbreviations: DC-FG is [2 Ca(II) (FG-H)2) (FG)2]2+ - FG; (FG+H)+ is the protonated 
flavonoid glucoside; -120 is the 0,2 cross-ring saccharide cleavage, -90 is the 0,3 cross-ring 
saccharide cleavage, -60 is the 0,4 cross-ring saccharide cleavage, -(FG-120) is the 0,2 cross-ring 
saccharide cleavage but retaining the cleaved saccharide while losing the aglycon part.   
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molecule and one aglycon unit from the metal complex.  However these fragment 
ions are not always above 5% intensity.  For more confident differentiation, a 
secondary stage of CID was performed to further interrogate the fragment ion 
stemming from the loss of one glucose moiety.  For the 4′-O-glucosyl flavonoid 
complexes, the resulting MS3 spectra display a cluster of fragment ions associated 
with the loss of one flavonoid glucoside molecule, a pathway that is absent or 
very weak for the 3-O-glucosyl flavonoid complexes (Figure 3.4).  The ion 
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Scheme 3.3. Glycosylation site determination by Ca complexation
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several post-dissociation solvent adducts are clearly observed, including the 
adduction of one or two methanol or water molecules. 
The ion labeled as DC-FG (“doubly-charged - flavonoid glycoside”) in 
Table 3.2 appears in the CID spectra of some of the calcium complexes.  This ion 
stems from the parent species [2•Ca(II) (FG-H)2 (FG)2]2+.  This 4:2 
analyte/calcium complex has the same mass/charge ratio as the desired 2:1 
complex, so both species are isolated simultaneously in the trap prior to 











































Figure 3.4. MS3 spectra of Ca(II) complexes involving 3-O-
and 4′-O-glucosyl flavonoids.  The second stage of CID was 
performed on the ion stemming from the loss of one glucose 
residue from [Ca(II) (FG-H) (FG)]+.
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glucoside molecule to form [2 Ca(II) (FG-H)2 (FG)]2+.   Although this 
dissociation pathway is observed for both 4′-O-glucosyl flavonoids in this study, 
it is not a useful diagnostic tool as it appears in the spectra of some 3-O- and 7-O-
glucosyl flavonoid complexes as well.  There may also be a concentration 
dependence that influences the ratio of 4:2 vs. 2:1 complexes.  An excessive 
amount of the 4:2 complex could mask the fragments from the 2:1 complex, 
which would complicate identification of the flavonoid glucoside. 
The Ca(II) complexes of the 6-C- and 8-C-glucosyl flavonoids display 
nearly identical CID mass spectra, necessitating the use of MS3 for differentiation.  
A further stage of fragmentation of the 0,2 cross-ring cleavage product results in 
clear spectral differences between these two categories of flavonoid glucosides.  
The loss of 312 Da (for vitexin and isovitexin) or 328 Da (for orientin and 
homoorientin) corresponds to the elimination of the remainder of the flavonoid 
glucoside molecule left after the initial cross-ring cleavage.  This fragmentation 
product, indicated by “-(FG-120)” in Table 3.2, is only significant for the 8-C-
glucosyl flavonoids.  Another low-intensity diagnostic ion for 8-C-glucosylation 
is the 0,4 cross-ring cleavage product (-60 Da). 
 
3.3.3 Magnesium Complexes 
The [Mg(II) (FG-H) (FG)]+ complexes offer comprehensive identification 
and differentiation of all five categories of flavonoid glucosides without the need 
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for MS3 analysis.  Figure 3.5 shows the CID spectra of the Mg(II) complexes 
involving flavonoid glucosides with molecular weight 448.  Each analyte is 
glycosylated at a different site, and the spectra provide an unambiguous means to 
differentiate these five isomers, and allow determination of the glycosylation site 
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Figure 3.5. CID spectra of [Mg(II) (FG-H) (FG)]+ complexes 
involving isomeric monoglucosyl flavonoids glycosylated at 
five different positions.
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kaempferol 3-O-Glc 100 — — — — — — — — — — 
quercetin 3-O-Glc 100 — — — — — — — — — — 
isorhamnetin 3-O-Glc 100 — — — — — — — — — — 
luteolin 4′-O-Glc 100 6 8 3 — — — — — — — 
quercetin 4′-O-Glc 100 6 8 — — — — — — — — 
apigenin 7-O-Glc 100 5 5 4 20 5 — — — — — 
naringenin 7-O-Glc 100 3 7 8 8 — — — — — — 
luteolin 7-O-Glc 100 2 3 5 16 2 — — — — — 
quercetin 7-O-Glc 100 10 5 9 20 5 — — — — — 
apigenin 6-C-Glc — — — — 100 44 5 3 10 — 4 
luteolin 6-C-Glc — — — — 100 42 5 3 12 — 5 
apigenin 8-C-Glc — — — — 100 4 — — — 7 22 
luteolin 8-C-Glc — — — — 100 4 — — — 5 18 
 
Relative intensity of each fragment ion is an average of 2 to 4 experiments carried out on different days.  
Abbreviations: -120 is the 0,2 cross-ring saccharide cleavage, -90 is the 0,3 cross-ring saccharide cleavage.  
 
 
Loss of the glucose moiety is indicative of O-glucosylation, while the 0,2 cross- 
ring cleavage of glucose (-120 Da) is the most significant fragmentation pathway 
for the C-glucosyl flavonoid complexes.  Like the calcium complexes, the 
magnesium complexes offer a means to distinguish the three O-glucosylation sites  
(Scheme 3.4).  Once O-glucosylation has been determined, the 7-O glucosylation 
site can be confirmed by the presence of the 0,2 cross-ring cleavage pathway.  3-
O-glucosyl flavonoid complexes display no significant losses other than that of 
the glucose moiety, whereas the 4′-O-glucosyl flavonoid complexes also lose an 
aglycon residue and an entire flavonoid glucoside molecule.  These diagnostic 
ions are sufficiently intense that MS3 is not necessary for differentiating the 3-O- 
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and 4′-O-glucosyl flavonoids.  The CID mass spectra of the magnesium 
complexes also allow differentiation of the two C-glucosylation positions.  
Complexes involving 6-C-glucosyl flavonoids undergo a prominent dehydration 
pathway that involves the loss of up to three water molecules, whereas 8-C-
glucosyl flavonoid complexes display only a minor loss of one water molecule.  
Another indicator of 6-C-glucosylation is the unique fragment resulting from the 
combination of the 0,2 cross-ring cleavage (-120 Da) and dehydration.  
Diagnostic ions for 8-C-glucosyl flavonoid complexes include the 0,3 cross-ring 






























Scheme 3.4. Glycosylation site determination by Mg complexation
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One concern in relying on the analysis of [Mg(II) (FG-H) (FG)]+ 
complexes for isomer differentiation is the possible isobaric overlap from [Na 
(FG)2]+ species, which can lead to misidentification due to different fragmentation  
pathways for the sodium-cationized species.  Although sodium adducts are 
routinely observed in the ESI mass spectra of flavonoid glycosides due to the 
ubiquitous presence of sodium in the environment, addition of a magnesium salt 
at the 10-5 M level usually results in formation of Mg(II) complexes that 
significantly outweigh the contribution from sodium adducts for the flavonoid 
glucosides in this study.  Increasing the magnesium concentration solves the 
problem in cases when there is a significant contribution from the sodium-
cationized species. 
 
3.3.4 Manganese Complexes 
Mn(II) complexes of the form [Mn(II) (FG-H) (FG)]+ provide a means to 
determine glucosylation sites of flavonoid glucosides in a similar manner to 
magnesium complexation.40  Table 3.4 summarizes the fragment ions obtained 
from each complex and shows how this data can be used to determine the 
glucosylation site.  The loss of a glucose moiety, -162 Da, is indicative of O-
glucosylation; the complexes of the C-glucosides do not display this loss.  The 3-
O-glucoside complexes yield no other significant fragmentation products, but the 
4′-O-glucoside complexes also display the loss of two glucose moieties, the loss 
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kaempferol 3-O-Glc 100 — — — — — — — — — — 
quercetin 3-O-Glc 100 — — — — — — — — — — 
isorhamnetin 3-O-Glc 100 — — — — — — — — — — 
luteolin 4′-O-Glc 100 8 7 10 — — — — — — — 
quercetin 4′-O-Glc 100 5 8 5 — — — — — — — 
apigenin 7-O-Glc 100 — 2 8 14 2 — — — — — 
naringenin 7-O-Glc 100 — 3 15 6 — — — — — — 
luteolin 7-O-Glc 100 2 2 10 13 2 — — — — — 
quercetin 7-O-Glc 100 2 2 12 11 3 — — — — — 
apigenin 6-C-Glc — — — — 100 40 4 3 15 5 4 
luteolin 6-C-Glc — — — — 100 40 4 3 14 5 4 
apigenin 8-C-Glc — — — — 100 3 — — — 6 6 
luteolin 8-C-Glc — — — — 100 2 — — — 6 7 
 
 
Relative intensity of each fragment ion is an average of 2 to 4 experiments carried out on different days.  
Abbreviations: -120 is the 0,2 cross-ring saccharide cleavage, -90 is the 0,3 cross-ring saccharide cleavage.   
 
 
of an aglycon unit, and the loss of an intact flavonoid glycoside.  It was also noted 
that the average amount of CID energy required to fragment the 4′-O-glucoside 
complexes is also higher than that required for the 3-O-glucoside complexes 
(24.2% versus 18.0%).  The 7-O-glucoside complexes are the only ones to display 
both the loss of a hexose moiety and a 0,2 cross-ring saccharide cleavage (-120 
Da).  C-glucosylation is indicated by the 0,2 cross-ring cleavage product as the 
most prominent fragment ion in the CID spectrum.  Useful diagnostic ions for 
differentiating the 6-C- and the 8-C-glucosides include a very abundant 
dehydration product and the combined loss of 120 Da and a water molecule (both 
characteristic of 6-C-glucosides).  The CID spectra of the 2:1 Mn complexes 
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involving flavonoid glycosides with molecular weight 448 (spanning five sites of 
glycosylation) are shown in Figure 3.6.  The five-way differentiation of the 
isomers is immediately apparent upon inspection of the data.   
Manganese complexation is superior to the previously described method 
using magnesium complexation for several reasons.  First, the magnesium 
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Figure 3.6. CID spectra of [Mn(II) (FG-H) (FG)]+
complexes of isomeric flavonoid glycosides.  Fragment 
ions are -120 (0,2 cross-ring saccharide cleavage), -90 







adduct, [Na (FG)2]+ that may complicate spectral interpretation.  The Mn(II) 
complexes do not have this problem.  Second, manganese is monoisotopic, 
leading to a potentially simpler spectrum and greater concentration of the 
molecular ion intensity into a single peak.  Finally, Mn(II) provides the ability to 
both determine glycosylation sites and to identify the saccharide moiety in the 
case of 3-O-glycosides (to be discussed in detail in Chapter 4), whereas Mg is not 
reliable for the latter application. 
 
3.3.5 Cobalt and Nickel Complexes  
Tables 3.5 and 3.6 list selected fragment ions observed from the [Co(II) 
(FG-H) (FG)]+ and the [Ni(II) (FG-H) (FG)]+  complexes.  The O-glycosyl 
flavonoids and C-glycosyl flavonoids are distinguishable in the same way as with 
the other metal complexes, discussed earlier.  Differentiation of the 6-C-
glucosides and the 8-C-glucosides is also possible as complexes involving 6-C-
glucosides have a prominent dehydration pathway that involves the loss of up to 
three water molecules, whereas 8-C-glucoside complexes display only a minor 
loss of one water molecule.  Another indicator of 6-C-glycosylation is the unique 
fragment resulting from the combination of the 0,2 cross-ring cleavage and the 
loss of one water molecule.  Among the O-glucosyl flavonoids, the 7-O-glucoside 
complexes are the only ones which display a significant loss of 120 Da.  
However, there are no unique fragment ions to differentiate the 3-O- and the 4′-O-
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glucosides.  Some level of differentiation can be made based on the intensity of 
fragment ions.  MS3 may also be used to increase confidence in the 
differentiation, but neither MS/MS nor MS3 provides fragment ions that are both 
intense and unique to differentiate these two categories of flavonoids.  The 
combined data from MS/MS and MS3 should be sufficient to make correct 














kaempferol 3-O-Glc 100 5 8 3 — — — — — — — 
quercetin 3-O-Glc 100 4 8 — — — — — — — — 
isorhamnetin 3-O-Glc 100 6 8 6 — — — — — — — 
luteolin 4′-O-Glc 100 10 17 3 — — — — — — — 
quercetin 4′-O-Glc 100 8 22 3 — — — — — — — 
apigenin 7-O-Glc 100 — 3 6 15 2 — — — — — 
naringenin 7-O-Glc 100 2 7 10 10 — — — — — — 
luteolin 7-O-Glc 100 — 2 6 13 2 — — — — — 
quercetin 7-O-Glc 100 — 3 12 12 3 — — — — — 
apigenin 6-C-Glc — 5 — — 100 51 10 8 12 4 6 
luteolin 6-C-Glc — 4 — — 100 46 10 6 10 4 5 
apigenin 8-C-Glc — — — — 100 4 — — — 4 — 
luteolin 8-C-Glc — — — — 100 2 — — — 4 — 
 
 
b) MS3 of –Glc ion 
 
flavonoid 
glucoside -Glc -Agl -120 - H2O 
kaempferol 3-O-Glc 95 100 6 6 
quercetin 3-O-Glc 78 100 5 4 
isorhamnetin 3-O-Glc 100 82 3 2 
luteolin 4′-O-Glc 100 33 — — 
quercetin 4′-O-Glc 100 55 3 — 
 
Abbreviations: -120 is the 0,2 cross-ring saccharide cleavage, -96 is the 0,4 cross-ring saccharide cleavage 





















kaempferol 3-O-Glc 100 5 6 — — — — — — — — 
quercetin 3-O-Glc 100 4 5 — — — — — — — — 
isorhamnetin 3-O-Glc 100 5 — — — — — — — — — 
luteolin 4′-O-Glc 100 8 16 4 — — — — — — — 
quercetin 4′-O-Glc 100 12 36 3 — — — — — — — 
apigenin 7-O-Glc 100 — 6 5 15 2 — — — — — 
naringenin 7-O-Glc 100 — 8 12 8 — — — — — — 
luteolin 7-O-Glc 100 — 5 6 14 3 — — — — — 
quercetin 7-O-Glc 100 2 5 10 10 3 — — — — — 
apigenin 6-C-Glc — — — — 100 59 18 8 14 4 10 
luteolin 6-C-Glc — — — — 100 50 14 8 13 4 8 
apigenin 8-C-Glc — — — — 100 5 — — — 2 — 
luteolin 8-C-Glc — — — — 100 2 — — — 2 — 
 
 
b) MS3 of –Glc ion 
 
flavonoid 
glucoside -Glc -Agl -120 - H2O 
kaempferol 3-O-Glc 76 100 9 9 
quercetin 3-O-Glc 55 100 5 6 
isorhamnetin 3-O-Glc 68 100 2 2 
luteolin 4′-O-Glc 100 37 — — 
quercetin 4′-O-Glc 100 79 3 2 
 
Abbreviations: 120 is the 0,2 cross-ring saccharide cleavage, -96 is the 0,4 cross-ring saccharide 




identifications, but this is a more complicated approach than using manganese 
complexation, as described earlier, which only requires MS/MS for glycosylation 
site determination. 
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3.3.6 Copper Complexes 
The copper complexes display significantly different behavior from the 
other transition metal complexes.  Copper is the only metal ion in this study that 
shows evidence of reduction to the +1 oxidation state in the full scan spectra.  
This behavior has been reported previously with electrospray ionization69-76 and is 
rationalized by the low reduction potential of Cu(II) due to its ability to achieve a 
closed-shell d10 electronic structure upon gaining an electron.  Copper is also 
unique in its tendency to induce radical losses upon CID of the metal complexes.  
Losses of the flavonoid glycoside and of the aglycon portion of the flavonoid can 
occur as neutral or radical losses, or both in the same spectrum.  Part of the reason 
for the divergence from the other transition metal complexes may be due to 
differences in the favored geometries of complexation (square planar is usual for 
Cu, whereas tetrahedral or octahedral is common for Co and Ni).77   
Table 3.7 lists selected fragmentation pathways that occur as a result of 
CID of the [Cu(II) (FG-H) (FG)]+ complexes.  The differentiation between O-
glucosyl and C-glucosyl flavonoids is the same as with the other metal 
complexes.  The 6-C-glucoside complexes lose up to three water molecules, with 
the first loss being particularly intense (65% – 80%).  In contrast, the 8-C-
glucosides complexes exhibit the loss of one water molecule at an intensity of less 
than 5%.  The difference in the prominence of the dehydration pathway is a clear 
indicator of 6-C versus 8-C glucosylation. 
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glucoside -Glc -FG -FG● -Agl -Agl● -2Glc -H -120 
kaempferol 3-O-Glc 100 12 3 65 — 58 7 — 
quercetin 3-O-Glc 100 6 — 51 — 24 — — 
isorhamnetin 3-O-Glc 100 18 3 65 5 39 6 — 
luteolin 4′-O-Glc 100 27 3 8 15 5 — — 
quercetin 4′-O-Glc 100 22 11 15 13 — — — 
apigenin 7-O-Glc 100 — 3 5 — 8 — 4 
naringenin 7-O-Glc 100 — 5 12 — 5 6 — 
luteolin 7-O-Glc 100 4 73 5 — 4 — 4 
quercetin 7-O-Glc 22 15 100 — — — — — 
apigenin 6-C-Glc — — 8 — — — 7 100 
luteolin 6-C-Glc — — 19 — — — 16 100 
apigenin 8-C-Glc — — 10 — — — 8 100 














x120) -66 -96 
apigenin 6-C-Glc 80 34 22 12 5 3 6 22 
luteolin 6-C-Glc 66 28 19 14 5 5 6 19 
apigenin 8-C-Glc 3 — — — — — — — 




b) MS3 of –Glc ion 
 
flavonoid 
glucoside -Glc -Glc● -Agl -Agl● -120 -H2O 
kaempferol 3-O-Glc 100 — 24 — 4 3 
quercetin 3-O-Glc 100 — 21 — 2 2 
isorhamnetin 3-O-Glc — — — — — — 
luteolin 4′-O-Glc 100 — 76 26 — — 
quercetin 4′-O-Glc 14 — 100 98 — — 
apigenin 7-O-Glc 100 — — — 3 — 
naringenin 7-O-Glc 100 — 5 2 3 — 
luteolin 7-O-Glc 87 2 11 100 — — 
quercetin 7-O-Glc 29 5 21 100 — 39 
Abbreviations: -120 is the 0,2 cross-ring saccharide cleavage, -66 is the 2,3 cross-ring saccharide 
cleavage with the loss of two water molecules, -96 is the 0,4 cross-ring saccharide cleavage with 
the loss of two water molecules. 
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However, the 3-O, 4′-O, and 7-O glycosylation positions are not so easily 
differentiated. The previously-discussed metal complexes allow the easy 
identification of the 7-O glycosylation site since only 7-O-glucosides undergo 
both the loss of an intact glucose moiety and a cross-ring cleavage of glucose (-
120 Da).  With the copper complexes, some 7-O-glucosides do not display the 
loss of 120 Da, negating this facile identification strategy.  It is tempting to use 
radical cleavages as diagnostic indicators, but there is a problem with relying on 
these ions.  Recent work by Hvattum and Ekeberg has shown that the amount of 
homolytic versus heterolytic cleavage is dependent on a number of factors, at 
least for unbound deprotonated flavonoids.78  These factors include the 
substituents of the flavonoid aglycon and the amount of collision energy used, in 
addition to the site of glycosylation.  It was shown that the intensity of a 
saccharide radical loss is dependent on the number of hydroxyl groups on the B 
ring, correlating positively for 3-O-glycosides but negatively for 7-O-glycosides.  
The fragmentation pathways observed for copper complexes are different, but 
similar types of relationships can be found.  All four 7-O-glucoside complexes 
undergo the loss of a flavonoid glycoside radical, but the prominence of this loss 
correlates with the number of hydroxyl group on the aglycon portion of the 
molecule.  The copper complexes of apigenin 7-O-glucoside and naringenin 7-O-
glucoside, both with only two hydroxyl groups on the aglycon subunit, undergo 
very small amounts of radical loss of a flavonoid.  The pathway involving loss of 
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one glucose moiety is clearly dominant for these complexes.  Luteolin 7-O-
glucoside has three hydroxyl groups on the aglycon; the result is that 
fragmentations of the copper complex involving loss of one glucose moiety and 
the radical loss of one flavonoid are comparable in intensity.  Quercetin 7-O-
glucoside has four hydroxyl groups on the aglycon, and the dominant pathway for 
its complex is the radical loss of a flavonoid glycoside.  The loss of one glucose 
moiety is less prominent than for the other 7-O-glycoside complexes.  The 
variability associated with the radical loss therefore affects the appearance of 
other peaks in the spectrum: it is quite possible that with the addition of another 
hydroxyl group, the pathway involving the loss of one glucose moiety may no 
longer be significant.  This reduces the utility of that fragmentation pathway as a 
universal indicator of O-glycosylation.  Other examples of the relationship 
between agylcon structure and radical fragmentation are seen in the MS3 loss of 
an aglycon radical for 4′-O- and 7-O-glucoside complexes.  In both cases, 
additional hydroxyl groups on the aglycon greatly increase the amount of radical 
cleavage, and suppress the intensity of the –Glc fragment ion. 
These examples corroborate the observations of Hvattum and Ekeberg, 
although we are working with copper complexes rather than free flavonoids.  
Whereas the other metal complexes in this chapter are rather impervious to the 
structure of the aglycon, the dissociation behavior of the copper complexes is 
strongly affected by this factor.  This may be useful for differentiating individual 
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isomers, but a universal strategy for determining the glycosylation site should not 
be strongly affected by other structural features.  Therefore copper complexation 
is not a reliable method for differentiating between the three sites of O-
glycosylation. 
 
3.3.7 Cobalt Complexes with an Auxiliary Ligand  
The various metal complexation modes discussed above have varying 
degrees of success in their ability to provide conclusive evidence about the 
location of the glucose moiety of monoglucosyl flavonoids.  However, one 
common theme is that the 3-O and 4′-O glycosylation sites are the most difficult 
to differentiate by the metal complexation approach.  Even the most generally 
useful strategies, those involving the complexes [Mg(II) (FG-H) (FG)]+ and 
[Mn(II) (FG-H) (FG)]+, rely upon low-abundance fragment ions (<10% relative 
abundance) to make this differentiation.  For the calcium, cobalt and nickel 
complexes, an additional CID step is needed to distinguish these two 
glycosylation sites, an approach that is not possible on many types of mass 
spectrometers. 
It is worth mentioning another complexation mode that was 
serendipitously found to provide a simple and obvious differentiation of the 3-O 
and 4′-O glycosylation sites.  The complex in question, [Co(II) (FG-H) (4,7-
dpphen)2]+, was originally used to identify flavonoid glucuronide metabolites (to 
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be discussed further in Chapter 6), but was later discovered to also be useful for 
this application.  Unlike the previously discussed work, the working solution 
consisted of 10 µM flavonoid glycoside, 5 µM CoBr2 and 5 µM auxiliary ligand, 
in this case 4,7-diphenyl-1,10-phenanthroline (4,7-dpphen).  When the relevant 
complex is dissociated by CID, an obvious difference is seen between the 3-O-
glycosyl flavonoid complexes and the 4′-O-glycosyl flavonoid complexes (Figure 
3.7).  In the case of the former, a prominent fragment ion is observed 
corresponding to the loss of the saccharide moiety and one auxiliary ligand.  This 
fragment ion is completely absent from the CID spectra of the 4′-O-glycosyl 
flavonoid complexes.  (Some of the fragmentation pathways occur as a mixture of 
homolytic and heterolytic cleavages, but this does not interfere with the 
identification process.)  Moreover, the unique diagnostic ion is observed not only 
in the case of 3-O-glucosides, but also when other monosaccharide moieties are 
present at the 3 position.  It does not occur for disaccharides, as evidenced by the 
examples of kaempferol 7-O-neohesperidoside and quercetin 3-O-rutinoside.  
This suggests a universal means to identify flavonoids with monosaccharide 
moieties located at the 3-O position; the precise identity of the saccharide moiety 
can be determined by other means (see Chapter 4). 
The dissociation patterns of the [Co(II) (FG-H) (4,7-dpphen)2]+ complexes are 
identical for both 7-O-glucosides and 4′-O-glucosides, so this complexation mode 
may not be used to differentiate all glycosylation sites, as
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manganese and magnesium complexation could.  However, it may be used as a 
robust means of differentiating the 3-O and 4′-O glycosylation sites in case of 
ambiguity using other types of metal complexes.  This discovery of this complex 
Figure 3.7. CID spectra of [Co(II) (FG-H) (4,7-dpphen)2]+ complexes 




















































































































invites speculation that diagnostic metal complexation modes may exist providing 
systematic determination of other structural features of flavonoid glycosides. 
 
3.4 CONCLUSIONS 
Dissociation of protonated, deprotonated or sodium-cationized flavonoid 
monoglucosides does not always provide sufficient diagnostic fragment ions for 
distinguishing isomers that differ only by their glycosylation site.  An alternative 
approach is to form flavonoid glucoside/metal complexes of the type [M(II) (FG-
H) (FG)]+ which give a broader array of fragments for structural analysis.  The 
dissociation pathways of the complexes are strongly dependent on the 
glycosylation site, offering a means to determine this important structural feature 
by mass spectrometry.  CID of Mg(II) and Mn(II) complexes resulted in 
distinctive fragmentation patterns that are indicative of five commonly observed 
flavonoid glycosylation sites.  Ca(II), Co(II) and Ni(II) can also be used to 
differentiate the glycosylation site if MS3 is employed.  Another type of complex 
involving the Co(II) ion and an auxiliary ligand, 4,7-diphenyl-1,10-
phenanthroline, is especially useful for differentiating 3-O-glycosyl and 4′-O-
glycosyl flavonoids, which are only distinguishable by small diagnostic ions using 
the other methods.  All of these metal complexation strategies are effective for 
hydroxylated and methoxylated flavone, flavonol, and flavanone glucosides; 
while the cobalt/4,7-dpphen methods can be generalized to monosaccharide 
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groups other than glucose.  Complexes involving Cu(II) were less successful 
because universal indicators of glycosylation position could not be found for all 
five glycosylation sites. 
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Chapter 4: Differentiation of Isomeric Saccharides  
in Monoglycosyl Flavonoids Using Manganese Complexation  
and Tandem Mass Spectrometry 
 
4.1 INTRODUCTION 
The previous chapter covered glycosylation site determination of 
monoglycosyl flavonoids, particularly flavonoid glucosides.  This chapter instead 
focuses on identifying the saccharide moieties of monoglycosyl flavonoids.  This 
is a particularly difficult problem because many isomeric saccharides are known 
to occur in natural flavonoid conjugates.  Typically either NMR spectrometry or 
comparison to standards is needed to identify these saccharide moieties.  The UV 
spectroscopy method discussed in Section 1.3 can not identify the saccharide 
moieties of flavonoid glycosides, though it is effective for assigning the 
glycosylation site.1,2  Due to the difficulty in characterizing flavonoid glycosides, 
some researchers opt to remove the saccharide moieties via hydrolysis prior to 
analysis and thus identify only the aglycon portion of molecules in their extracts 
and samples.3-8  As the saccharide moieties play an important though not well-
understood role in determining bioactivity, such an approach results in the loss of 
critical information. 
A few tandem mass spectrometry methods have been reported for 
differentiating isomeric saccharides.9-17  There are also several reports of 
systematic differentiation between flavonoid rutinosides and neohesperidosides, 
78 
such as hesperidin and neohesperidin, shown in Figure 1.3.  This may be done 
using metal complexation18-25 or without it.26-31  Other than these applications, 
very little has been published regarding systematic saccharide identification of 
flavonoid glycosides using mass spectrometry.  Cuyckens and Claeys published 
the only available mass spectrometric method for identifying isomeric 
monosaccharide moieties (i.e. glucose vs. galactose) of flavonoid glycosides,32 
but their method requires isolation and an overnight derivatization of the analytes 
prior to analysis.  This chapter covers an alternative means to differentiate the 
isomeric saccharide moieties of monoglycosyl flavonols, flavones, and 
flavanones.  The approach involves the use of manganese complexation to yield 
saccharide-specific fragmentation.  Unlike the method of Cuyckens and Claeys, 
the metal derivatization occurs quickly and does not require prior isolation of the 
flavonoid glycoside analytes. 
 
4.2 EXPERIMENTAL 
Quercetin 3-O-glucoside (isoquercitrin), quercetin 3-O-galactoside 
(hyperoside), syringetin 3-O-glucoside and syringetin 3-O-galactoside were 
purchased from Extrasynthèse (Genay, France).  Kaempferol 3-O-glucoside 
(astragalin), isorhamnetin 3-O-glucoside and quercetin 3-O-rhamnoside 
(quercitrin) were purchased from Indofine (Somerville, NJ).  Quercetin 3-O-
arabinofuranoside (avicularin) and quercetin 3-O-xyloside (reynoutrin) were 
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purchased from Apin (Abingdon, UK).  Manganese (II) chloride was purchased 
from Aldrich (Milwaukee, WI).  All materials were used without further 
purification. 
All experiments were performed using an LCQ Duo quadrupole ion trap 
mass spectrometer (Thermo Electron, Waltham, MA) with an electrospray 
ionization (ESI) source.  For direct infusion experiments, the sample introduction 
rate was 5 µL/min and the ion injection time was 10 msec for full scans and 50 
msec for collision-induced dissociation (CID) experiments.  100 microscans were 
averaged for each spectrum.  The metal complexes were analyzed in positive ion 
mode using the following spray conditions: spray voltage, +5 kV; sheath gas flow 
rate, 5 arbitrary units; no auxiliary gas; heated capillary temperature, 200 °C; 
capillary voltage, 20 V; tube lens offset, 20 V.  Analyte solutions were made in 
methanol, with the flavonoid standard and metal salt each added at 1.0 x 10-5 M.  
The ion abundances from the CID experiments are reported relative to the most 
abundant ion in the spectrum, which is designated as 100%.  When collecting CID 
data, the collision energy was chosen such that the precursor ion was reduced to 
5-10% relative abundance.  Collision energies are reported as a percentage of the 
maximum 5 Vp-p, normalized for the m/z of the parent.33  Isolation windows of 4-
6 m/z were used because many of the metal complexes require a wide window in 
order to yield a stable fragmentation spectrum.  Several different types of non-
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covalent complexes have been reported to require wider than average windows 
for effective isolation34-36 due to their fragility.37 
 
4.3 RESULTS AND DISCUSSION 
4.3.1 Initial Results 
The goal of this project was to develop a simple MS method for 
differentiating isomeric monoglycosyl flavonoids that differ only in the identity of 
the saccharide moiety.  The first indication that this might be possible came from 
examining the fragmentation pathways of metal complexes involving a flavonoid 
rhamnoside (quercitrin).  There was interest in determining whether a flavonoid 
rhamnoside complex would dissociate by pathways similar to those of the 
flavonoid glucosides.  The fragmentation pathways from quercitrin/metal 
complexes were thus compared to the complexes of the flavonoid glucosides. 
There were a number of differences in the spectra of the complexes 
involving quercitrin.  One example is the MS/MS fragmentation of 2:1 
quercitrin/Ni(II) complexes, in which the loss of one aglycon unit is a more 
significant fragmentation pathway than for complexes of the 3-O-glucosyl 
flavonoids (Figure 4.1).  Comparison of the MS3 results, where the parent ion is 
the 2:1 flavonoid glycoside/Ni(II) complex after the loss of one saccharide 
moiety, reveals even more striking differences (Figure 4.2).  The dehydration 
pathway is much more significant for the quercitrin complex, which shows 
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intense losses of one and two water molecules, compared to a minor loss of just 
one water molecule for the analogous glucoside complexes.  The cross-ring 
cleavages are also more significant and more varied.  (Because rhamnose is a 
deoxyhexose,  the mass of the cleaved portion of the saccharide is 16 Da less than 
it would be for glucose.)  The 0,2 cross-ring saccharide cleavage (m/z 703) is the 
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Figure 4.1. MS/MS spectra of [Ni/(II) (FG-H) (FG)]+
complexes of isomeric flavonoid glycosides. 
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cleavage (-120 Da) is minor for the flavonoid glucoside complexes.  The 
quercitrin complex also displays a 0,1 cleavage (-134 Da) and a 0,4 cleavage 
followed by loss of two water molecules (-80 Da), neither of which is observed 
for the flavonoid glucoside complexes.  Furthermore, the quercitrin complex does  
not undergo a significant loss of an aglycon unit, which is the dominant loss for 
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Figure 4.2.  MS3 spectra of [Ni/(II) (FG-H) (FG)]+ complexes 
of isomeric flavonoid glycosides.  
83 
the saccharide can play an important role in determining the fragmentation 
pathways of metal complexes. 
  Flavonoid rhamnosides are easily distinguishable from other types of 
monoglycosyl flavonoids because rhamnose is the only deoxyhexose that 
commonly forms conjugates with flavonoids.  The distinctive mass loss due to 
cleavage of the saccharide moiety (-146 Da) is sufficient to identify flavonoid 
rhamnosides.  In contrast, several hexoses and pentoses are known to form 
conjugates with flavonoids, such that losses due to intact saccharide cleavage are 
not sufficient to identify the monosaccharide.  While glucose is the most typical 
hexose found in naturally-occurring flavonoid glycosides, galactose is also 
common.  These two monosaccharides are diastereomers, differing only in their 
stereochemistry (Figure 4.3).  Furthermore, several isomeric pentoses, including 









Figure 4.3. Structures of isomeric monosaccharide moieties, with 





















Tandem mass spectrometry using protonated, deprotonated and sodium-
cationized flavonoid glycosides does not provide a sufficient means for 
differentiating the isomeric saccharide moieties of these compounds.  But the 
results obtained from metal complexation involving quercitrin were promising in 
terms of developing a similar strategy to identify isomeric monosaccharides 
conjugated to flavonoids.  Thus, a wide variety of metals, including Mg, Ca, Sr, 
Ba, Mn(II), Fe(II), Co(II), Ni(II), Cu(II), Zn(II), K, Ag, and Al was evaluated for 
this purpose in the present study. ESI-MS analysis of solutions containing a 
flavonoid glycoside and a metal(II) salt resulted in detection of 1:1 complexes, 
[M(II) (FG – H)]+, and 2:1 complexes, [M(II) (FG - H) (FG)]+.  The ion 
abundance from these metal complexes was typically on the same order as the 
protonated flavonoid glycoside, (FG+H)+, with the 2:1 complex generally more 
intense than the 1:1 complex.  The fragmentation patterns of both the 1:1 and 2:1 
flavonoid glycoside/metal complexes were evaluated, and MS3 fragmentation was 
performed on key diagnostic fragment ions.  Some degree of isomer 
differentiation was possible using the MS/MS spectra of several of the 1:1 
complexes; however the fragmentation patterns were always very complicated 
and subject to post-dissociation solvent adduction, and in many cases 
differentiation was based only on relative intensities of fragment ions rather than 
on the presence or absence of unique diagnostic fragment ions.  In contrast, the 
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MS/MS spectra of the 2:1 complexes were much simpler, but usually did not 
provide sufficient differentiation of isomers.   
 
4.3.2. Manganese Complexation   
The best differentiation of the flavonoid glucoside/galactoside pairs comes 
from MS3 experiments using the Mn(II) complexes.  Several species are observed 
in the full scans (Figure 4.4), including (FG+H)+ and [Mn(II) (FG-H)]+, but 
typically the most abundant species under the working conditions is the 2:1 
complex, [Mn(II) (FG) (FG-H)]+.  When the 2:1 complexes of the 3-O-hexosides 
are subjected to CID, the only fragment ion is the result of the loss of one hexose 
moiety, -162 Da (data not shown).  However, performing a second stage of CID 
Figure 4.4. Full scan negative ion mode spectra of selected flavonoid 
glycosides (FG) with Mn(II).  Ions are identified as 347: (FG+H)+ –
Hex; 531: (FG+Na)+; 562: [Mn(II) (FG-H)]+; 746: [Mn(II) (FG-H) 


























on this key primary fragment ion leads to a clear differentiation of the 3-O-
glucosides and –galactosides (Figure 4.5).  All of the complexes  exhibit losses of  
the second hexose moiety and of one aglycon unit, but the two flavonoid 
galactoside complexes display the additional loss of an aglycon plus 102 Da, 
providing a means to distinguish these compounds from the corresponding 
flavonoid glucosides.   The loss of  102 Da from saccharide/metal complexes  was  
 
Figure 4.5. MS3 spectra of [Mn(II) (FG-H) (FG)]+ complexes 
of 3-O-hexosides following the loss of one hexose moiety. The 






















































reported by Gaucher and Leary in a study to differentiate hexose sugars using a 
Zn(II)-dien complex.9 They performed isotopic labeling studies indicating that 
sugar carbons 3 through 6 were lost.  Based on this information, they proposed a 
mechanism for this fragmentation which we have adapted for the present case 
(Scheme 4.1).  Starting with the 2:1 complex, one galactoside moiety is lost in the 
first stage of dissociation, followed by the aglycon in the second stage, in effect 
leaving behind a 1:1 complex.  The additional loss of 102 Da is attributed to a 
rearrangement/fragmentation of the remaining galactose moiety, resulting in the 
elimination of C4H6O3.  The flavonoid glucoside complexes do not display this 
fragmentation pathway even up to 50% CID energy, presumably because of 
conformational differences which disfavor this process. 
It is interesting that the [Mn(II) (FG) (FG-H)]+ complexes of flavonoid 3-
O-galactosides fragment identically to the analogous complexes of flavonoid 3-O-
glucosides via MS/MS, yet the difference is revealed in the MS3 experiment.  The 
significance of this result is that the glycosylation site of flavonoid 3-O-
glucosides and 3-O-galactosides may be determined in the same manner.  
Scheme 4.1. Proposed mechanism for the loss of 102 Da from Mn












































Conveniently, the same complex is able to differentiate these isomeric saccharide 
moieties.  MS/MS of the analogous complex involving quercetin 3-O-
arabinofuranoside yielded a different fragmentation pattern.  Thus such 
complexes are not able to universally indicate 3-O-glycosylation.  The only metal 
complex that has thus far shown a saccharide-independent glycosylation site 
signature is [Co(II) (FG-H) (4,7-dpphen)2]+ for 3-O-glycosides (see Section 
3.3.7), and then only for monosaccharide derivatives.   
None of the 2:1 flavonoid glycoside/metal complexes provides a 
satisfactory differentiation of quercetin 3-O-arabinofuranoside and quercetin 3-O-
xyloside.  Instead, differentiation is achieved based on CID of the 3:1 Mn 
complexes, [Mn(II) (FG-H) (FG)2]+ (Figure 4.6).  Below 20% CID energy, the 
arabinoside complex gives only one signficant product ion stemming from the 
loss of one flavonoid glycoside.  However the xyloside complex also yields an 
Figure 4.6. MS/MS spectra of [Mn(II) (FG-H) (FG)2]+
complexes of 3-O-pentosides. DC-FG refers to ([2 Mn(II) 
(FG-H)2 (FG)4]2+ - FG).
quercetin 3-O-xyloside
















abundant fragment ion corresponding to the loss of a flavonoid glycoside plus a 
pentose moiety (m/z 790), in addition to some lower abundance fragments.  Using 
a CID energy around 17% provides the best differentiation of the two isomers. 
 
4.4 CONCLUSIONS 
Performing CID on complexes of the form [Mn(II) (FG-H) (FG)]+ and 
[Mn(II) (FG-H) (FG)2]+ provides information on the glycosylation site and 
saccharide identity of these compounds based on unique and consistent 
fragmentation patterns.  There is a robust differentiation of glucose and galactose 
moieties, at least at the 3-O position, as determined by the similarity of fragment 
ions for glycosides based on two different flavonoids, quercetin and syringetin.  
This type of differentiation will be shown in Chapter 5 to hold for derivatives of 
kaempferol and isorhamnetin derivatives as well.  The differentiation of xylose 
and arabinose has only been demonstrated on quercetin derivatives; therefore it 
cannot be concluded that the same strategy will work on other compounds.  
Additionally, arabinose is known to form conjugates in either its 5-membered ring 
form (furanoside) or its 6-membered ring form (pyranoside).  No standards are 
available to search for contrasting fragmentation of arabinofuranosides and 
arabinopyranosides, so currently this differentiation is not currently possible using 
the metal complexation approach. 
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Chapter 5: Liquid Chromatography-Tandem Mass Spectrometry 
Analysis of Monoglycosyl Flavonoids in Food and Plant Extracts 
Using Postcolumn Manganese Complexation 
 
5.1 INTRODUCTION 
The previous two chapters detail how metal complexation methods in 
conjunction with mass spectrometry can be used to provide conclusive 
identifications of monoglycosyl flavonoids.  However, these experiments 
involved commercially-available analytical standards, which were pre-purified 
and pre-characterized.  Any useful method that purports to identify flavonoid 
glycosides de novo must be tested on real samples.  Furthermore, it is extremely 
difficult and time-consuming to purify each component of a complex mixture 
prior to qualitative analysis.  Therefore, the next goal was to adapt the previously-
described metal complexation methods to LC-MS analysis in order to eliminate 
the need to purify individual compounds, and to test the effectiveness of the 
analytical methods against real food and botanical extracts.  By combining 
purification and identification into a single step, the methods described herein 
provide an efficient and effective means to obtain qualitative information about 
monoglycosyl flavonoids in complex mixtures. 
First, an assessment of the sample requirements for the LC-MS technique 
is given.  The results of three applications are then presented.  The flavonoid 
contents of apple peel and red onions have already been studied, so these analytes 
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provide a means to compare the information obtained by the new technique of 
LC-MS combined with metal complexation to more established (and more time-
consuming) techniques.  Apple peel is known to contain flavonoid glycosides 
with many different saccharide groups,1-5 so it provides a good opportunity to test 
the saccharide identification technique described in Chapter 4 on a real sample.  
Onions, on the other hand, produce flavonoid glycosides with varying O-
glycosylation sites,6-10 which makes it ideal for testing methods for determining 
the position of saccharide groups as discussed in Chapter 3.  After the analyses 
were completed, literature reports on the contents of these foods were used to 
gauge the success of identifying the various flavonoid glycosides in the extracts. 
The third application involves the analysis of an extract from the leaves of 
Silphium albiflorum Gray, a member of the Asteraceae plant family found only in 
central and north-central Texas.11  This analysis represents the more typical case 
in which there is little prior knowledge as to the flavonoid contents of the sample.  
The extract used was known to contain monoglycosyl flavonoids, but ambiguous 
results were obtained by NMR analysis due to the difficulty in isolating each 
component.  This application tested the ability of the new LC-MS/metal 
complexation method to provide conclusive compound identifications when 




5.2.1 Materials   
Manganese (II) chloride was purchased from Aldrich (Milwaukee, WI).  
Quercetin 3-O-galactoside (hyperoside) was purchased from Extrasynthèse 
(Genay, France).  All materials were used without further purification. 
 
5.2.2 Flavonoid Extraction from Apple Peel   
Organic Fuji apples (Malus domestica Borkh. cv. Fuji) were purchased 
from a local supermarket and refrigerated until used.  The extraction procedure 
was adapted from one described by Dick et al.1  One apple was washed and 
peeled, and the peel (~15 g) was immersed in liquid nitrogen before being 
chopped in a blender.  The finely chopped apple peel was added to a flask 
containing 100 mL methanol.  The flask was heated to 50 °C and stirred for 30 
minutes.  The contents of the flask were then filtered through a fritted glass 
funnel, and the extract solvent was passed through 0.2 µm PTFE syringe filters 
(Fisher, Pittsburgh, PA).  This clean-up procedure proved ineffective as a solid 
precipitate formed upon refrigeration of the sample.  The methanol was then 
evaporated with nitrogen, and the extract was redissolved in 8 mL of water with 
0.33% formic acid (mobile phase A).  A C18 SepPak (Waters, Milford, MA) was 
used to purify and concentrate the flavonoid species in the extract.  The cartridge 
was conditioned with 10 mL of acetonitrile with 0.33% formic acid (mobile phase 
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B) followed by 8 mL mobile phase A.  The extract was loaded and washed with 5 
mL of 98:2 A:B.  The flavonoid species were eluted with 2 mL of 67:33 A:B.  
The sample was refrigerated until analyzed, and was injected onto the HPLC 
column without further treatment. 
 
5.2.3 Flavonoid Extraction from Onions 
Red onions (Allium cepa L., unknown cultivar) were purchased from a 
local supermarket and refrigerated until used.  The extraction procedure was 
adapted from one described by Marotti and Piccaglia.6  An onion was peeled and 
sliced, then immersed in liquid nitrogen before being chopped in a blender.  
Approximately 20 g of the chopped onion was added to a flask containing 50 mL 
of 50:42:8 methanol:water:acetic acid.  The flask was covered and refrigerated for 
48 hours.  The extraction mixture was then filtered through a fritted glass funnel, 
and the solvent was evaporated with nitrogen.  The extract was redissolved in 15 
mL of mobile phase A.  A solid phase extraction procedure similar to the one 
described for the apple peel extract was used to purify and concentrate the onion 
extract.  The sample was refrigerated until analysis, and was diluted tenfold with 
methanol prior to injection onto the HPLC column. 
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5.2.4 Flavonoid Glycosides from Silphium Albiflorum  
The extraction was performed by Jeffrey Williams and Małgorzata 
Wojcińska of the University of Texas Department of Biology and Poznań 
University of Medical Sciences, respectively.  The procedure is detailed 
elsewhere.12  One fraction containing several flavonoid glycosides proved 
difficult to purify enough for NMR analysis, so LC-MSn with metal complexation 
was used as an alternate identification method.  Approximately 0.1 mg of this 
fraction was dissolved in 0.5 mL methanol, and this solution was injected onto the 
HPLC column without further treatment. 
 
5.2.5 LC-MS Conditions   
Chromatography was performed using a Waters Alliance 2695 HPLC 
system (Milford, MA).  The column was a Waters Symmetry C18, 2.1 x 50 mm, 
3.5 µm particle size, with a guard column.  The flow rate was 0.3 mL/min, and an 
injection volume of 10 µL was used for most experiments; however 40 µL 
injections were used to verify minor components of the Silphium albiflorum 
extract.  For the apple peel extract, the two-component mobile phase system (see 
Section 5.2.2) was held isocratically at 12% B for 26 minutes, then was increased 
to 98% B over 2 minutes.  For the onion extract, the gradient began at 10% B, 
increased to 25% B over 10 minutes, then to 95% B over 1.5 minutes.  For the 
Silphium albiflorum extract, an isocratic separation method using 14% B for 16 
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minutes was employed.  An ultraviolet (UV) detector monitored the column 
effluent at 280 nm.  The column effluent was directed into the LCQ mass 
spectrometer without splitting.  For negative ion mode experiments, the following 
MS conditions were used: spray voltage, -4.5 kV; sheath gas, 20 units; auxiliary 
gas, 5 units; heated capillary temperature, 200 °C; capillary voltage, -45 V; tube 
lens offset, -45 V.  When flavonoid glycoside/manganese complexes were 
analyzed, 500 µM MnCl2 dissolved in methanol was added at 20 µL/min via a 
mixing tee between the UV detector and the mass spectrometer.  (A diagram of 
the instrumental set-up was shown in Figure 2.1.)  In these cases the positive ion 
mode was employed, using the same spray conditions with the following 
exceptions:  spray voltage, +4.5 kV; capillary voltage, +44 V; tube lens offset, 
+35 V. 
 
5.3 RESULTS AND DISCUSSION 
5.3.1 Sensitivity Assessment 
When a new analytical chemistry technique is developed, it is customary 
to measure the sensitivity of the new method.  The limit of detection (LOD) is 
usually reported, and is defined as the amount or concentration of analyte required 
to produce a signal-to-noise ratio of 3.  But in the case of these metal 
complexation methods, a true LOD is not the most applicable figure of merit.  It is 
not sufficient to simply observe the metal complexes; the complexes must also be 
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fragmented by CID to yield a sufficiently recognizable pattern in order to make 
the proper structural determination.  CID fragmentation processes always involve 
some signal loss due to scattering, so it is more important to evaluate the quality 
of the fragment ion spectrum than the signal-to-noise ratio of the parent complex. 
In order to estimate the sample requirements, a standard of hyperoside 
(quercetin 3-O-galactoside) was chosen because this compound requires two 
fragmentation steps for identification of the saccharide moiety.  A determination 
can be made as to whether the distinguishing fragment ions are clearly observed 
from injections of different amounts of sample (Figure 5.1).  A 200 pmol injection 
of hyperoside yields a clean MS/MS spectrum with the –Hex fragment ion clearly 
visible.  There is a small amount of noise in the MS3 spectrum, but recognition of 
the three expected product ions, including the key –(Agl+102) fragment of m/z 
416 that allows the identification of the galactose moiety, is unimpeded.  In the 
100 pmol injection, the MS/MS data is still fairly free of noise, while the m/z 416 
ion is just visible above the noise in the MS3 spectrum.  In the 50 pmol injection, 
there is more noise in the MS/MS spectrum, though the –Hex fragment is still 
clear.  However, the quality of the MS3 spectrum is so low that it would be 
difficult to distinguish the relevant fragment ions from the noise.  Hence, in this 
example 100 pmol (50 ng) is deemed to be the lowest analyzable quantity below 
which identification becomes uncertain.  This experiment provides a ballpark 
assessment of the sensitivity of the LC-MS metal complexation methods, though 
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there will be variability be compound, by tuning, and by the number of 
fragmentation steps required to identify the flavonoid glycoside. 
Figure 5.1: LC-MSn spectra of hyperoside (quercetin 3-O-
galactoside) complexes, [Mn(II) (FG-H) (FG)]+ using varying 
injection amounts.  a) 200 pmol injection; b) 100 pmol injection; c) 
50 pmol injection.  Some unlabeled peaks in the MS3 spectra are 















































5.3.2 Apple Peel Extract   
Apples were a special target of interest because they are known to contain 
several monoglycosyl flavonoid isomers that differ only by the identity of the 
saccharide moieties, and thus make an excellent test subject for the newly 
developed methods.  The extracts were examined using both negative ion mode 
and positive ion mode (for the Mn complexes) because complementary 
information was obtained from each type of experiment.  The extracts were 
prepared as described in Section 5.2.2.  
The UV chromatogram of the Fuji apple peel extract (Figure 5.2) showed 
eight major flavonoid components, labeled 1 through 8.  LC-MSn analysis in the 
negative ion mode provides the molecular weights of the flavonoid glycosides 
(full scan mode) and the aglycon portions (MS/MS mode), as well as the number 
and weight of the saccharide moieties for each compound (MS/MS mode).  For 









Figure 5.2. UV chromatogram of the Fuji 















example, a loss of 162 Da indicates an O-hexoside, a loss of 146 Da indicates an 
O-deoxyhexoside, and a loss of 132 Da indicates an O-pentoside.13  Losses 
associated with cross-ring saccharide cleavages, such as 120 Da or 90 Da, are 
indicative of C-glycosylation.14  Upon sequential stages of fragmentation (MSn), 
the saccharide moieties can be enumerated and some of their possible identities 
can be eliminated based on molecular weight.  Following the loss of all of the 
saccharide moieties, the weight of the aglycon portion is obtained, and the 
aglycon may be identified by comparing the fragmentation pattern with standards 
or by elucidating its structure based on well-known dissociation pathways of the 
flavonoid aglycons.13,15-18  The process of determining this information for the 
eight major flavonoid species observed in the Fuji apple peel extract is 
summarized in Scheme 5.1.  Compounds 1 through 7 all lose a single saccharide 
moiety, leaving behind a deprotonated aglycon with mass 301 Da.  Further 
1: 463 301 (aglycon)
2: 463 301 (aglycon)
3: 433 301 (aglycon)
4: 433 301 (aglycon)
5: 433 301 (aglycon)
6: 433 301 (aglycon)
7: 447 301 (aglycon)







Scheme 5.1. Summary of negative ion mode 
MS/MS structural data from the flavonoid 




fragmentation of m/z 301 identifies the aglycon as quercetin based on comparison 
to published spectra15 and to the CID spectrum of a commercial standard.  Thus 1 
and 2 are quercetin O-hexosides, 3 through 6 are quercetin O-pentosides, and 7 is 
a quercetin O-deoxyhexoside.  8 was later determined to be a member of the 
chalcone family, a minor flavonoid class that is outside the scope of the current 
study. 
Negative ion mode LC-MSn provides useful structural information but 
does not reveal the nature of the saccharide moieties.  At this point one would 
typically need to isolate each flavonoid glycoside and undertake NMR 
characterization to identify the saccharide moieties.  Another approach would be 
to inject standards to check for matching retention times (although many 
flavonoid glycosides are not commercially available).  In this study, LC-MSn with 
post-column Mn(II) complexation was used to probe the identities and locations 
of the saccharides.  As discussed in Section 3.3.4, complexes of the form [Mn(II) 
(FG-H) (FG)]+ are effective in determining the glycosylation site of flavonoid 
glucosides, and of flavonoid galactosides conjugated at the 3 position (see Section 
4.3.2).  LC-MS/MS of these 2:1 Mn(II) complexes of 1 and 2 in each case yielded 
a single fragment stemming from the loss of one hexose residue.  This is the 
hallmark of 3-O-glycosylation.  A second stage of CID undertaken on this 
fragment ion resulted in spectra that differentiate the two analytes (Figure 5.3).  
The diagnostic loss of one aglycon unit plus 102 Da was observed only for 1.   
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Therefore 1 was determined to be a galactoside and 2 was identified as a 
glucoside.  Upon integration of all of this data, 1 and 2 were identified as 
quercetin 3-O-galactoside and quercetin 3-O-glucoside.  This is in agreement with 
the observation that flavonoid galactosides generally elute before flavonoid 
glucosides.2,19,20 
Of the quercetin pentosides, only 3 and 5 gave Mn(II) complexes of 
sufficient abundance for analysis.  In order to determine the identity of the 
saccharides, LC-MS/MS was performed on the 3:1 complex, [Mn(II) (FG-H) 
(FG)2]+ (Figure 5.4).  The CID spectra of these complexes identify 3 as a xyloside 
and 5 as an arabinofuranoside.  Fragmentation of 7 was not necessary to identify  
Figure 5.3. MS3 of [Mn(II) (FG) (FG-H)]+ complexes 
involving components 1 and 2 of the Fuji apple peel extract. 
The CID energy was 24%.  Some of the unlabeled peaks in 
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this analyte as a quercetin O-rhamnoside because rhamnose is the only saccharide 
of molecular weight 146 known to form natural flavonoid conjugates.13,21 
 Retention time matching with commercial standards confirmed the 
identities of 1 and 2.  The retention times of 3, 5 and 7 matched those of quercetin 
3-O-xyloside, quercetin 3-O-arabinofuranoside, and quercetin 3-O-rhamnoside, 
respectively.  The retention order of these five compounds agrees with other 
published studies of apple flavonoids.1-5  The Mn complexation method provided 
no additional information on compounds 4, 6 and 8.  Using as a guide a 
particularly detailed study of apple waste components by Sánchez-Rabaneda et 
al.,3 it is believed that 4 is quercetin 3-O-arabinopyranoside and 8 is phloretin 2′-


















Figure 5.4. MS/MS spectra of [Mn(II) (FG)2 (FG-H)]+
complexes involving components 3 and 5 of the Fuji 
apple peel extract. The CID energy was 17%.  The ions 
labeled as DC-FG refers to ([2 Mn(II) (FG)4 (FG-
H)2]2+ – FG). 
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reference).  From the same source, some of the early eluting peaks are thought to 
be various cinnamic acid derivatives.  Like the present case, Sánchez-Rabaneda et 
al. observed an unidentified quercetin O-pentoside (6) co-eluting with quercetin 
3-O-rhamnoside.  It is speculated that 6 may be an apiose derivative of quercetin.5 
 
5.3.3 Onion Extract 
There were at least seven different flavonoid species present in the onion 
extract, labeled 9 through 15 in order of elution (Figure 5.5). As with the apple 
extract, negative ion mode LC-MSn was used to determine the weights of the 
aglycon portions and the number and types of glycosyl groups.  This data is 
summarized in Scheme 5.2.  The deprotonated aglycon of m/z 301 Da (9, 10, 12, 
13 and 15) was determined to be quercetin based on comparison of the 
fragmentation pattern to published spectra15 and to the CAD spectrum acquired 














Figure 5.5. UV chromatogram of the red 











from a commercial standard.  15 was further confirmed to be quercetin based on 
comparison of the retention time with a commercial standard.  The deprotonated 
aglycon of m/z 315 (11 and 14) was similarly determined to be isorhamnetin 
based on comparison of the fragmentation pattern with published spectra2 and 
with a commercial standard.  9, 10 and 11 all contain two hexose moieties while 
12, 13 and 14 have one each.  This agrees with the observation that additional 
saccharide moieties increase the polarity of a flavonoid glycoside, thus leading to 
faster elution in reversed-phase chromatography.19   
To reveal the identities, locations, and configurations of the saccharide 
moieties of these analytes, post-column Mn complexation was performed.  9 and 
11 did not form sufficient quantities of the complexes due to their low abundance 
and 15 (a flavonoid aglycon, quercetin) was fully characterized in the negative ion 
mode, so only 10, 12, 13 and 14 were studied using Mn complexation.  The 
9: 625 463 301 (aglycon)
10: 625 463 301 (aglycon)
11: 639 477 315 (aglycon)
12: 463 301 (aglycon)
13: 463 301 (aglycon)









Scheme 5.2. Summary of negative ion mode 
MS/MS structural data from the flavonoid 
components in the red onion extract.
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MS/MS spectra of the 2:1 complexes (Figure 5.6) were collected in order to 
determine the glycosylation sites of these compounds.  The lack of any cross-ring 
saccharide cleavage fragments suggested that all four are 3-O- or 4′-O-glycosides.  
Fragments indicative of 4′-O-glycosides include the loss of one flavonoid 
glycoside molecule and the loss of an aglycon portion, whereas 3-O-glycoside 
complexes generally display only one major loss of a saccharide.  13 clearly
Figure 5.6. CID spectra of [Mn(II) (FG-H) (FG)]+ complexes 
involving components of the red onion extract.  The CID 
energy was 21-22%.  Some unlabeled peaks are post-CID 
adducts of acetonitrile (+41 Da) or water (+18 Da).
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shows these additional fragments, while they do not appear for 12; therefore 13 is 
suggested to be a 4′-O-glycoside while 12 is assigned as a 3-O-glycoside.  14 also 
shows these diagnostic fragment ions, so it is identified as a 4′-O-glycoside of 
isorhamnetin.  10 is a special case: diglycosyl flavonoids are generally outside the 
scope of this study but 10 nonetheless formed complexes of the type [Mn(II) (FG-
H) (FG)]+ of m/z 1306.  Performing sequential stages of fragmentation on this 
complex yielded an ion m/z 982 after the loss of two hexose moieties, presumably 
one from each flavonoid glycoside molecule.  At this point what remained was 
effectively a 2:1 monoglycosyl flavonoid complex, so the position of the 
remaining hexoses could be studied using the same techniques as discussed 
above.  The fragments obtained from m/z 982 match the ones from 13; thus it was 
concluded that at least one of the hexose moieties of 10 is at the 4′-O position. 
The spectral quality is somewhat worse for these LC-MS experiments 
compared to the direct infusion experiments described in Chapter 3.  Considering 
that the diagnostic ions in Figure 5.6 are of fairly low abundance, supporting 
information regarding the glycosylation site is desirable.  Additional evidence is 
obtained through a judicious choice of CID energy.  As described in Section 
3.3.4, the amount of CID energy required to fragment the [Mn(II) (FG-H) (FG)]+ 
complexes of flavonoid 4′-O-glucosides is higher than that of the analogous 
flavonoid 3-O-glucosides.  More specifically, the CID energy required to reduce 
the parent ion of the 3-O-glycoside complexes to 5-10% overall abundance is 
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below 19%, while for the 4′-O-glycoside complexes it is above 22%.  If a 
collision energy between these values is chosen, the survival rate of the parent ion 
can be used as a useful piece of confirming evidence.  A CID energy of 21-22% 
was used to collect the data shown in Figure 5.6.  It was observed that a 
significant amount of the parent ions survive for 10, 13 and 14, which is 
consistent with their assignments as 4′-O-glycosides.  The parent ion of 12 does 
not survive, supporting its identification as a 3-O-glycoside.  Additionally, the 
elution order of these compounds can be used as evidence.19,22  Experience has 
shown that flavonoid 3-O-glycosides generally elute earlier than flavonoid 4′-O-
glycosides (to be discussed further in Section 7.3.3).  This is consistent with the 
assignment of 12 and 13 as 3-O- and 4′-O-glycosides of quercetin, respectively. 
Finally, a second stage of fragmentation determined the identity of the 
hexose moiety of 12.  When the ion of m/z 820 was activated, the fragment ion 
corresponding to the loss of quercetin aglycon plus 102 Da was not observed 
(Figure 5.7).  It is clear that the hexose cannot be galactose, and is therefore 
assigned as glucose.  10, 13 and 14 also lack the diagnostic ion for galactose, but 
this evidence is inconclusive because no standards are available to determine 
whether the Mn complexes of 4′-O-galactosides can be differentiated from 4′-O-
glucosides in the same manner as at the 3-O-position. 
In summary, the peak assignments based solely on these LC-MS methods 
are: 9 – quercetin dihexoside, 10 – quercetin dihexoside (with at least one of the  
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hexoses located at the 4′ position), 11 – isorhamnetin dihexoside, 12 – quercetin 
3-O-glucoside, 13 – quercetin 4′-O-hexoside (possibly glucoside), 14 – 
isorhamnetin 4′-O-hexoside (possibly glucoside), 15 – quercetin.  Standards of 
quercetin 3-O-glucoside and quercetin had the same retention times as 12 and 15, 
respectively, confirming those identifications.  A quercetin 4′-O-glucoside 
standard had the same retention time as 13.  No standard for isorhamnetin 4′-O-
glucoside was available, but isorhamnetin 3-O-glucoside did not match the 
retention time of 14.  The accuracy of these assignments was assessed by 





























Figure 5.7. MS3 spectra of [Mn(II) (FG) (FG-H)]+ complexes 
involving components of the red onion extract. The CID 
energy was 23% in all cases.  Some unlabeld peaks are post-
CID acetonitrile adducts (+41 Da).
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components.6,8-10 Based on the literature, it is believed that 12, 13, 14 and 15 have 
been identified correctly using the LC-MS method with Mn complexation.  10 is 
almost certainly quercetin 3,4′-di-O-glucoside,10 and 9 may be quercetin 7,4′-di-
O-glucoside.9  11 may be isorhamnetin 3,4′-di-O-glucoside, which has been 
reported as a minor flavonoid glycoside in onions.7 
 
5.3.4 Silphium albiflorum Extract 
LC-MS analysis of the Silphium albiflorum extract revealed four 
components, two (16 and 17) of molecular weight 448 and two (18 and 19) of 
molecular weight 478 (Figure 5.8).  In negative ion mode, CID resulted in the loss 













Figure 5.8. Mass chromatograms of flavonoid components 
of a Silphium albiflorum fraction, acquired in negative ion 
mode with selected ion monitoring.
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determined to be kaempferol derivatives and 18 and 19 were identified as 
isorhamnetin derivatives by comparing the fragmentation patterns of the aglycon 
portions with commercial standards.  In order to determine the locations and 
identities of the hexose moieties, LC-MSn with post-column manganese 
complexation was used.  Performing CID on the [Mn(II) (FG-H) (FG)]+ 
complexes yielded a single fragment ion corresponding to the loss of one hexose 
moiety (Figure 5.9 a).  This result is indicative of 3-O-glycosylation.  Further 
dissociation of these initial fragment ions allowed the hexose moieties to be 
identified (Figure 5.9 b).  Losses of the second hexose moiety and of an aglycon 
Figure 5.9.  (a) MS/MS and (b) MS3 spectra of the [Mn(II) (FG-H) (FG)]+
complexes involving components of the Silphium albiflorum extract.  Some 

































































portion were observed for all four complexes.  However an additional fragment 
ion corresponding to the loss of an aglycon portion plus 102 Da was observed 
only for 16 and 18.  Thus the compounds in the extract were identified as: 16 – 
kaempferol 3-O-galactoside, 17 – kaempferol 3-O-glucoside, 18 – isorhamnetin 
3-O-galactoside, and 19 – isorhamnetin 3-O-glucoside.  The identities of 17 and 
19 were confirmed by retention time comparison with commercial standards.  No 
standards were available for 16 and 18, but their identifications are supported by 
the observation that flavonoid galactosides generally elute slightly earlier than 
flavonoid glucosides using reversed-phase HPLC.2,19,20 
 
5.4 CONCLUSIONS 
Performing CID on complexes of the form [Mn(II) (FG-H) (FG)]+ and 
[Mn(II) (FG-H) (FG)2]+ provides information on the glycosylation site and 
saccharide identity of these compounds based on unique and consistent 
fragmentation patterns.  This method of identifying flavonoid glycosides was 
applied to the on-line LC-MS analysis of a Fuji apple peel extract, a red onion 
extract and an extract from Silphium albiflorum.  Combined with information 
obtained from the deprotonated analytes, this method allowed the identification of 
several of the flavonoid glycosides in the extracts.  Supporting evidence was 
obtained by using retention time comparison with commercial standards and 
knowledge of the elution order associated with various structural features.  The 
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identifications were in agreement with the literature.  Although complete 
identifications could not be made in all cases, significantly more structural 
information was obtained than was previously possible using conventional LC-
MS techniques.  Furthermore, metal complexation has been shown to be a 
promising approach to mass spectrometric differentiation of flavonoid glycosides 
even when standards are not available.  It is hoped that further correlations 
between structure and dissociation behavior will be found such that full 
characterization of these and similar compounds will be possible using simple 
LC-MS techniques.  This would be a significant advantage over the isolation and 
purification of each compound followed by NMR analysis that is currently the 
standard method for characterizing the saccharide moieties of flavonoid 
glycosides. 
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Chapter 6: Identification of Monoglucuronyl  
Flavonoid Metabolites in Urine, Plasma and Cell Cultures  
Using Metal Complexation and LC-MSn 
 
6.1 INTRODUCTION 
Chapters 3, 4 and 5 covered structural identification of flavonoid 
glycosides, with applications in botanical and food analysis.  This chapter and the 
next focus on the metabolic and biotransformational products of flavonoids.  The 
investigation of metabolic pathways is a vital step in understanding the 
mechanism of action of bioactive molecules.  Recent work has begun to shed light 
on the biotransformation of dietary flavonoids.1  It is now known that while 
flavonols, flavanones and flavones are consumed in the diet mainly as glycoside 
conjugates, the saccharide portions are removed during absorption.2-4  Because 
metabolism occurs rapidly, it is mainly the glucuronidated, sulfated and 
methylated derivatives that are present in plasma following consumption of 
flavonoids.5,6  As a result of these findings, concerns have been raised about the 
reliability of much of the in vitro data on flavonoid bioactivity.7,8  Most in vitro 
studies have involved either flavonoid aglycons or glycosides that are not present 
for any appreciable amount of time in the body, and the doses applied are often at 
much higher levels than are achieved in vivo after eating foods rich in flavonoids.  
It has therefore been suggested that in vitro studies of flavonoids should use 
metabolites rather than commercially available aglycons and the glycoside forms 
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found in foodstuffs.7,8  However, the problem remains that far less is known about 
the in vivo metabolites than about their precursors, and relatively few analytical 
methods have been developed for studying these metabolites.  The commercial 
availability of flavonoid metabolite standards is extremely limited. 
As with all flavonoid derivatives, determining the substitution patterns of 
flavonoid glucuronides is a considerable challenge.  Nuclear magnetic resonance 
(NMR) spectroscopy may be used to obtain this information,9,10 but this technique 
is less applicable to dietary metabolites which are present in very low 
concentrations.  A UV-Vis spectroscopic method11 has also been used to 
determine the position of the glucuronide moieties on flavonoid metabolites,12 but 
this is a complicated method involving the use of several shift reagents.  Liquid 
chromatography/tandem mass spectrometry (LC-MSn) is in many ways an ideal 
method for analyzing and identifying flavonoid metabolites due to its high 
sensitivity, applicability to complex mixtures, and ability to provide structural 
information.  However, full structural characterization is often not possible by 
mass spectrometry (MS).  While flavonoid glucuronides can be identified by the 
characteristic loss of the glucuronic acid moiety (-176 Da) upon dissociation, it 
has not yet been possible to determine the location of the glucuronic acid moiety 
by mass spectrometry.13-17  Previous work has shown that the positions of 
saccharide moieties have a large effect on the bioactivity of flavonoids18,19 and a 
similar effect was noted for conjugated metabolites.12  Thus the ability to 
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elucidate the structure of flavonoid metabolites as comprehensively as possible is 
extremely useful. 
Metal complexation combined with tandem mass spectrometry was shown 
in earlier chapters to be an effective strategy for the structural identification of 
flavonoid glycosides.  This chapter introduces metal complexation methods that 
allow the position of glucuronidation to be determined for flavonoid metabolites 
containing a single glucuronic acid moiety.  Four isomeric quercetin 
monoglucuronides were differentiated based on characteristic fragmentation 
patterns observed upon collision-induced dissociation (CID) of the complexes.  
Moreover, consistent product ion signatures were found for complexes involving 
7-O-glucuronides and 3-O-glucuronides in the flavonol, flavone, and flavanone 
groups.  The metal complexation methods were adapted for the analysis of 
flavonoid glucuronides in complex biological matrices via LC-MS with post-
column complexation.  The four quercetin glucuronides were spiked into rat 
plasma in order to estimate the sensitivity of the method.  Finally, several 
applications are presented.  The in vivo human urinary metabolites of citrus 
flavonoids were identified following consumption of grapefruit juice and oranges, 




6.2.1 Materials   
Quercetin 3-O-glucuronide,20 quercetin 3′-O-glucuronide,20 quercetin 4′-
O-glucuronide,21 quercetin 7-O-glucuronide21 and naringenin 7-O-glucuronide22 
were synthesized by Paul Needs and Paul Kroon at the Institute of Food Research 
(Norwich, UK).  The above compounds were analyzed in their sodium salt form. 
Baicalin (baicalein 7-O-glucuronide) was purchased from Extrasynthèse (Genay, 
France).  Kaempferol 3-O-glucuronide was purchased from Apin Chemicals 
(Abingdon, UK).  Cobalt(II) bromide, 4,7-dimethyl-1,10-phenanthroline (4,7-
dmphen), and 4,7-diphenyl-1,10-phenanthroline (4,7-dpphen) were purchased 
from Aldrich (Milwaukee, WI).  Structures of the phenanthroline ligands and a 
representative flavonoid glucuronide are depicted in Figure 6.1.  Rat plasma was 




(4,7-dmphen)  C14H12N2, MW=208
X=Ph:  4,7-diphenyl-1,10-phenanthroline
(4,7-dpphen)  C24H16N2, MW=332















The urine samples from the grapefruit study were obtained from an earlier 
set of experiments, the details of which are published elsewhere.17  The urine and 
plasma samples from the orange feeding study were obtained from the Institute of 
Food Research.  Volunteers were given either 150 g of fresh orange segments or 
300 g of orange juice as part of a standard breakfast.  Blood and urine samples 
were collected from the volunteers.  Full details of the study design will be 
available in an upcoming publication.  The qualitative analysis of some of these 
samples is presented here.  The CaCo-2 cell culture samples were prepared by 
Robert Barrington of the Institute of Food Research.  All urine, plasma and cell 
culture samples were kept frozen until analysis. 
 
6.2.2 Direct Infusion Experiments 
The complexes were formed in methanol by adding CoBr2, a flavonoid 
glucuronide, and either 4,7-dpphen or 4,7-dmphen, all at 10 µM concentrations.  
Experiments were performed on an LCQ Duo quadrupole ion trap mass 
spectrometer (Thermo Electron, Waltham, MA) with an ESI source.  Solutions 
were introduced at a flow rate of 5 µL/min.  The metal complexes were analyzed 
in the positive ion mode with a spray voltage of +5 kV and a heated capillary 
temperature of 150 °C.  The gas flow rates, capillary voltage and tube lens offset 
were optimized for maximum signal intensity on a daily basis.  An ion injection 
time of 10 msec was used for full scan mass spectra and 50 msec was used for 
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CID experiments.  100 individual scans were averaged for each spectrum.  The 
CID collision energies were converted from the Normalized Collision Energy23 
values given by the LCQ mass spectrometer into absolute voltages applied to the 
ion trap during dissociation.  Because the non-covalent complexes are relatively 
“fragile”, isolation windows of 3-5 Da were required to obtain stable 
fragmentation spectra.24  Such wide isolation windows have been reported for a 
variety of other non-covalent complexes examined by quadrupole ion trap mass 
spectrometry.25-27  Product ion abundances are reported relative to the most 
abundant ion in the spectrum, which is designated as 100%. 
 
6.2.3 Analysis of Spiked Rat Plasma 
The four quercetin glucuronides were spiked into 500 µL of rat plasma to 
achieve 1 µM concentrations.  The analytes were stabilized as described by Day et 
al.28 by the addition of 50 µL of 0.65 mM acetic acid and 10 µL of 50 mM 
ascorbic acid as an antioxidant.  After gentle mixing, 1 mL of acetonitrile was 
added to precipitate the plasma proteins.  The sample was vortexed for 1 min and 
centrifuged for 10 min at 16000 g.  The supernatant was collected and evaporated 
with nitrogen.  The sample was reconstituted with 200 µL of water, 20 µL of 0.65 
mM acetic acid and 20 µL of 50 mM ascorbic acid.  Chromatography was 
performed on a Waters Alliance 2695 HPLC system (Milford, MA).  The 
stationary phase was a Waters Symmetry C18 column, 2.1 x 50 mm, 3.5 µm 
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particles, with a matching guard column.  An injection volume of 10 µL was used.  
A gradient method was employed using water with 0.05% formic acid as mobile 
phase A and methanol with 0.05% formic acid as mobile phase B.  The gradient 
started at 35% B and increased to 75% B over 20 min, then increased to 95% B 
over 1 min, followed by re-equilibration.  The flow rate was 0.1 mL/min.  The 
UV signal was monitored at 370 nm.  Post-column addition was performed by 
mixing the column effluent with a 5 µM methanolic solution of CoBr2 and 4,7-
dpphen flowing at 20 µL/min, which was added via a tee connection and 
controlled by a syringe pump.  This mixture was introduced directly into the mass 
spectrometer, which was operated with a spray voltage of +4.5 kV and a capillary 
temperature of 200 °C.  The gas flow rates, capillary voltage and tube lens offset 
were optimized for the highest signal intensity of the complex of interest.  The 
automatic gain control (AGC) settings were used with a target of 2 x 107 ions and 
5 microscan averaging. 
 
6.2.4 Urine Analysis from Grapefruit Juice Study 
  Samples of human urine collected after the consumption of grapefruit 
juice were obtained in a previous study.17  Only samples from one human 
volunteer were re-analyzed.  The 4.25 hour timepoint was used because this was 
near the time of highest metabolite concentration excreted.17  The frozen sample 
was thawed, and 400 µL of urine was added to 800 µL methanol and centrifuged 
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for 5 min at 16000 g.  The supernatant was drawn off and evaporated with 
nitrogen.  The sample was reconstituted in 1 mL of water with 0.05% formic acid 
(v/v).  Solid phase extraction was performed using a C18 SepPak (Waters, 
Milford, MA).  The SepPak was conditioned with methanol and 0.33% formic 
acid followed by water and 0.33% formic acid.  The urine extract was loaded, 
washed with 90:10:0.33 water/methanol/formic acid, and eluted with 2 mL 
25:75:0.33 water/methanol/formic acid.  The chromatographic hardware, 
stationary phase and mobile phases were the same as described in Section 6.2.3.  
An injection volume of 10 µL was used.  The isocratic separation method used 
70% mobile phase B with a flow rate of 0.1 mL/min.  The column effluent was 
sent to a UV detector operated at 280 nm prior to MS analysis.  Post-column 
addition and analysis of the metal complexation was performed as described in 
Section 6.2.3. 
 
6.2.5 Urine Analysis from Orange Intervention Study 
2.5 mL aliquots of urine were added to 7.5 mL of methanol to effect 
protein precipitation.  The mixture was vortexed and centrifuged for 15 min at 
1380 g.  The supernatant was collected and evaporated with nitrogen down to 
approximately 500 µL. The chromatographic hardware, stationary phase and 
mobile phases were the same as described in Section 6.2.3.  Injection volumes of 
20-40 µL were used.  The gradient began at 25% B, increased to 30% B over 10 
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min, then increased to 50% B over 10 min, then to 100% B over 5 min, and was 
held constant at 100% B for 2 additional min.  The flow rate was 0.3 mL/min 
throughout.  For negative ion mode experiments, a spray voltage of -4.5 kV was 
used.  The conditions used for metal complexation experiments were as described 
in Section 6.2.3. 
 
6.2.6 Analysis of Cell Culture Extracts 
CaCo-2 cell cultures were treated with kaempferol or galangin to produce 
glucuronidated and sulfated metabolites.  The synthesis and extraction of these 
metabolites was performed at the Institute of Food Research, and details of these 
procedures will be available in a forthcoming publication.  10 µL aliquots of the 
extracts were injected and analyzed by LC-MS.  All chromatography and mass 
spectrometry parameters were the same as described in Section 6.2.5. 
 
6.3 RESULTS AND DISCUSSION 
6.3.1 Direct Infusion Experiments 
Before focusing on metal complexation, the ability to differentiate 
isomeric flavonoid glucuronides based on tandem MS of the protonated or 
deprotonated species was evaluated.  Because most of the standards were 
analyzed in their salt forms, these compounds provided very good signal intensity 
in the negative ESI mode.  The MS/MS spectra of the [FG-H]- ions, however, 
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showed few distinguishing features (Figure 6.2).  Three of the quercetin 
glucuronides yielded only one significant product ion (>5% relative abundance) 
resulting from the loss of the glucuronic acid moiety.  It is impossible to 









































Figure 6.2. MS/MS spectra of the [FG - H]- species. The CID energy 







of dissociation (MSn) were not helpful.  Quercetin 7-O-glucuronide provided 
additional product ions due to cross-ring cleavages29 of the glucuronic acid 
moiety, such as 0,3X- and 0,2X-, but these extra product ions were not observed in 
the CID spectra of the other flavonoid 7-O-glucuronides.  Furthermore, 
naringenin 7-O-glucuronide and baicalein 7-O-glucuronide both displayed a 
prominent loss of the aglycon portion of the molecule, which did not occur for 
quercetin 7-O-glucuronide.  Ideally, a distinctive fragmentation pattern would be 
indicative of a particular site of glucuronidation regardless of the aglycon portion 
(which can be identified by other MS strategies).  CID of the deprotonated 
flavonoid glucuronides does not provide such consistent indicators.  The 
protonated species were also examined, but they proved difficult to observe as 
two protons must be transferred to the negatively-charged analytes to produce 
singly-charged positive ions.  The positively-charged analytes could not be 
observed consistently even with the addition of acid, so attempts to work with 
these species were abandoned. 
 Given the similarity between flavonoid glucosides and flavonoid 
glucuronides, it was hypothesized that a metal complexation approach30-36 might 
be effective in determining the position of the glucuronide moiety, but the 
intrinsic negative charge on the flavonoid glucuronides proved to be a major 
obstacle in emulating these earlier methods.  Divalent metal cations like Mn(II) 
and Mg(II), which had been so useful in previous applications,35,36 did not form 
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sufficiently abundant complexes with the analytes.  This may be explained by the 
formation of neutral complexes of the type [M(II) (FG-H)2]0, which are 
“invisible” to the mass spectrometer.  The metal ions Fe(III) and Al(III) were 
expected to form [M(III) (FG-H)2]+ products, but these metals also failed to 
provide observable complexes.  Monovalent metals such as Li and Na would form 
neutral adducts [M(I) (FG-H)]0 and so were not suitable candidates in the positive 
ESI mode, but the [M(I) (FG-H)2]- species were quite abundant in the negative 
ESI mode.  However, identical fragmentation profiles were obtained upon CID of 
isomeric species.   
The formation of neutral flavonoid glycoside/metal complexes is a dead 
end for MS strategies, and one solution has been found based on the use of 
auxiliary ligands.30  A neutral ligand replaces a negatively-charged flavonoid 
conjugate in the complex, ensuring an overall net positive charge.  The use of 
auxiliary ligands in flavonoid glycoside/metal complexes has been shown to 
improve the sensitivity of analysis,30 and the ligand itself plays a vital role in 
determining how the complex will dissociate.32  Phenanthroline-based ligands had 
been fruitful in the past, so they were selected for the present application.  Two 
different auxiliary ligands, 4,7-dmphen and 4,7-dpphen, were found that formed 
complexes with the flavonoid glucuronides and cobalt(II) while also allowing 
isomer differentiation by CID.  Nickel(II) formed similar complexes, but the 
fragmentation results were rather less useful than with cobalt(II). 
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The best metal complexation mode found for differentiating the four 
quercetin monoglucuronide isomers involves the use of complexes of the form 
[Co(II) (FG-H) (4,7-dmphen)]+.  Dissociation of these complexes by CID results 
in four different fragmentation patterns, each with a unique set of product ions 
(Figure 6.3).  The differentiation is based on the presence or absence of three key 
product ions: m/z 442 (loss of quercetin aglycon), m/z 536 (loss of the 4,7-
dmphen molecule), and m/z 568 (loss of the glucuronic acid moiety).  The 
quercetin-3-O-glucuronide complex dissociates to yield only one significant ion 
(>5% relative intensity) of m/z 536, in contrast to the other quercetin glucuronide 
complexes, for which the ion of m/z 568 is the most abundant product ion.  The 
Figure 6.3. MS/MS spectra obtained from [Co(II) (FG-H) (4,7-
dmphen)]+. Insets show magnifications of the region between m/z




























































































loss of the glucuronic acid moiety is the only significant product ion yielded by 
the quercetin 4′-O-glucuronide complex, while the quercetin 3′-O-glucuronide 
complex and the quercetin 7-O-glucuronide complex yield small but significant 
losses of 4,7-dmphen and quercetin aglycon, respectively.  It is hypothesized that 
the characteristic fragmentation patterns of these isomeric complexes are due to 
conformational differences which favor or disfavor the various dissociation 
pathways.  This hypothesis is supported by the recent work of Clowers and Hill,37 
who used dual gate-ion mobility-quadrupole ion trap mass spectrometry to show 
that isomeric flavonoid glycosides complexed to various metal ions have different 
collisional cross-sections, an indication of conformational differences.  Some 
complexes in that study assumed more than one stable conformation. 
Energy variable CID experiments were undertaken to determine the 
dependence of these characteristic fragmentation pathways on collision energy 
(Figure 6.4).  It was found that the key product ions appear for all complexes 
beginning at around 1.0 V applied to the trap during dissociation, and these ions 
are fairly stable in their appearance until at least 1.6 V.  The insensitivity of the 
fragmentation pathways to collision energy is beneficial in that there is no need 
for fine control of this parameter in order to make the differentiation.  In addition, 
these results are promising in terms of the ability to transfer this method to other 
tandem mass spectrometers which may be calibrated differently with respect to 
CID energies and performance. 
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While the [Co(II) (FG-H) (4,7-dmphen)]+ complexes are extremely useful 
for differentiating the position of the glucuronide moiety of quercetin  
monoglucuronides, the same patterns of product ions were not observed for 
compounds derived from other flavonoids.  Instead two other types of complexes 
were found that provide consistent fragments based on the glucuronidation 
position, regardless of the type of flavonoid.  For example, complexes of the form 
[Co(II) (FG – H) (4,7-dmphen)2]+ yield consistent product ion profiles that reflect 
Figure 6.4. Energy variable CID results from [Co(II) (FG-H) (4,7-
dmphen)]+ complexes involving quercetin glucuronides. The precursor 
ion and minor product ions are omitted.  Fragments are identified as: 
m/z 568 (loss of the glucuronic acid moiety), m/z 536 (loss of 4,7-
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Figure 6.5. MS/MS spectra obtained from [Co(II) (FG-H) (4,7-dmphen)2]+. 









































































the position of glucuronidation for flavonols, flavones and flavanones (Figure 
6.5).  The quercetin-3-O-glucuronide complex is differentiated from its isomers 
by the lack of a significant product ion corresponding to the loss of 4,7-dmphen    
(m/z 744).  This ion is also absent from the CID spectrum of the kaempferol 3-O-
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glucuronide complex, suggesting a consistent indicator of glucuronidation at the 3 
position.  The quercetin 7-O-glucuronide complex is differentiated from its 
isomers as it is the only one that yields abundant product ions stemming from the 
individual losses of 4,7-dmphen and of the glucuronide moiety.  Only one of these 
two fragments appears with significant abundance in the MS/MS spectra of the 
other quercetin glucuronide complexes.  Both product ions are also seen for the 
naringenin 7-O-glucuronide and the baicalein 7-O-glucuronide complexes.  The 
presence of significant amounts of both product ions (loss of 4,7-dmphen and loss 
of the glucuronide moiety) in the MS/MS spectra of only the complexes involving 
the flavonoid 7-O-glucuronides suggests a potential general method for 
identifying flavonols, flavones and flavanones with a glucuronide moiety at 
position 7.  The complexes involving quercetin 3′-O-glucuronide and quercetin 4′-
O-glucuronide may be differentiated by the relative intensities of the ions of m/z 
568 and m/z 744, but this type of differentiation is not expected to be applicable 
to flavonoid glucuronides based on aglycons other than quercetin.  Generally, the 
fragmentation pattern displayed by these complexes may only be said to be 
indicative of B-ring glucuronidation, without specifying the particular position of 
conjugation. 
A third type of complex, [Co(II) (FG-H) (4,7-dpphen)2]+, provides results 
similar to those obtained from [Co(II) (FG-H) (4,7-dmphen)2]+, but is worth 
discussion because this complex was found to be the most adaptable to LC-MS 
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analysis.  The results of the energy variable CID experiments are shown in Figure 
6.6.  It is seen that the [Co(II) (FG-H) (4,7-dpphen)2]+ complex involving 
quercetin 7-O-glucuronide provides a unique signature of product ions (among the 
quercetin-based complexes), including significant losses of the glucuronic acid 
moiety and the 4,7-dpphen ligand, both individually and concurrently, as well as 
loss of the flavonoid aglycon.  Naringenin 7-O-glucuronide and baicalin also 
share these distinctive fragmentation characteristics (not shown).  Quercetin 3-O-
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Figure 6.6. Energy variable CID results from [Co(II) (FG-H) (4,7-dpphen)2]+
complexes involving quercetin glucuronides.  The precursor ion and minor 
product ions are omitted.  Fragments are identified as: m/z 1024 (loss of the 
glucuronic acid moiety), m/z 898 (loss of the aglycon portion), m/z 868 (loss of 
4,7-dpphen), m/z 692 (loss of 4,7-dpphen and the glucuronic acid moiety).
m/z 898













































dpphen.  Two other compounds, quercetin 3′-O-glucuronide and quercetin 4′-O-
glucuronide, are differentiated based on relative ion abundances.  The two most 
abundant products, the ions of m/z 692 and m/z 868, correspond to the loss of a 
4,7-dpphen molecule either with or without the glucuronic acid moiety.  In the 
range of 1.5-1.8 V of activation potential, the ion of m/z 868 is consistently the 
more abundant fragment of the quercetin 3′-O-glucuronide complex, while the ion 
of m/z 692 is the more abundant fragment of the quercetin 4′-O-glucuronide 
complex.  Therefore these two isomers can be confidently differentiated using a 
CID voltage in the range of 1.5-1.8 V.  As with the other complexation modes, the 
differentiation of 3′-O-glucuronide from 4′-O-glucuronide applies only to 
quercetin derivatives and is not expected to be effective for derivatives of other 
flavonoids. 
 
6.3.2 Spiked Rat Plasma 
The concentration of flavonoid glucuronides in human blood is typically 
between 0.1 to 2 µM following the consumption of flavonoid-rich foods.6,28  
Experiments were performed to determine whether metal complexation methods 
are effective at these low concentrations.  A solution of the four quercetin 
glucuronide standards (1 µM each) was prepared and analyzed by LC-MSn with 
post-column complexation.  Each compound could be identified based on the 
fragmentation of [Co(II) (FG - H) (4,7-dpphen)2]+ (m/z 1200). 
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Having established that 1 µM concentrations can be analyzed in this way, 
the quercetin glucuronides were spiked into rat plasma at the 1 µM level, and 
were then extracted and analyzed as described in Section 6.2.3.  All four 
compounds could be observed and identified in this manner.  Based on the 
similarities between these MS/MS results and those obtained by direct infusion, 
the four compounds were identified as: quercetin 7-O-glucuronide (retention time 
10.5 min), quercetin 3-O-glucuronide (retention time 14.1 min), quercetin 4′-O-
glucuronide, (retention time 17.4 min), and quercetin 3′-O-glucuronide (retention 
time 20.5 min).  These results are promising in terms of using LC-MS methods to 
identify flavonoid glucuronides from blood samples obtained from in vivo studies. 
 
6.3.3 Grapefruit Juice Study 
Urine samples were obtained from a metabolism study involving the 
consumption of grapefruit juice.17  In that study, several glucuronidated and 
sulfated metabolites were partially identified by LC-MS on the basis of 
characteristic losses from the metabolites.  However, the positions of 
glucuronidation could not be determined conclusively.  One of these urine 
samples was re-analyzed using the new methods reported herein. The sample was 
prepared and analyzed as described in Section 6.2.4.  Two naringenin 
glucuronides were found using LC-MS in the negative ESI mode by the m/z value 
 136
of the deprotonated analyte (m/z 447) and the characteristic loss of the glucuronic 
acid moiety (-176 Da) upon dissociation. 
When post-column complexation was employed, the analytes formed 
ample complexes of the type [Co(II) (FG - H) (4,7-dpphen)2]+ of m/z 1170.  
Identification of the glucuronidation position was made by comparing the MS/MS 
data (Figure 6.7) to those collected by direct infusion as described above.  The 
fragmentation behavior of complex 1 matched that of the naringenin 7-O-
glucuronide complex.  This assignment is consistent with the results of an 
alternate identification method based on retention time matching with the 
Figure 6.7. LC-MS/MS spectra of [Co(II) (FG-H) (4,7-dpphen)2]+ (m/z
1170) from human urine following consumption of grapefruit juice.  A 
collision energy of 1.59 V was used. The direct infusion MS/MS 
spectrum of the same complex involving a standard of naringenin 7-O-
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authenticated standard from the Institute of Food Research.  Complex 2 represents 
the more typical case where an authenticated standard is not available and the 
dissociation behavior of the complex is not known beforehand.  This complex 
yields two significant product ions corresponding to the loss of 4,7-dpphen with 
and without the glucuronide moiety.  This mirrors the behavior of the quercetin 
3′-O-glucuronide and quercetin 4′-O-glucuronide complexes.  As naringenin does 
not possess a hydroxyl group at the 3′ position, 2 was assigned as naringenin 4′-
O-glucuronide.  This assignment is in agreement with Abe et al., who noted that 
naringenin 4′-O-glucuronide is retained longer by reversed-phase chromatography 
than the analogous 7-O-glucuronide.38  The similarity of the fragmentation 
pathways suggests that consistent fragments found for model compounds may be 
extended to identify other flavonoid glucuronides without standards. 
 
6.3.4 Orange Intervention Study 
Urine samples from nineteen volunteers in an orange intervention study 
were screened for flavonoid metabolites.  Five metabolites (3-7) were identified at 
the Institute of Food Research and were independently and blindly confirmed 
using metal complexation methods.  Negative ion mode analysis of components 3 
(retention time = 11.7 min) and 4 (RT = 12.9 min) revealed the masses of both of 
these compounds to be 448 Da.  In each case, CID led to the loss of 176 Da, 
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corresponding to a glucuronic acid moiety and producing a fragment ion of m/z 
271.  The second-generation fragment ions stemming from the aglycon portion 
(m/z 271) matched the fragmentation pattern of deprotonated naringenin, a 
member of the flavanone group whose glycosides are known to occur in 
oranges.39  Post-column metal complexation was then performed to pinpoint the 
specific sites of glucuronidation of the two metabolites.  The fragmentation of the 
metal complexes of 3 and 4 were very similar to those of 1 and 2 from the 
grapefruit juice study.  Using the same reasoning as before, 3 was identified as 
naringenin 7-O-glucuronide and 4 as naringenin 4′-O-glucuronide. 
  Similar evidence was used to identify unknowns 5 (RT = 14.9 min) and 6 
(RT = 17.8 min).  Negative ion mode LC-MS revealed two compounds of mass 
478 Da (based on the formation of deprotonated molecular ions of m/z 477) that 
fragmented to yield a single neutral loss of 176 Da, corresponding to the 
glucuronic acid moiety.  The second-generation fragment ions from subsequent 
MS3 experiments are indicative of hesperetin as revealed based on comparison to 
the fragmentation pattern of a standard (Figure 6.8).  Fragmentation of the metal 
complex of 5 indicates a glucuronic acid moiety at the 7 position, whereas the 
metal complex of 6 indicates B-ring glucuronidation, i.e. at the 3′ position of 
hesperetin (Figure 6.9).  Thus 5 was positively identified as hesperetin 7-O-
glucuronide and 6 as hesperetin 3′-O-glucuronide.  7 was partially identified as a 
hesperetin sulfate based on its mass (382 Da), the loss of 80 Da upon 
 139
fragmentation (corresponding to SO3), and second-generation fragment ions that 
resemble those of hesperetin.  To the best of my knowledge, there is no purely 
mass spectrometry-based method for determining the location of sulfate groups on 
flavonoids. 
In addition to the above compounds, the LC-MSn analysis additionally 
revealed several disubstituted metabolites in the urine samples.  A hesperetin 
glucuronide sulfate (RT = 16.6 min) was identified based on its mass (558 Da), 
neutral losses of 80 Da and 176 Da upon CID, and an aglycon fragmentation 
signature matching that of hesperetin.  Surprisingly, metal complexation was able 
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Figure 6.8.  Negative ion mode LC-MS3 spectra used to identify 
flavonoid glucuronides in urine samples from the orange 
intervention study.  A direct infusion MS/MS spectrum of a 
hesperetin standard is shown for comparison.
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complexation technique was developed originally for the characterization of 
flavonoid monoglucuronides, but the hesperetin glucuronide sulfate also formed a 
metal complex of the correct stoichiometry, observed at m/z 1280 in the positive 
mode ESI mass spectrum.  The first stage of CID led to the loss of the sulfate 
group (-80 Da), effectively resulting in a metal complex of a flavonoid 
monoglucuronide, which was then characterized based on its fragmentation 
pattern as described for the other compounds above.  The second stage of 
fragmentation, using m/z 1200 as the precursor ion, yielded a CID mass spectrum 
similar to that shown in Figure 6.9 for unknown 5.  This strongly suggests that the 
glucuronic acid moiety of this hesperetin glucuronide sulfate is located at the 7 
position. A similar strategy was used previously to partially identify a diglycosyl 
flavonoid from an onion extract while employing metal complexes designed to 























Figure 6.9.  LC-MS/MS spectra of [Co(II) (FG-H) (4,7-dpphen)2]+ 
(m/z 1200) of hesperetin glucuronides in urine samples from the 
orange intervention study.
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diglucuronidated flavonoids were found in the urine samples.  Two early-eluting 
components (RT = 4.8 and 9.9 min) were identified as hesperetin diglucuronides.  
These analytes both had a mass of 654 Da, exhibited two sequential losses of 
glucuronic acid (-176 Da), and yielded fragmentation patterns of the aglycon 
group that corresponded to hesperetin.  In addition there was at least one other 
low-intensity compound resembling a naringenin diglucuronide that appeared in 
only a few urine samples.  This analyte had a mass of 624 Da, had a retention 
time of 1.9 minutes, and lost two glucuronic acid moieties upon sequential stages 
of CID.  However, the low abundance of this analyte combined with signal losses 
due to scattering during each stage of fragmentation led to a MS4 spectrum with a 
poor signal-to-noise ratio.  While there was evidence of naringenin aglycon, the 
spectrum was too noisy to make a conclusive identification.  Metal complexes 
could not be formed for any of the purported naringenin or hesperetin 
diglucuronides, possibly due to low abundance of these compounds. 
 
6.3.5 Cell Culture Extracts 
Two cell culture samples were prepared, one treated with galangin and the 
other with kaempferol.  Full scan mass chromatograms were obtained from each 
sample, and the data was subsequently examined for the presence of likely 
galangin and kaempferol metabolites: glucuronides, sulfates, and combinations 
thereof.  The first cell culture sample showed, in addition to unreacted galangin, 
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three potential monoglucuronides 8-10 (m/z 445) and one potential sulfate 11 
(m/z 349).  There was no evidence of doubly-substituted galangin in the sample. 
Multiple-stage tandem mass spectrometry was used to check these 
tentative identifications.  A fragmentation spectrum of the galangin aglycon in the 
sample was taken for comparative purposes.  In negative ion mode, each of the 
three suspected galangin glucuronides lost 176 Da upon CID, confirming the 
presence of glucuronic acid in their chemical structures.  Likewise, the purported 
galangin sulfate lost the correct mass of 80 Da upon fragmentation, corresponding 
to a sulfate group.  The second-generation fragmentation ion patterns were used to 
check the structure of the aglycon portion of the molecule.  The four suspected 
galangin conjugates all yielded second-generation fragment ion spectra that are 
similar to that of galangin aglycon.  Postcolumn metal complexation was 
performed as described in the Experimental section to determine the positions of 
the glucuronic acid moieties of compounds 8-10 (Figure 6.10).  The metal 
complex of 9 gave the most distinctive fragmentation pattern, clearly identifying 9 
as a 7-O-glucuronide based on the unique losses of the aglycon portion with and 
without an auxiliary ligand.  Such losses only occur for flavonoid 7-O-
glucuronides.  Besides the 7 position, galangin has two other positions occupied 
by hydroxyl groups that might be conjugated with glucuronic acid: the 3 position 
and the 5 position (see Figure 1.2).  The presence of three galangin 
monoglucuronides in the sample suggests that the conjugation products of all 
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three hydroxylation positions are present.  Yet the metal complexation fragments 
of 8 and 10 are nearly identical.  The fragmentation pattern is apparently 
indicative of 3-O-glucuronidation based on the absence of a fragment ion 
corresponding to the loss of an auxiliary ligand.  This trait was observed from 
complexes of quercetin 3-O-glucuronide, but not from any of its isomers (see 
Figure 6.6).  Yet either 8 or 10 must be galangin 5-O-glucuronide.  In order to 
decide which is the 3-O-glucuronide and which is the 5-O-glucuronide, a search 
through the literature was conducted in order to determine the relative elution 



















Figure 6.10. LC-MS/MS spectra of [Co(II) (FG-H) (4,7-dpphen)2]+
flavonoid glucuronide complexes (m/z 1168) from cell cultures 
treated with galangin.
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order of 3-O- and 5-O-glycosides of flavonoids.  Grayer et al. showed that 
luteolin 5-O-glucoside elutes slightly before luteolin 7-O-glucoside, and apigenin 
5-O-glucoside elutes slightly before apigenin 7-O-glucoside in reversed-phase 
chromatography.40  Similarly, Harborne and Boardley demonstrated that quercetin 
5-O-glucoside elutes before quercetin 3-O-glucoside using reversed-phase 
HPLC.41  Finally, the spiked rat plasma sample showed that quercetin 7-O-
glucuronide elutes before quercetin 3-O-glucuronide (described in Section 6.3.2).  
Taken together, along with the general observation that similar types of elution 
order trends have been found for flavonoid and their glycosides, these examples 
imply that for flavonoid glycoside isomers having the same parent aglycon and 
saccharide but differing only by position of conjugation, the generalized order of 
elution is 5-O-glycoside, 7-O-glycoside, 3-O-glycoside.  Thus this is the proposed 
elution order of the three galangin glucuronides, and it fits with the metal 
complexation data.  The identical fragmentation of the 3-O-glucuronide and 5-O-
glucuronide complexes suggests that these positions may not be differentiated 
only on the basis of the [Co(II) (FG-H) (4,7-dpphen)2]+ fragmentation patterns. 
In the cell culture sample that had been treated with kaempferol, there 
appeared two potential kaempferol glucuronides (12 and 13) and one potential 
kaempferol sulfate (14), as determined by mass.  Again, there was no evidence of 
any doubly-substituted conjugates.  The loss of a glucuronic acid moiety (-176 
Da) or a sulfate group (-80 Da) was confirmed in the first stage of CID.  
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Confirming the aglycon structure was more difficult.  In contrast to most other 
cases, the MS3 fragmentation of kaempferol derivatives sometimes fails to closely 
resemble the MS/MS fragmentation of native kaempferol aglycon using negative 
ion mode analysis. This unusual phenomenon will be explored more thoroughly in 
Chapter 8.  The MS3 spectra of the metabolites in the cell culture showed only a 
subset of the numerous peaks yielded by fragmenting a standard of native 
kaempferol aglycon.  However, this was enough to confirm that the 
glucuronidated and sulfated conjugates were indeed kaempferol derivatives. 
The two glucuronidated compounds were subjected to postcolumn metal 
complexation for further structural analysis.  The metal complex of 12 yielded the 

















Figure 6.11. LC-MS/MS spectra of [Co(II) (FG-H) (4,7-dpphen)2]+
flavonoid glucuronide complexes (m/z 1184) from cell cultures 




loss of the aglycon portion of the molecule (Figure 6.11).  The metal complex of 
13 fragmented into a minor product corresponding to the loss of an auxiliary 
ligand and a major product corresponding to the loss of an auxiliary ligand with a 
glucuronic acid moiety.  This pattern typically denotes a 3-O-glucuronide, but the 
galangin cell culture example shows that the same pattern may be indicative of 5-
O-glucuronides as well.  Once again, the evidence of retention time is used to 
settle the question.  As unknown 13 elutes after kaempferol 7-O-glucuronide, it is 
assigned as kaempferol 3-O-glucuronide rather than kaempferol 5-O-glucuronide. 
 
6.4 CONCLUSIONS 
A versatile method for differentiating isomeric flavonoid glucuronides by 
mass spectrometry has been discovered.  Complexes are formed by mixing a 
flavonoid glucuronide, CoBr2 and an auxiliary ligand (either 4,7-dmphen or 4,7-
dpphen) in solution.  Performing ESI-MS/MS on these complexes leads to 
characteristic product ions that allow isomer differentiation and determination of 
the position of the glucuronide moiety.  Four isomeric quercetin glucuronides 
were differentiated based on unique product ion profiles obtained from these 
complexes.  Glucuronide derivatives of kaempferol, naringenin and baicalein 
formed similar complexes which fragmented in an analogous manner to the 
quercetin glucuronides, allowing the location of the glucuronide moiety to also be 
determined for these compounds.  These examples suggested the possibility that 
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glucuronide derivatives of other flavonols, flavones and flavanones may be 
characterized in the same way.  This method may be performed by direct infusion 
ESI-MS/MS (using pure flavonoid glucuronides) or by LC-MS/MS of mixtures 
using post-column complexation.  The method was also proven to be sensitive 
enough for in vivo plasma analysis at realistic analyte concentrations.  The LC-
MS/MS method was used to support the identification of naringenin 7-O-
glucuronide and naringenin 4′-O-glucuronide in human urine following the 
consumption of grapefruit juice.  The same compounds were found in human 
urine after consumption of orange juice, as well as hesperetin 7-O-glucuronide, 
hesperetin 3′-O-glucuronide, and a hesperetin glucuronide sulfate with the 
glucuronic acid moiety at the 7 position.  The identities of the metabolites from 
the orange intervention study were confirmed independently at the Institute of 
Food Research.  Glucuronidated derivatives of galangin and kaempferol were also 
identified in cell cultures.  Evidence suggests that 5-O-glucuronidation and 3-O-
glucuronidation may be indistinguishable by the current method, but retention 
time analysis may help resolve ambiguous cases.  Overall, metal complexation 
has proven to be a successful and widely applicable approach to determining the 
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Regioselectivity of Human UDP-Glucuronosyltransferase 1A1 
in the Synthesis of Flavonoid Glucuronides Determined by Metal 
Complexation and Tandem Mass Spectrometry 
 
7.1 INTRODUCTION 
Much progress has been made in the understanding of flavonoid 
metabolism over the past decade.  The currently-accepted paradigm involves the 
consumption of flavonoid glycosides in plant-based food products, 
deglucosylation in the small intestine by β-glucosidase or lactose phloridzin 
hydrolase, and rapid metabolism by Phase I and (especially) Phase II enzymes.1-3  
Glucuronidation and sulfation are important metabolic routes for most flavonoids, 
while methylation or hydroxylation may also occur depending on the structure of 
the molecule in question.2,3  There has also been a report of glutathione-related 
metabolites in human urine4  As a result of these rapid conjugation reactions, 
neither the original flavonoid glycosides (except anthocyanins) nor the aglycon 
forms (except catechins) are found in plasma.5-8  Early reports of unmodified 
flavonoid glycosides circulating in the bloodstream9-11 were likely mistaken 
identifications of flavonoid glucuronides, which have similar chromatographic 
and ultraviolet (UV) spectroscopic characteristics.7,12  Flavonoids that fail to be 
absorbed in the small intestine may be broken down by microflora in the large 
intestine.1-3  This process may release the free aglycons, which can then be 
absorbed and metabolized, but mostly results in the release of small phenolic 
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acids, which are expelled in the urine.1-3  Quantitative in vivo studies generally 
show that only a small percentage of consumed flavonoid glycosides is recovered 
in urine as conjugated phase II metabolites.13-15  Walle et al. used 14C-labelled 
quercetin to show that up to 81% of the administered dose ultimately is exhaled in 
the form of carbon dioxide.16  There remains considerable interest in the 
conjugated metabolites as they may retain some of the bioactivity of the original 
molecules.5,17 
In spite of breakthroughs in the field of flavonoid metabolism, much is 
still unknown about the precise structure of Phase II flavonoid metabolites, 
particularly in terms of the conjugation positions.  Most reports do not supply this 
information, identifying observed metabolites imprecisely as, for example, 
unspecified quercetin glucuronides.  A recent review5 listed all conjugated 
metabolites that have been identified in human in vivo studies, but the very short 
list included conjugates of only a few flavonoid aglycons.  One reason for the 
dearth of such information is a lack of sensitive and specific analytical methods.  
While there are several approaches currently available, there are problems 
associated with each.  The standard method for structural determination of organic 
molecules is nuclear magnetic resonance (NMR) spectroscopy, but its lack of 
sensitivity does not lend itself to analysis of low-concentration metabolites.  Thus 
few metabolism studies have employed this technique.18,19  An alternative method 
using UV spectroscopy20 to determine the conjugation position of flavonoids has 
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been used only rarely for metabolites,17 possibly due to the complex set of 
experiments with numerous UV shift reagents required to make this 
determination.  A third strategy requires synthesis of suspected metabolites and 
comparison of the chemical properties of these synthetic compounds to those of 
the observed metabolites.  While this approach is sometimes employed to identify 
flavonoid metabolites,13,21,22 it is too laborious for routine use. 
Chapter 6 gave details on a metal complexation/tandem mass spectrometry 
method for differentiating the conjugation positions of monoglucuronidated 
flavonols, flavones and flavanones.31  The metal complexation strategy entailed 
formation of complexes of the type [Co(II) (FG - H) (4,7-dpphen)2]+    where (FG 
- H) is one molecule of deprotonated flavonoid glucuronide and (4,7-dpphen)2 are 
two molecules of an auxiliary ligand, 4,7-diphenyl-1,10-phenanthroline. Upon 
CID, this complex yielded product ions corresponding to the loss of a glucuronic 
acid moiety, of an auxiliary ligand, and of the aglycon portion of the flavonoid, in 
various combinations and ratios that correlated with the position of 
glucuronidation.  A four-way differentiation of the 3-O-, 7-O-, 3′-O- and 4′-O-
glucuronides of quercetin was demonstrated.  This previous investigation focused 
on a limited set of flavonoid glucuronides, but it was speculated that the 
versatility and sensitivity of the method would allow facile adaptation to other 
flavonoid metabolites, such as the ones produced enzymatically in the present 
study. 
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The purpose of the current work is twofold.  In order to add to the growing 
body of knowledge regarding flavonoid metabolism, the regiospecificity of 
flavonoid glucuronidation by the 1A1 isozyme of human UDP-
glucuronosyltransferase (UGT1A1) is probed.  While there have been several 
studies on the glucuronidating activity of various isozymes of UGT using 
flavonoids as substrates,32-38 fewer have explored the regioselectivity of such 
reactions.19,39 The second goal is to explore the wider applicability of the 
described metal complexation methods to flavonoid metabolism studies.  The 
glucuronidated derivatives of ten flavonols, flavones and flavanones provide a 
diverse set of analytes to challenge the performance of the new method.  The 
correlation between flavonoid conjugation sites and reversed-phase high-
performance liquid chromatography (HPLC) retention time is also discussed and 





UGT1A1 isozyme (human, recombinant), UDP-glucuronic acid (UDPGA) 
trisodium salt, 4,7-diphenyl-1,10-phenanthroline (4,7-dpphen), cobalt(II) 
bromide, acacetin, myricetin, hesperetin, naringenin and quercetin were purchased 
from Sigma-Aldrich (St. Louis, MO).  Eriodictyol, kaempferol, luteolin, luteolin 
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7-O-glucoside and luteolin 4′-O-glucoside were purchased from Indofine 
(Hillsborough, NJ).  Apigenin, homoeriodictyol, quercetin 3-O-glucoside and 
quercetin 4′-O-glucoside were purchased from Extrasynthèse (Genay, France).  
Quercetin 7-O-glucoside was purchased from Apin (Abingdon, UK).    Quercetin 
3-O-glucuronide, quercetin 7-O-glucuronide, quercetin 3′-O-glucuronide and 
quercetin 4′-O-glucuronide were synthesized 22,31 by Paul Needs and Paul Kroon 
at the Institute of Food Research (Norwich, UK).  Potassium phosphate was 
purchased from Thermo Fisher Scientific, Inc. (Waltham, MA).   
 
7.2.2 Enzymatic Synthesis of Flavonoid Glucuronides   
The method for synthesizing the flavonoid glucuronides was adapted from 
one described by Plumb et al.40  The UGT1A1 enzyme, having an estimated 
concentration of 12 mg/mL, was divided into 25 µL aliquots which were stored at 
-80 °C until use.  Flavonoids were prepared as 10 mM solutions in methanol, 
which were employed despite turbidity of a few solutions.  Synthesis occurred in 
a microcentrifuge tube, to which were added 2 mM aqueous UDPGA (65 µL), 20 
mM potassium phosphate buffer pH 7.0 (378.75 µL) and 10 mM flavonoid (6.25 
µL).  The reaction was initiated by adding a 25 µL aliquot of UGT1A1 to the 
tube.  The tubes were incubated in a 37 °C water bath (VWR Model 1227, West 
Chester, PA) with gentle agitation for 6 hours.  A few reactions were repeated 
with 1 hour incubation times, but these gave similar results to the 6 hour 
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incubations, so these data will not be specifically presented here.  Reactions were 
stopped by adding 1.5 mL acetone.  The tubes were centrifuged for 10 minutes at 
16000 g, and the supernatants were removed and blown with nitrogen to 
evaporate the acetone.  The remaining supernatant was refrigerated until analysis. 
 
 7.2.3 LC-MS Conditions 
Liquid chromatography took place on a Waters Alliance 2695 HPLC 
system (Milford, MA).  The stationary phase was a Waters Symmetry C18 
column, 2.1 x 50 mm, 3.5 µm particle size, with a guard column.  Typical 
injection volumes were 15 to 30 µL for negative ion mode analyses, and 30 to 45 
µL for positive ion mode.  The mobile phases were 0.33% formic acid in water 
(A) and 0.33% formic acid in methanol (B).  A typical gradient began at 35% B, 
increased to 50% B over 25 minutes, then increased to 95% B over 2 minutes, 
with a constant flow rate of 0.1 mL/min.  For the naringenin, eriodictyol and 
homoeriodictyol reaction products, the first part of the gradient increased from 
30% B to 45% B in 25 minutes; while for acacetin the first part of the gradient 
increased from 40% B to 55% B in 25 minutes.  The column effluent was sent 
directly to the mass spectrometer. 
All mass spectrometry was performed on an LCQ Duo (Thermo Electron, 
Waltham, MA) quadrupole ion trap with electrospray ionization (ESI).  Samples 
were analyzed in both negative and positive ion modes.  In both polarities, a spray 
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voltage of 5.0 kV was used, the heated capillary temperature was 200 °C, and the 
automatic gain control was set to a target of 2 x 107 ions with a maximum 
injection time of 500 msec and 5 microscan averaging.  All other mass 
spectrometer parameters were set as needed to obtain optimal signal.  Negative 
ion mode was used to search for flavonoid glucuronides and to confirm the 
identities of the aglycon portion of these molecules.  Positive ion mode was used 
for analysis of metal complexes, which were formed by post-column addition of a 
methanolic solution of 5 µM CoBr2 and 4,7-dpphen.  These reagents were infused 
at a rate of 20 µL/min controlled by a syringe pump, and added to the column 
effluent via a tee between the column and the mass spectrometer.  Due to the 
fragility of the metal complexes, an isolation width of 4 Da was used.41  A 
constant normalized collision energy42 of 35% (of 5 Vp-p) was used to dissociate 
the complexes. 
 
7.2.4 HPLC Retention Time Analysis 
Retention time was used as a source of supplementary data for the 
identification of the flavonoid glucuronides.  In order to determine trends in 
retention order, flavonoid glycoside standards were injected individually, and the 
retention times were measured by a Waters 486 UV detector.  All other 
chromatographic equipment was the same as previously described.  The gradient 
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employed began at 15% B, increased to 70% B over 12 minutes, then increased to 
95% B over 2 minutes, with a flow rate of 0.3 mL/min. 
 
7.3 RESULTS AND DISCUSSION 
7.3.1 Strategy 
For identification of the flavonoid glucuronides, the two key steps include 
the determination of the aglycon skeleton and the location of the site of 
conjugation.  In our approach, the aglycon skeleton is elucidated from MSn 
spectra of the deprotonated flavonoid glucuronide with spectral comparison to 
standard flavonoid aglycons.  The site of conjugation is pinpointed based on 
interpretation of the MS/MS spectra of metal complexes of the type [Co(II) (FG - 
H) (4,7-dpphen)2]+.  As discussed in Chapter 6, the characteristic signs of 7-O-
glucuronidation from this type of metal complex include significant losses of the 
glucuronic acid moiety (-GlcA) and of the auxiliary ligand (-Aux), both 
individually and concurrently, as well as the loss of the flavonoid aglycon (-Agl), 
which is a diagnostic fragment for the 7-O-glucuronidation position.  The metal 
complexes of B-ring-glucuronides typically display significant amounts of the –
Aux and –(Aux + GlcA) fragment ions upon CID, but yield only minor amounts 
of the -GlcA fragment ion.31  Upon CID, metal complexes of flavonol 3-O-
glucuronides produce the –(Aux + GlcA) fragment ion predominantly.31 
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7.3.2 Single-Product Reactions 
After the enzymatic incubation of each of the ten flavonoids, the initial 
screening employed LC-MS with negative ion mode analysis.  The total ion 
chromatograms were searched for masses corresponding to the aglycon 
(unreacted starting material), the monoglucuronidated flavonoid (aglycon + 176 
Da) and the diglucuronidated flavonoid (aglycon + 176 Da + 176 Da).  Unreacted 
aglycon was observed in most cases, but no diglucuronidated products were 
produced in any of the reactions.  All of the reactions produced 
monoglucuronidated products, with five flavonoids generating a single product, 
and the other five producing either two or three products.  This section concerns 
the former group, consisting of apigenin, naringenin, acacetin, kaempferol and 
homoeriodictyol. 
Although most research involving the identification of flavonoid 
conjugates by mass spectrometry does not employ MSn for verification of the 
flavonoid skeleton, a urinary metabolite with the correct mass and initial 
fragments for a quercetin glucuronide sulfate was recently encountered,  but 
which required MS4 analysis to prove that it was not a quercetin derivative at 
all.43  Hence confirming the identity of the aglycon portion is an important step in 
identifying these molecules.  MS/MS of the all monoglucuronidated products 
showed the characteristic loss of a glucuronic acid residue, -176 Da.  An 
additional isolation/dissociation step (MS3) was used to fragment the aglycon 
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portions of these molecules.  The resulting spectra are shown in Figure 7.1.  
Because the flavonoid aglycons yield a variety of product ions, the structures 
were easily confirmed by comparing the MS/MS spectra of the aglycon standards, 
Figure 7.1. MSn spectra used to confirm the identities of the aglycon
skeletons of deprotonated flavonoid monoglucuronides.  a) apigenin
monoglucuronide, 445→269→ b) naringenin monoglucuronide, 
447→271→ c) acacetin monoglucuronide, 459→283→ 268→ d) 
kaempferol monoglucuronide, 461→285→ e) homoeriodictyol
monoglucuronide, 477→301→.
m/z




































which were nearly identical to the spectra shown.  Acacetin, like many 
methoxylated flavonoid aglycons, yields only a single fragment ion due to the loss 
of a methyl radical, which is not a diagnostic dissociation pathway.44,45  Hence, 
the MS4 spectrum of the acacetin monoglucuronide is shown in Figure 7.1 rather 
than the MS3 spectrum, and it was compared to the MS3 spectrum of the acacetin 
standard.  Some of the diagnostic dissociation routes include retro Diels-Alder 
pathways that lead to the 1,3A-  ion (m/z 151) and small molecule losses such as –
H2O, -CO and –CO2.46,47 
The metal complexation methods described in the Experimental section 
were used to elucidate the location of the glucuronic acid moiety of these 
monoglucuronidated flavonoids.  In particular, complexes of the type [Co(II) (FG 
- H) (4,7-dpphen)2]+ self-assembled in solution, were transported to the gas phase 
by ESI, and analyzed by tandem mass spectrometry.  The CID mass spectra of 
these complexes are shown in Figure 7.2.  All five of the complexes show 
evidence of glucuronidation at the 7 position, based on the diagnostic pathways 
summarized above (e.g. -Aux, -GlcA, -Agl), and thus all products are identified as 
the 7-O-glucuronides of the relevant flavonoid.   
The fragmentation patterns also show some dependence on the class of 
flavonoid in the complex.  Complexes involving flavanone (naringenin and 
homoeriodictyol) 7-O-glucuronides produce greater relative abundances of the 
diagnostic ion due to loss of the aglycon moiety (-Agl), as well as those due to 
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loss of a glucuronic acid residue (–GlcA) and loss of the auxiliary ligand in 
conjunction with the elimination of a glucuronic acid residue –(Aux + GlcA).  
Additionally, they produce a significant fragment ion resulting from the loss of 
both the auxiliary ligand and the aglycon group, –(Aux + Agl).  The relative 
abundances of these ions are lower for the complex involving the flavonol 
































































Figure 7.2. CID mass spectra of [Co(II) (FG-H) (4,7-dpphen)2]+
complexes of flavonoid monoglucuronides.  a) FG=apigenin, 1168→ b) 
FG=naringenin, 1170→ c) FG=acacetin, 1182→ d) FG=kaempferol, 
1184→ e) FG=homoeriodictyol, 1200→.
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(kaempferol) 7-O-glucuronide, and lowest for those complexes involving flavone 
(apigenin and acacetin) 7-O-glucuronides.  The analogous complex involving 
baicalin (a flavone 7-O-glucuronide) was reported to show similarly low 
abundances of these fragment ions.31 
The remaining potential  glucuronidation sites should also be considered 
in case of  ambiguous  fragment ion signatures  from the  metal complexes.   The 
–(Agl) and –(GlcA) ions do not feature prominently as dissociation products of 
flavonoid B-ring-glucuronide complexes, so the glucuronidation at the 3′ and 4′ 
positions is ruled out.  Flavonoid 5-O-conjugates are said to be unfavorable 
products due to hydrogen bonding to the 4-keto group.3,47  Nonetheless, an 
enzymatic synthesis of flavonoid 5-O-glucuronides has been reported.48,49  Our 
work has suggested that the fragmentation of metal complexes containing 
flavonoid 5-O-glucuronides mimics that of the 3-O-glucuronides (see Section 
6.3.5).  None of the spectra in Figure 7.2 display the –(Aux + GlcA) ion as the 
only abundant fragment, so both the 3-O- and 5-O-glycosylation positions are 
ruled out, further corroborating the initial identification of the five unknown 
compounds as 7-O-glucuronides. 
 
7.3.3 HPLC Retention Time Analysis 
The enzymatic incubations of the other five flavonoids (luteolin, 
eriodictyol, quercetin, hesperetin, and myricetin) all produced more than one 
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glucuronide derivative.  The presence of multiple products means that retention 
time analysis can be used to assist in compound identification.  Since this 
information plays a crucial role in identifying some of the glucuronidated 
products, a discussion of this approach is warranted before presenting the 
remaining mass spectral data. 
 There are several known trends regarding flavonoid structure and 
reversed-phase HPLC retention times.  Since saccharides are more polar than 
flavonoid aglycons, flavonoid diglycosides elute before flavonoid 
monoglycosides, which elute before flavonoid aglycons.50  It has also been 
reported that the retention time order is flavanones <  flavonols < flavones, for 
compounds that otherwise have the same substitution patterns.50  Studies have 
also shown that the identities of the saccharides influence HPLC mobility in 
predictable ways.  For example, when all else is equal, a 7-rutinoside elutes before 
a 7-neohesperidoside, and a 3-galactoside elutes before a 3-glucoside.50  Such 
trends are upheld in numerous articles which report reversed-phase HPLC 
retention times, regardless of the exact chromatographic method employed.30,51-55 
Similar generalizations can be made in cases in which both the flavonoid 
portion and the glycosidic portion are the same, with only the glycosylation site 
differing between compounds.  Table 7.1 lists the retention times for three groups 
of such isomers.  In all three groups, the 7-O-glycoside elutes before the 4′-O-
glycoside.  When the 3-O-glycoside is included, it elutes between these two 
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isomers.  Finally, quercetin 3′-O-glucuronide elutes after quercetin 4′-O-
glucuronide.  Thus the retention times of such isomers can be ordered based on 
glycosylation site as 7 < 3 < 4′ < 3′.  This elution order for quercetin 
monoglucuronides has been reported previously.12,19,56,57  Regarding the rarer 5-
O-glycosides, Grayer et al. reported that the 5-O-glucosides of luteolin and 
apigenin elute before their 7-O-glucoside analogs.58  Harborne and Boardley 
report the retention time of quercetin 5-O-glucoside as lower than that of 
quercetin 3-O-glucoside.59  Finally metal complexation has been used to show 
that the 5-O-glucuronide, the 7-O-glucuronide and the 3-O-glucuronide of 
galangin elute in that order (Section  6.3.5).  The evidence points towards an 
overall flavonoid glycoside elution order (by position of conjugation) of 5 < 7 < 3 
< 4′ < 3′, at least for flavonoid glucosides and glucuronides. 
The significance of deciphering this elution rule is that it may be used to 
confirm the identities of flavonoid glucosides or glucuronides that have been 
aglycon linkage saccharide retention time (min) 
quercetin 7-O- glucoside 8.19 
quercetin 3-O- glucoside 9.04 
quercetin 4′-O- glucoside 9.82 
    
luteolin 7-O- glucoside 7.87 
luteolin 4′-O- glucoside 10.09 
    
quercetin 7-O- glucuronide 8.72 
quercetin 3-O- glucuronide 9.28 
quercetin 4′-O- glucuronide 10.46 
quercetin 3′-O- glucuronide 11.32 
Table 7.1. Retention time dependence on conjugation position
 165
elucidated by tandem mass spectrometric methods.  Moreover, an otherwise 
unidentifiable isomer may be assigned by retention time if the some of the other 
isomers have been identified.  Both strategies will be applied to the identification 
of compounds from reactions that yielded multiple products. 
 
7.3.4 Multi-Product Reactions 
The same LC-MS negative ion mode screening strategy described earlier 
was also performed on the reaction products of luteolin, eriodictyol, quercetin, 
hesperetin and myricetin.  Two or three different glucuronides were identified in 
each elution profile based on the diagnostic loss of a glucuronic acid moiety (-176 
Da) in the CID mass spectra.  Once identified as glucuronides, these products 
were subjected to MS3 analysis to yield the aglycon-specific fragmentation 
patterns shown in Figure 7.3.  The monoglucuronidated flavonoid isomers in each 
reaction mixture yielded almost identical MS3 profiles, though only the results 
from the earliest-eluting isomer is shown.  All of these spectra matched the 
MS/MS spectra obtained from standards of the flavonoid aglycons. 
After confirming that the reaction products were monoglucuronides and 
identifying the aglycon structures, CID of the [Co(II) (FG-H) (4,7-dpphen)2]+ 
complexes was used to identify the glucuronidation positions in a manner similar 
to that described above.  The MS/MS fragmentation patterns of the earliest-
eluting isomer from each mixture are shown in Figure 7.4, and the characteristic 
 166
array of fragments indicate 7-O-glucuronidation in each case.  The flavanone 
(eriodictyol and hesperetin) 7-O-glucuronide complexes again yield the highest 
abundance of the –Agl and several other fragment ions, while the flavone 
(luteolin)  7-O-glucuronide  complex   shows  the   lowest   abundances   of   these  
Figure 7.3. MSn spectra used to confirm the identities of the aglycon
skeletons of deprotonated flavonoid monoglucuronides (earliest eluting 
isomer from each mixture is shown).  a) luteolin monoglucuronide, 
461→285→ b) eriodictyol monoglucuronide, 463→287→ c) quercetin
monoglucuronide, 477→301→ 268→ d) hesperetin monoglucuronide, 
477→301→ e) myricetin monoglucuronide, 493→317→.






























fragment ions.  The relative yield of 7-O-glucuronides was very low in the 
quercetin and myricetin reaction mixtures based on the intensities of these 
components in the chromatographic profiles, and 75 µL injections were required 
to obtain good mass spectra.  The low signal intensity of myricetin 7-O-
Figure 7.4. CID mass spectra of [Co(II) (FG-H) (4,7-dpphen)2]+
complexes of earliest eluting flavonoid monoglucuronides from multi-
product reactions.  a) FG=luteolin, 1184→ b) FG=eriodictyol, 1186→
c) FG=quercetin, 1200→ d) FG=hesperetin, 1200→ e) FG=myricetin, 
1216→.




























































glucuronide resulted in a very noisy MS/MS spectrum from the complex, 
especially in the high mass range.  The diagnostic –Agl fragment ion is 
indistinguishable from the noise.  
The enzymatic reactions involving eriodictyol and hesperetin yielded only 
one product in addition to the 7-O-glucuronide, while the remaining flavonoids 
produced two additional products.  All of these products eluted after the 
respective 7-O-glucuronides.  The CID mass spectra from the metal complexes of 
the latest-eluting isomers in each mixture are shown in Figure 7.5.  These 
fragmentation patterns are indicative of B-ring-glucuronidation.  As stated earlier, 
the two characteristic fragmentation pathways of complexes containing B-ring-
glucuronides are –Aux and –(Aux + GlcA).  The fragment ion abundances from 
these B-ring-glucuronide metal complexes appear to be partially dependent on the 
class of the flavonoid, as noted earlier for the 7-O-glucuronide complexes.  While 
all of the spectra show both of the characteristic fragment ions of B-ring-
glucuronides, the metal complex of the flavone (luteolin) B-ring-glucuronide 
strongly favors the loss of the auxiliary ligand, while the complexes of the 
flavanone (eriodictyol and hesperetin) B-ring-glucuronides preferentially yield the 
–(Aux + GlcA) ion.  The flavonol (quercetin and myricetin) B-ring-glucuronide 
complexes display intermediate behavior, yielding similar amounts of each of 
these two fragment ions.  Hence, knowledge of the flavonoid class helps in the 
interpretation of the fragmentation patterns of these metal complexes. 
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Some of the spectra also contain small amounts of the –GlcA fragment 
ion, which is usually associated with 7-O-glucuronidation.  For the hesperetin 
glucuronide data in Figure 7.5 d, this is likely a contribution from the earlier-
eluting hesperetin 7-O-glucuronide, as the two compounds were only partially 



































Figure 7.5. CID mass spectra of [Co(II) (FG-H) (4,7-dpphen)2]+
complexes of latest eluting flavonoid monoglucuronides from multi-
product reactions.  a) FG=luteolin, 1184→ b) FG=eriodictyol, 1186→
c) FG=quercetin, 1200→ d) FG=hesperetin, 1200→ e) FG=myricetin, 
1216→.
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separated.  However, the -GlcA fragment ion appears to be an intrinsic part of the 
spectrum for the complexes of the quercetin and myricetin B-ring-glucuronides 
because there are no co-eluting isomers in these cases.  A reasonable guideline is 
that the MS/MS of flavone 7-O-glucuronide complexes displays at least 15% 
relative abundance of the –GlcA fragment ion (Figures 7.2 a, 7.2 c and 7.4 a), but 
this fragment ion is absent from the MS/MS of flavone B-ring-glucuronide 
complexes (Figure 7.5 a).  For flavonols, the same product ion appears ~50% 
relative abundance for the 7-O-glucuronides (Figures 7.2 d, 7.4 c and 7.4 e), but at 
~10% relative abundance for B-ring-glucuronides (Figures 7.5 c and 7.5 e).  Since 
product ion distributions are dependent on collision energy,31 these guidelines are 
only applicable to the conditions used in this set of experiments. 
The collision energy used in the current set of experiments was 
specifically chosen to take advantage of a subtle difference in the fragmentation 
of the complexes of quercetin 4′-O-glucuronide and quercetin 3′-O-glucuronide.31  
When a collision voltage in the range of 1.5-1.8 V was used,31 it was noted that a 
greater abundance of the –Aux fragment ion relative to the –(Aux + GlcA) 
fragment ion, as occurs in Figure 7.5 c, is indicative of quercetin 3′-O-
glucuronide.  If the relative abundances are reversed, this is characteristic of 
quercetin 4′-O-glucuronide, and this was observed for an isomeric compound in 
the quercetin reaction mixture that eluted just prior to quercetin 3′-O-glucuronide 
(data not shown).  The retention time guidelines also support the identification of 
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these two products as quercetin 4′-O-glucuronide and quercetin 3′-O-glucuronide, 
in order of elution.   
There are no known rules for differentiating the 3′-O- and 4′-O-
glucuronides of flavonoids other than quercetin.  Hence other means are required 
to precisely identify the remaining B-ring-glucuronides.  The hesperetin B-ring-
glucuronide is easiest to assign.  Hesperetin has only one B ring hydroxyl group, 
so the unknown compound must be hesperetin 3′-O-glucuronide.  Like quercetin, 
both the luteolin and myricetin reaction mixtures also display two glucuronide 
species that elute after the 7-O-glucuronide.  As luteolin has two B ring hydroxyl 
groups, the two unknowns are assigned as luteolin 4′-O-glucuronide and luteolin 
3′-O-glucuronide, in order of elution.  These assignments were possible despite 
the failure of luteolin 4′-O-glucuronide to form significant amounts of the metal 
complex in question, for reasons that remain unknown.  Both late-eluting 
myricetin glucuronides form complexes which dissociate to provide the same two 
major fragment ions shown in Figure 7.5 e.  Myricetin has three B ring hydroxyl 
groups but two are equivalent, so the two isomers are identified as myricetin 4′-O-
glucuronide and myricetin 3′-O-glucuronide, in order of elution.  The eriodictyol 
derivative is the most difficult to assign because there are two B ring hydroxyl 
groups but only one B-ring-glucuronide is formed.  While it is impossible to 
precisely identify this compound based on the available data, it is hypothesized to 
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be eriodictyol 3′-O-glucuronide, not eriodictyol 4′-O-glucuronide, for reasons that 
will be explained in the next section. 
An estimate of the relative product yields of these multi-product reactions 
was made based on the peak areas of the initial negative ion mode MS scan 
(Table 7.2).  Some of our results can be compared with data presented by 
Boersma et al.,19 who reported product distributions for reactions of luteolin and 
quercetin with UGT1A1 based on HPLC, LC-MS and NMR spectroscopy.  Their 
observed product distribution was 21:29:50 for the 7-O-, 3′-O- and 4′-O-
glucuronides of luteolin, which is similar to our results.  The distribution for 
quercetin was 6:85:9, which also parallels our data.  As in the current study, 
quercetin 3-O-glucuronide was not observed as a reaction product. 
 
7.3.5 Structure-Activity Relationships 
The flavonoids that produce a single monoglucuronidated product and 
those which produce multiple products constitute two distinct groups, 
Table 7.2. Estimated product distributions from multi-product reactions
aglycon % 7-O-GlcA % 3′-O-GlcA % 4′-O-GlcA
eriodictyol 40 60* –
hesperetin 70 30 –
luteolin 10 30 60
quercetin trace 90 10
myricetin trace 70 30
All values were rounded to the nearest 10%
* this compound may be eriodictyol 4′-O-glucuronide
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distinguished by the presence or the absence of a 3′ hydroxyl group.  The sole 
reaction product for compounds that lack this structural feature is the 7-O-
glucuronide.  The regioselectivity of UGT1A1 shifts toward the flavonoid B ring 
when a 3′ hydroxyl group is present, but the extent to which this happens depends 
on other structural features of the flavonoid.  The two flavanones with a 3′ 
hydroxyl group, eriodictyol and hesperetin, form only one product in addition to 
the 7-O-glucuronide.  The additional product of hesperetin was identified as the 
3′-O-glucuronide, but the additional product of eriodictyol could not be 
conclusively determined.  However, the important activating properties of the 3′ 
hydroxy group suggest that eriodictyol 3′-O-glucuronide is the product that is 
formed.  For both eriodictyol and hesperetin, there remains a significant yield of 
the 7-O-glucuronide (relative yields of 40% and 70%, respectively).  Luteolin is 
the only flavone in the study that features a 3′ hydroxyl group.  There is a larger 
shift toward B-ring-glucuronidation as luteolin 7-O-glucuronide makes up only 
about 10% of the product.  For the flavonols containing the 3′ hydroxyl group 
(quercetin and myricetin), only trace amounts of their 7-O-glucuronides were 
formed.  Hence, while the presence or absence of the 3′ hydroxyl group is the 
major determinant of the regioselectivity of glucuronidation, there are secondary 
effects due to flavonoid class. 
The structural features that govern the regioselectivity of the 
glucuronidation reaction (the presence or absence of the 3′ hydroxyl group, the 
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C2-C3 double bond, and the 3 hydroxyl group) are also important factors in the 
antioxidant capability of flavonoids, and may act synergistically in that capacity 
as well.60  The same structural features have also been cited as important 
determinants of the antiproliferative effects of flavonoids against several cancer 
cell lines.61  It is interesting to note that while the presence of the ortho-catechol 
group (i.e. the 3′ and 4′ hydroxyl groups) is often claimed to be a source of 
beneficial flavonoid activity, our work shows a tendency for this group to be 
preferentially metabolized by UGT1A1, which would potentially mitigate the 
bioactivity of these molecules.  On the other hand, the B-ring-glucuronides of 
quercetin retain the inhibitory effects of the aglycon against xanthine oxidase and 
lipoxygenase better than when quercetin is conjugated at other positions.17 
 
7.4 CONCLUSIONS 
A three-part tandem mass spectrometry strategy that entails MS/MS 
analysis of deprotonated metabolites to pinpoint those that are glucuronides, then 
MS3 analysis to elucidate the specific aglycon structure, then MS/MS analysis of 
metal complexes of the type [Co(II) (FG-H) (4,7-dpphen)2]+ allows confident 
identification of enzymatically-synthesized flavonoid glucuronides, including the 
conjugation site.  This strategy was used to determine the regioselectivity of 
UGT1A1 toward flavonol, flavone and flavanone substrates.  The 7 position of 
the flavonoid is the sole site of glucuronidation except when a 3′ hydroxyl group 
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is present.  A 3′ hydroxyl group promotes the formation of B-ring-glucuronides in 
addition to 7-O-glucuronides.  The flavonoid class determines the product 
distribution in such cases.  This result represents a significant advance in 
understanding the of flavonoid metabolism.  Studies involving other UGT 
isozymes are planned.  Furthermore, we have demonstrated the success of metal 
complexation methods in the identification of new flavonoid monoglucuruonides 
with the assistance of HPLC retention time analysis.  Neither NMR nor 
authenticated standards were required to make the assignments.  Of the eighteen 
flavonoid monoglucuronides produced, only one remains ambiguous (the 
eriodictyol B-ring-glucuronide).  Insights regarding the effect of flavonoid class 
on the fragmentation of the metal complexes will prove useful for future 
applications of this method. 
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Chapter 8: Homolytic and Heterolytic Saccharide Loss During 
Collision-Induced Dissociation of Flavonol 3-O-Glycosides 
 
8.1 INTRODUCTION 
Throughout the earlier chapters of this dissertation, it was demonstrated 
that identifying the aglycon portion of flavonoid conjugates is a fairly simple 
process.  This is usually true if a mass spectrometer that provides multiple stages 
of collision-induced dissociation (CID), such as a quadrupole ion trap, is used.  
The first stage of fragmentation of deprotonated O-glycosyl flavonoids is 
typically the neutral loss of the saccharide moiety.  After the saccharide moiety is 
lost, the second stage of fragmentation usually provides a wide variety of product 
ions that is highly specific to the flavonoid aglycon.  In fact, these fragment ions 
usually closely match those yielded by deprotonated flavonoid aglycons 
standards.  Identifying the structure of the aglycon portion of a flavonoid 
glycoside, therefore, is usually as simple as matching spectra between the 
unknown compound and a native flavonoid aglycon.1-7 
However, in the course of identifying the flavonoid glycosides in a 
Siphium albiflorum extract (described in Section 5.3.4), a prominent exception to 
these generalizations was noted.  The second stage of fragmentation of some of 
the unknown monoglycosyl flavonoids in the extract did not match any known 
aglycon fragmentation patterns.  After a series of further tests, the aglycon portion 
of the unknown compounds was identified as a common flavonol, kaempferol, 
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despite the fact that the fragmentation pathways did not closely match those of 
kaempferol aglycon.  As the overall goal of this body of research is to provide a 
means to confidently identify flavonoid conjugates using tandem mass 
spectrometry, this chapter will document this unusual phenomenon and attempt to 
explain why some flavonoid conjugates undergo atypical fragmentation behavior.  
A firm understanding of this behavior will make it less likely that incorrect 
conclusions will be drawn from the fragmentation patterns of flavonoid 
derivatives. 
The investigation quickly centered on the phenomenon of homolytic 
saccharide cleavage, first described by Hvattum and Ekeberg.8  It was shown that 
during the first stage of CID many deprotonated flavonoid glycosides undergo 
homolytic saccharide losses in addition to the usual heterolytic cleavages.  
Hvattum and Ekeberg found correlations between the ratio of homolytic vs. 
heterolytic cleavage products and the structures of the molecules, particularly the 
position of the saccharide group and the degree of hydroxylation on the B ring of 
the aglycon.  Most relevant to this discussion is the positive correlation they found 
between the number of hydroxyl groups on the B ring of 3-O-glycosyl flavonols 
and the amount of homolytic saccharide cleavage.  The unusual behavior of the 
kaempferol glycosides provides an exception to these general guidelines that is 
related to the complications in structural analysis.  Understanding homolytic 
saccharide cleavage is of particular importance because researchers have 
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increasingly begun using this feature as an indicator of flavonoid structure.9-14  
Here an expanded study of the phenomenon of homolytic saccharide cleavage is 
presented, with a focus on the implications for flavonoid identification. 
 
8.2 EXPERIMENTAL 
Kaempferol 3-O-rutinoside, quercetin 3-O-glucoside, quercetin 3-O-
galactoside and myricetin 3-O-rhamnoside were purchased from Extrasynthèse 
(Genay, France).  Kaempferol 3-O-glucoside and quercetin 3-O-rhamnoside were 
purchased from Indofine (Somerville, NJ).  Quercetin 3-O-arabinofuranoside and 
quercetin 3-O-xyloside were purchased from Apin Chemicals (Abingdon, UK).  
Quercetin 3-O-rutinoside was purchased from Sigma-Aldrich (St. Louis, MO).  
The extract from Silphium albiflorum was provided by Jeffrey Williams and 
Malgorzata Wojcinska of the University of Texas Department of Biology; a 
detailed extraction procedure is provided elsewhere.15 
 
8.3 RESULTS AND DISCUSSION 
The fragmentation pathways of deprotonated flavonoid O-glycosides are 
usually very simple.  In general, the glycosidic bond is cleaved heterolytically 
causing the neutral loss of the saccharide and leaving behind the deprotonated 
aglycon portion of the molecule.10,16-19  Sometimes a few other product ions are 
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also observed.  In the case of molecules containing more than one saccharide, it 
varies as to whether the loss of individual monosaccharides occurs or whether the  
concurrent loss of all saccharide units predominates.  Often both results are 
observed in the same MS/MS spectrum in varying proportions.12,20 
Hvattum and Ekeberg described a variation on this pattern, in which 
saccharide moieties may be lost through homolytic cleavage in addition to typical 
heterolytic saccharide cleavage, resulting in radical product ions.8  For the 
flavonol 3-O-glycosides, a positive correlation was reported between the number 
of hydroxyl groups on the B ring of the flavonoid and the proportion of saccharide 
losses in the form of radical species.  In the current study, this trend was 
duplicated using the same set of analytes (Table 8.1).  The collision energy in a 
QIT mass spectrometer is lower than in a triple-quad,21 so the proportions of 
radical cleavage were lower than previously reported when typical QIT collision 
energies were employed.  However, the amount of radical cleavage increases with 
flavonoid glycoside
% radical loss 
(CID=25-30%)








kaempferol 3-O-rutinoside* 5 12 28 33
quercetin 3-O-arabinofuranoside 9 31 29 28
quercetin 3-O-rhamnoside* 28 46 29 28
quercetin 3-O-xyloside 24 47 29 29
quercetin 3-O-glucoside* 24 53 30 29
quercetin 3-O-rutinoside* 31 55 30 29
quercetin 3-O-galactoside* 34 59 29 28
myricetin 3-O-rhamnoside* 76 85 30 29
kaempferol 3-O-glucoside 71 95 25 41
* indicates compounds studied by Hvattum and Ekeberg8
Table 8.1. Radical saccharide losses from deprotonated flavonol 3-O-glycosides
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collision energy (as reported), and using a much higher energy yielded values 
similar to the previous study.  The lack of homolytic cleavage from 4′-O-
glycosides was also confirmed.  It was difficult to produce enough of the radical 
species from the 7-O-glycosides to confirm the assertion that homolytic cleavage 
of these compounds is favored by fewer hydroxyl groups on the B ring.  By this 
criterion, apigenin 7-O-glucoside should have produced the most homolytic 
cleavage products, and indeed it was one of the few 7-O-glycosides for which 
radical fragment ions were observed.  As the amount observed was very small, it 
makes sense that no radical cleavage was observed from flavonoid 7-O-glycosides 
with a higher degree of B ring hydroxylation. 
Although the results were confirmed for the same analytes used in the 
earlier study, an expanded sample set revealed that the correlation between B ring 
hydroxylation and radical saccharide cleavage of flavonol 3-O-glycosides is not 
perfect.  This is due to the kaempferol 3-O-glycosides, which vary widely in their 
radical losses despite sharing the same parent aglycon.  Kaempferol 3-O-
rutinoside exhibited the lowest amount of radical cleavage of all the 3-O-
glycosides, while kaempferol 3-O-glucoside exhibited the highest amounts.  
Kaempferol 3-O-galactoside, present in the Silphium albiflorum extract, behaved 
similarly to kaempferol 3-O-galactoside, but is omitted from Table 8.1 because 
this compound could not be analyzed from the extract under the same conditions 
as the purified standards.  The variable behavior of the kaempferol glycosides 
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demonstrates that another factor besides B-ring hydroxylation is driving the 
homolytic cleavage of the saccharide moiety.  In contrast, the 3-O-rutinoside, 3-
O-glucoside, and 3-O-galactoside derviatives of quercetin exhibit nearly identical 
behavior in terms of homolytic vs. heterolytic cleavage; so the saccharide moiety 
by itself cannot be the reason for the disparity of the kaempferol derivatives.  
However, even the fragmentation of the quercetin 3-O-glycosides exhibits a small 
dependence on the identity of the saccharide.  For example, quercetin 3-O-
arabinofuranoside exhibits only half the radical saccharide cleavage as quercetin 
3-O-galactoside.  No simple general correlation between homolytic cleavage 
behavior and either the identity of the aglycon or the saccharide is apparent from 
the data.  The structural features of the aglycon portion and the saccharide portion 
of the molecule interact in unpredictable ways. 
Dissociation of the radical aglycon product ions [Y0-H]-● also yields 
unexpected results.    Performing an additional stage of CID on the Y0- and [Y0-
H]-● ions of the flavonoid 3-O-glycosides proves that the two species dissociate 
via vastly different routes.  Quercetin 3-O-glucoside provides a good example of 
this (Figure 8.1).  The Y0- ion (m/z 301) generates the same product ions as 
deprotonated quercetin ([M-H]-, m/z 301).  The main product ions in each case 
are the 1,3A- ion of m/z 151, the 1,2A- ion of m/z 179, and ions stemming from the 
loss of CO2 and CO of m/z 257 and m/z 273, respectively.1,2  In contrast, the [Y0-
H]-● radical product ion of qurecetin 3-O-glucoside (m/z 300) produces just two 
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second-generation product ions of m/z 255 and m/z 271, which do not appear in 
the CID mass spectrum of the nonradical Y0- anion.  The structures of these two 
new product ions are hypothesized to be similar to m/z 257 and m/z 273, but 
involving the loss of additional hydrogen atoms.  Plausible structures of these ions 
are proposed (Figure 8.2).  Similar structures have also been proposed in other 
contexts.1,22 
If the Y0- and [Y0-H]-● first-generation product ions of quercetin 3-O-
glucoside are dissociated together by using an isolation window that encompasses 
both, the mixture of second-generation product ions that is obtained is dependent 
mainly on the collision energy of the first stage of fragmentation.  Figure 8.3 
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Figure 8.1. CID spectra quercetin and quercetin 3-O-glucoside.  (a) 
MS/MS of deprotonated quercetin.  (b) Second-generation ions 
produced by Y0- ion of quercetin 3-O-glucoside.  (c) Second-generation 





shows the results of several experiments performed with varying collision 
energies.  First the collision energy of the initial stage of CID was varied while 
the second stage of CID was held constant at 27%, which is low enough to 
preserve the some of the first-generation Y0- and [Y0-H]-● ions in the MS3 
spectrum.  When the first stage of CID is also performed at 27% collision energy, 
the Y0- ion of m/z 301 is more abundant than the [Y0-H]-● ion of m/z 300 (Figure 
8.3 a).  Increasing the fragmentation energy of the first CID step to 100% boosts 
the proportion of homolytic saccharide cleavage such that the [Y0-H]-● ion is more 
abundant (Figure 8.3 b).  These differences in turn affect the abundances of the 
second-generation product ions.  The product ions of m/z 255 and m/z 271, which 
are exclusively produced from the first-generation [Y0-H]-● ion, become more 
abundant compared to the other second-generation product ions as the proportion 



































Figure 8.2. Proposed structures of ions yielded by quercetin
glycosides.
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Figure 8.3. MS3 spectra of deprotonated quercetin 3-O-glucoside with varying 
CID energy.  The Y0- ion and the [Y0-H]-● ion were dissociated together in the 
second stage of fragmentation.  The fragmentation energies of the two CID 


















































of the [Y0-H]-● ion increases due to higher CID energy in the first step.  The same 
trend is apparent when 50% CID energy is used in the second fragmentation stage 
instead of 27% (Figure 8.3, c and d).  In this case, although the Y0- and [Y0-H]-● 
ions do not survive the second CID stage, the increase in the abundances of m/z 
255 and m/z 271 is clearly due to higher levels of [Y0-H]-● produced in the first 
CID step.  On the other hand, the second-stage CID energy has less of an effect on 
the relative abundance of second-generation product ions, demonstrated by 
keeping the second stage CID energy constant while varying the CID energy in 
the first stage (compare Figure 8.3 a and c or b and d). 
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In all of these spectra, the product ions (m/z 255 and m/z 271) from the 
first-generation [Y0-H]-● ion are more abundant than the corresponding product 
ions (m/z 257 and m/z 273) from the first-generation Y0- ion.  This trend is 
observed among the other quercetin 3-O-glycosides with subtle differences based 
on the saccharide (Figure 8.4).  The most noticeable difference occurs with 
quercetin 3-O-arabinofuranoside, which shows almost no preference for the first-
generation [Y0-H]-● ions product ions over the corresponding Y0- product ions 
(Figure 8.4 f).  Not surprisingly, this compound also shows a significantly lower 
tendency towards homolytic saccharide cleavage than the other quercetin-3-O-
glycosides (Table 8.1).  Additionally, this compound experiences relatively less of 
the fragmentation pathways that involve the loss of CO and CO2, either as radical 
losses or normal losses.  These significant differences are surprising because the 
spectra are examples of MS3 scans taken following the loss of the saccharide 
moiety.  Since the parent compounds differ only by the identity of the saccharide, 
it might be expected that the results of the second CID step would be the same in 
all cases.  Because this does not happen, it must be concluded that even though 
the only distinguishing feature of these compounds is lost in the first 
fragmentation stage, the resultant first-generation product ions are dissimilar 
enough structurally to produce different distributions of second-generation 
product ions. 
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Many of the same trends observed for the quercetin 3-O-glycosides are 
also seen for the kaempferol 3-O-glycosides and the myricetin 3-O-glycosides.  In 
































Figure 8.4. CID spectra of quercetin and quercetin 3-O-glycosides.  
The CID energy is 50% in all cases. (a) MS/MS of deprotonated
quercetin, precursor ion [M-H]- (b-g) MS3 of quercetin 3-O-























































are descended from the first-generation [Y0-H]-● ion do not greatly interfere with 
the identification of the quercetin aglycon.  The 1,3A- and 1,2A- product ions still 
appear in the MS3 spectra of the quercetin-3-O-glycosides, and the unexpected 
fragment ions m/z 255 and m/z 271 are clearly associated with m/z 257 and m/z 
273, which are also still observed.  However, the myricetin and kaempferol 3-O-
glycosides in this study are more likely to cause errors in identification due to the 
dissimilarities between the first-generation product ions of the aglycon and the 
second-generation product ions of the glycosides. 
 Myricetin 3-O-rhamnoside produces both Y0- and [Y0-H]-● ions upon CID, 
and the two species again produce different second-generation product ions.  
Those produced by the Y0- ion (Figure 8.5 b) are identical to those produced by 
the [M-H]- ion of the native deprotonated aglycon (Figure 8.5 a).  The [Y0-H]-● 
ion produces a completely new series of product ions (Figure 8.5 c), somewhat 
analogous to those produced by [Y0-H]-● species of the quercetin 3-O-glycosides.  
But when dissociated together, the second generation product ions from the [Y0-
H]-● species dominate the spectrum (Figure 8.5 d), giving a completely different 
signature than deprotonated myricetin.  This is particularly true because 
deprotonated myricetin does not produce any significant product ions above m/z 
200.  If MS3 analysis is used to identify the aglycon portion of myricetin 3-O-
rhamnoside, proper identification will be hindered if the homolytic cleavage 
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product [Y0-H]-● is dissociated along with or instead of the typical heterolytic 
cleavage product, Y0-. 
The possibility of misidentification is even greater in the case of the 


































Figure 8.5. Negative ion mode CID spectra of myricetin and 
myricetin 3-O-rhamnoside. (a) MS/MS of deprotonated myricetin, 
[M-H]- (m/z 317), CID=50%;  (b) MS3 of myricetin 3-O-rhamnoside, 
precursor ion Y0- (m/z 317), CID=27%, 50%; (c) MS3 of myricetin 3-
O-rhamnoside, precursor ion [Y0-H]-● (m/z 316), CID=27%, 50%; (d) 
MS3 of myricetin 3-O-rhamnoside, precursor ions Y0- and [Y0-H]-●, 
CID=27%, 50%.
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very complicated, with nearly a dozen major fragment ions and many more minor 
ones (Figure 8.6 a).  The Y0- and [Y0-H]-● ions of kaempferol 3-O-glucoside 
produce different second-generation product ions as expected, but neither shows 
nearly the same complexity in their fragmentation pathways as native kaempferol.  
Whether dissociated separately or together, it is impossible to match the MS3 
spectrum of kaempferol 3-O-glucoside with the MS/MS spectrum of kaempferol.  
Thus the aglycon portion of this molecule cannot be determined by simple 
comparison with kaempferol.  All three kaempferol 3-O-glycosides (including 
kaempferol 3-O-galactoside) behave similarly when the Y0- and [Y0-H]-● ions are 
dissociated separately, but a difference is observed when these two species are 
dissociated together due to the relative stabilities of these two species (Table 8.1).  
Not only does kaempferol 3-O-glucoside yield more of the [Y0-H]-● product ion, 
this ion requires less CID energy to fragment than the Y0- product ion.  As a 
result, the second-generation product ions from the [Y0-H]-● ion dominate the MS3 
spectrum (not shown).  In contrast, kaempferol 3-O-rutinoside produces much less 
of the [Y0-H]-● product ion, and its dissociation energy is similar to that of the 
non-radical product ion Y0-.  Thus the MS3 spectrum favors the second-generation 
product ions from the Y0- ion (Figure 8.6 d).  But this spectrum is still quite 
different from the MS/MS spectrum of deprotonated kaempferol (Figure 8.6 a). 
Hence it is not always so simple to use tandem mass spectrometry to 
identify the aglycon portion of flavonoid conjugates.  Among the compounds 
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available for study, the MS3 spectra of the kaempferol 3-O-glycosides and of 
myricetin 3-O-rhamnoside showed the greatest deviance from the MS/MS spectra 
of their parent aglycons.  The kaempferol 3-O-glycosides in the Silphium 
albiflorum extract (described in Section 5.3.4) were therefore confirmed as 
kaempferol derivatives by comparison to a standard of kaempferol 3-O-glucoside, 
not native kaempferol.  On the other hand, the MS3 spectrum of kaempferol 7-O-
glucuronide showed a fragmentation pattern similar to that of kaempferol aglycon 























Figure 8.6. Negative ion mode CID spectra of kaempferol and kaempferol 3-
O-glycosides. (a) MS/MS of deprotonated kaempferol, [M-H]- (m/z 285), 
CID=50%;  (b) MS3 of kaempferol 3-O-glucoside, precursor ion Y0- (m/z 285), 
CID=31%, 50%; (c) MS3 of kaempferol 3-O-glucoside, precursor ion [Y0-H]-●
(m/z 284), CID=31%, 50%; (d) MS3 of kaempferol 3-O-rutinoside, precursor 
ions Y0- and [Y0-H]-●, CID=27%, 50%.
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(see Figure 7.1 d).  Kaempferol 3-O-glucuronide, identified from a cell culture 
sample (Section 6.3.5), also provided a rich and varied fragmentation pattern 
similar to native kaempferol.  These examples further illustrate the convoluted 
interactions between saccharide and glycosylation site in influencing the 
characteristics of the MS3 spectra. 
 
8.4 CONCLUSIONS 
The MS3 spectra of some flavonoid derivatives differ significantly from 
the MS/MS spectra of their parent aglycons.  This phenomenon appears to be 
related to radical saccharide cleavage, which is in turn influenced by the 
glycosylation position, the nature of the conjugated saccharide and the structure of 
the aglycon portion of the molecule.  The explanation for why different 
compounds undergo more or less radical saccharide cleavage is still unknown, but 
molecular modeling is ongoing to help answer this question.  The practical 
implication of the observations presented in this chapter is that the aglycon 
portion of flavonoid derivatives that exhibit this behavior cannot be easily 
identified by performing sequential fragmentation and comparing the results to a 
library of MS/MS spectra obtained from native aglycons, a strategy that was 
heavily utilized in the applications described in previous chapters.  The 
compounds most likely to cause problems are the kaempferol 3-O-glycosides and 
the myricetin 3-O-glycosides.  To identify the aglycon portions of these 
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molecules, it may be necessary to compare the MS3 fragmentation to that of 
another 3-O-glycoside of that shares the same parent aglycon.  Vigilance is 
needed to avoid mistaken assignments, but as long as the exceptions are known, 
even these compounds may be identified with confidence. 
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Chapter 9: Conclusions 
 
This dissertation represents a body of work that aims toward and succeeds 
in expanding the utility of mass spectrometry to characterize monoglycosyl 
flavonoids and flavonoid metabolites.  The simplicity and the utility of the 
method have been proven in numerous practical applications, as described in 
earlier chapters.  As with any analytical technique, it is important to understand 
the capabilities, requirements and limitations of the method. 
The capabilities of the described methods should be sufficiently clear 
given the number of applications presented.  Specifically, metal complexation 
combined with tandem mass spectrometry provides a means to identify 
flavonoids, flavonoid glycosides and flavonoid glucuronides without resorting to 
more difficult techniques that require larger amounts of sample or authenticated 
standards.  Conjugated flavonoids are challenging compounds to fully identify 
because of many possible positions of conjugation.  The glycosyl portions of the 
molecules are often isomeric (such as glucose vs. galactose), and these structural 
features must also be determined to fully identify the analyte.  Mass spectrometry 
is a powerful analytical technique because mass is a highly specific chemical 
property.  But mass spectrometry may be less useful in applications involving 
several analytes of the same or similar masses.  It is not uncommon to find reports 
in the scientific literature of new mass spectrometric methods for resolving a 
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particular pair or set of isomers, such as the amino acids leucine and isoleucine.  
But there is so much variability in flavonoid structure that the ability to resolve 
specific isomers is not especially useful.  Thus the most important applications of 
the work described here are based not on the ability to differentiate specific 
isomers, but rather in the discovery of systematic indicators of particular 
structural features such that newly-encountered compounds may be characterized 
and identified with very little prior information necessary.  Methods were 
presented for determining the five most common glycosylation sites of 
monoglycosyl flavonoids (Chapter 3); differentiating isomeric sugars, particularly 
glucose and galactose, at the 3 position (Chapter 4); and determining 
glucuronidation sites of flavonoid metabolites (Chapter 6).  Each of these methods 
has been used to confidently identify molecules in food or biological samples, 
even in cases where standards were not available for comparative purposes.  
Some of these molecules have not been identified previously by any other 
method. 
The instrumentation required to perform these analyses is not particularly 
difficult to obtain.  First, a quadrupole ion trap mass spectrometer is required.  
Results have only been obtained on QIT mass spectrometers, and it is believed 
that this type of mass spectrometer is necessary to reproduce the data presented 
here.  The specific features that make the QIT a necessary tool are its low-energy 
CID processes and the availability of multiple-stage CID (MSn).  Many other 
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types of mass spectrometers implement CID with higher collision energies, so the 
results of such experiments are not directly comparable to those obtained on a 
QIT.  More importantly, MSn capabilities were absolutely essential to the success 
of the applications presented in this work.  Not only is it required for 
differentiating glucosides from galactosides (as described in Section 4.3.2), but it 
is also necessary to identify the aglycon portion of flavonoid conjugates.  
Targeted MSn is easily implemented on QIT mass spectrometers and comes as a 
standard feature on commercial instruments, whereas MSn is difficult or 
impossible in most other types of mass spectrometers.  The requirement of a QIT 
is not especially prohibitive.  Mass spectrometry continues to grow in popularity, 
and it can be found in many laboratories that deal extensively in the molecular 
sciences.  The QIT is one of the most cost-effective and robust types of mass 
spectrometers.  Commercial QITs are sold by several instrument manufacturers, 
so availability of this instrument is not a problem. 
The second instrumentation requirement is a gentle ionization source.  To 
date, the only ionization method that had been tested on the flavonoid/metal 
complexes described in this work is electrospray ionization.  ESI is one of the 
most widely-used ionization techniques for mass spectrometry and comes as a 
standard feature on many commercial instruments.  The important characteristic 
of ESI that makes it especially applicable to the current work is its ability to 
transfer analytes to the gas phase without depositing large amounts of energy that 
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could disrupt fragile non-covalent species such as flavonoid/metal complexes.  In 
fact, an attempt to analyze flavonoid/metal complexes using an ESI source known 
to be somewhat harsher than usual failed.  It may be possible that other soft 
ionization methods can be used to reproduce the results shown in this work. 
A third piece of instrumentation, less required than highly desirable, is an 
HPLC system that can be interfaced to the QIT mass spectrometer.  While all of 
the methods described can be implemented without chromatography, this would 
require isolation and purification of each flavonoid analyte.  It is far more 
efficient to forgo these steps and identify compounds in mixtures using HPLC 
with post-column complexation strategies.  The ease and speed of this approach 
make it far less work-intensive than standard NMR methods. 
Finally, a frank assessment of the limitations of the techniques presented 
here is warranted.  One must recall that only flavonoids of a few specific classes 
(flavonols, flavones and flavanones) can be analyzed by these methods.  
However, flavonols and flavones occur widely throughout the plant kingdom and 
are thus present in nearly all plant-based food products.  Flavanones occur less 
widely, but are especially abundant in citrus fruits, which are important 
commercial crops and contribute a significant portion of the flavonoids consumed 
in the human diet.  Hence while not all flavonoids can be characterized using the 
described methodology, those that can are among the most widespread and 
important members in terms of botanical and nutritional significance.   
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Many flavonoids researchers are interested in quantification, not just 
identification.  The metal complexation methods described here are not well-
suited for meeting this goal.  First, the formation of metal complexes involves a 
loss of sensitivity in the mass spectrometer of approximately two orders of 
magnitude.  Second, it would be difficult to obtain a standard curve that is linear 
over a wide range of concentrations.  When flavonoids and metal salts are mixed 
together, complexes of several different stoichiometries are formed.  This was 
pointed out in Section 3.3.1 and Section 4.3.1, but is true for all of the metal 
complexation work in this dissertation.  Varying the proportions of the flavonoids 
and the metal salts will shift the equilibrium ratios of the various complexes.  
Thus attempts to quantify flavonoid derivatives using metal complexation are not 
likely to be successful.  Quantification of uncomplexed flavonoid derivatives 
using mass spectrometry or LC-MS is a simpler and more sensitive approach. 
Another limitation lies in the fact that all identifications are based on 
analogy.  The metal complexation strategies are developed using a small training 
set of flavonoids containing particular structural features of interest.  Thus any 
compounds that contain unusual structural features (such as, for example, 8-O-
glycosylation) cannot yet be identified via this methodology.  At best, an 
incomprehensible fragmentation pattern will be obtained, signaling a breakdown 
in the method.  At worst, the fragmentation pattern will mimic that of another 
structural feature, and an incorrect identification will be made.  The potential for 
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this occurrence was realized in the case of galangin 5-O-glucuronide, recounted in 
Section 6.3.5.  The training set of flavonoid glucuronides did not contain any 5-O-
glucuronides, so it could not be anticipated that the relevant [Co(II) (FG-H) (4,7-
dpphen)2]+ complexes of flavonoid 5-O-glucuronides would fragment identically 
to the analogous flavonoid 3-O-glucuronide complexes.  The confidence of 
identification is therefore proportional to the size and diversity of the training set 
of flavonoids used to develop the method.  Additional confidence is gained as 
each method is successfully applied to new analytes.  For example, the manganese 
compexation method for differentiating flavonoid glucosides and galactosides was 
developed using a set of only two pairs of isomers (Section 4.3.2), but the 
subsequent identification of two more pairs of similar isomers using the same 
method (Section 5.3.4) lends credence to the efficacy and wider applicability of 
this type of metal complex. 
It is important to note that while some types of differentiation are still not 
possible, this is more a result of lacking sufficiently diverse molecules to create 
training sets than of failing to find metal complexes that systematically 
differentiate isomers.  It is significant that thus far a successful metal 
complexation mode has been found for every type of flavonoid isomer 
differentiation that has been attempted.  One may speculate that nearly any 
systematic structural determination of flavonoid derivatives can be made in this 
fashion, provided one has access to a training set of flavonoids containing the 
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structural features in question and a variety of metal ions and auxiliary ligands.  A 
particular discovery made this speculation more probable.  The metal complexes 
that provide five-way differentiation of glycosylation site always have the most 
trouble differentiating glycosylation at the 3-O and 4′-O positions because the 
diagnostic fragment ions that distinguish these two structural features are of very 
low abundance.  However, after the discovery of the [Co(II) (FG-H) (4,7-
dpphen)2]+ complexes for applications involving flavonoid glucuronides, the same 
complexes were tested on the monoglycosyl flavonoids.  As recounted in Section 
3.3.7, the same complex provides a robust way of determining 3-O-glycosylation.  
All of the complexes involving flavonoid 3-O-glucosides, 3-O-galactosides, 3-O-
rhamnosides, 3-O-xylosides and 3-O-arabinofuranosides yielded a prominent 
fragment ion that is completely lacking from complexes of flavonoid 7-O-
glycosides and 4′-O-glycosides.  This method may be employed if ever there is 
ambiguity between 3-O-glycosylation and 4′-O-glycosylation based on results 
from a different metal complex.  This research may then be thought of as a work 
in progress, as more metal complexes may be discovered in the future that will 
identify compounds that are currently indistinguishable. 
The impact of this work has already been significant.  The Sliphium 
albiflorum project (described in Section 5.3.4) provided a direct contrast between 
the metal complexation / tandem mass spectrometry methods used to identify the 
unknowns in an impure fraction and the traditional NMR methods used to identify 
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the remaining compounds.  Jeffrey Williams of the University of Texas at Austin 
Department of Biology explained that 1 kg of leaves had to be harvested in order 
to isolate enough of the flavonoid glycosides for NMR identification.  He said, 
only half-joking, that he was afraid of eradicating the species in his attempt to 
characterize it.  This is a particular concern as the habitat of Silphium albiflorum 
is limited to central and north-central Texas.  The isolation and purification steps 
required for NMR were difficult, tedious, and in the end, not completely 
successful.  The fraction that remained impure gave ambiguous NMR results.  In 
contrast, mass spectrometry made quick work of the sample.  A small scraping of 
the powdered fraction, approximately 0.1 mg, was all that was needed for the 
analysis.  Three of the four components were quickly identified, while the fourth, 
being less abundant in the sample, required slightly more material for a confident 
identification.  The chromatography did not need to be highly optimized, and in 
fact two of the compounds co-eluted, as shown in Figure 5.8.  The savings in time 
and effort afforded by the use of mass spectrometry instead of NMR was 
immediately obvious to all involved. 
The ability to characterize flavonoid glucuronides may be of even greater 
significance.  It is amazing how few in vivo or in vitro metabolism studies manage 
to provide complete identification of the metabolic products, despite great interest 
in obtaining this information.  This is a testament to the difficulties involved in 
using established methods to provide such information.  Already the metal 
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complexation technique has identified metabolites such as naringenin 4′-O-
glucuronide and hesperetin 3′-O-glucuronide that to knowledge have not 
previously been identified in human biological samples.  The broad applicability 
of the technique was demonstrated by the identification of seventeen products of 
an enzymatic incubation of an enzyme involved in flavonoid metabolism (Chapter 
7).  The elucidation of enzyme reactivity represents a significance step towards 
better understanding the metabolism and hence the bioactivity of dietary 
flavonoids.  It is hoped that future researchers will continue this important work 
and take advantage of these new methods to obtain vital structural information 
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